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Chapter 1
General inTroducTion
Introduction
The rational prescribing of medicines is an essential skill for physicians. Because most consultations 
end with doctors writing a prescription, it is essential that they can prescribe drugs effectively 
and safely. However, even though the importance of rational prescribing is recognized, medical 
students find the teaching and training they receive in pharmacotherapy unsatisfactory.1-3  Many 
medical students feel inadequately prepared for their prescribing responsibilities immediately 
after graduation,1;4-7 and several studies have concluded that the prescribing skills of medical 
students and junior doctors are often inadequate. 8-12
In the past 20 years, many initiatives have been taken to improve teaching in pharmacology, clinical 
pharmacology, and pharmacotherapy, with an emphasis on increasing the therapeutic knowledge 
and skills of medical students, often in the preclinical phase of training.13-15 However, in addition 
to knowledge and skills, future doctors also need to learn how to apply their knowledge and skills 
in practice, for example in role-playing sessions during the preclinical phase and with real patients 
during their internships, in order to improve their competence in rational prescribing.16;17  Many 
people have voiced concern about the current preparation of future doctors in a time when the 
prescribing of medication is ever more complicated.18;19  This concern has led to initiatives such as 
Prescribing Safety Assessments (PSA) in the UK18 and the Netherlands,16;20 and to the introduction 
of prescribing ‘crash courses’ for junior doctors, to prepare them last minute for daily work as a 
physician.21-24 It should, however, be the responsibility of every medical faculty, wherever in the 
world, to allot the complex task of prescribing medication sufficient time in both the preclinical 
and clinical phases of the curriculum in order to produce junior doctors who are able to prescribe 
safely, cost-consciously, and effectively. 
WHO Guide to Good Prescribing
The rational prescribing of medicines as defined by the WHO is “the situation in which 
patients receive medications appropriate to their clinical needs, in doses that meet their 
own individual requirements for a sufficient length of time, with the lowest cost to them and 
their community”.13 To promote the teaching of rational prescribing, the WHO published the 
Guide To Good Prescribing in 199413 and the Teachers Guide to Good prescribing in 2001.14 
These manuals provide medical students and medical teachers with a normative model (or 
structure) for therapeutic reasoning and prescribing, in the form of a six-step plan for rational 
prescribing (see table 1). 
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 Table  1 | World  Health  Organization  six-step  model  of  rational prescribing
 
Steps Description
Step 1 Define the patient’s problem
Step 2 Specify the therapeutic objective
Step 3a Choose your standard treatment (P-drug)
Step 3b Verify the suitability of your treatment (P-drug)
Step 4 Start the treatment
Step 5 Give information, instructions and warnings
Step 6 Monitor (and stop?) treatment
Several intervention studies have investigated the effects of various educational initiatives to 
improve the teaching of prescribing.25-34  A recent systematic review by Ross et al. showed that 
the WHO Guide to Good Prescribing is the only model that is widely used and which has been 
shown to improve prescribing.35  This was confirmed in the 2013 systematic review of educational 
interventions designed to improve prescribing competence, in which Kamarudin et al. stated that 
“the WHO Guide to Good Prescribing has the largest body of evidence supporting its use to improve 
prescribing competencies internationally”.36  A recent nationwide curriculum mapping study of 
teaching in prescribing for older patients in the Netherlands, initiated by the Expertise Centre 
Pharmacotherapy in Old Persons (EPHOR) and the working group Research in Education of the 
Dutch Society of Clinical Pharmacology and Biopharmacy (NVKF&B), revealed that all the medical 
faculties in the Netherlands use the WHO six-step plan as main teaching strategy to train rational 
prescribing.37  However, the WHO Guide To Good Prescribing was published in 1994 and it has never 
been updated or modified to meet the challenges of prescribing today. In the past 20 years, much 
has changed in health care (for example, the use of ICT, electronic patient records, etc) and, indeed, 
in medical education. It is time to see whether the WHO six-step method can be improved and to 
investigate whether the scope of this teaching method can be broadened. As the WHO six-step 
method has mainly been used to train undergraduate medical students in the preclinical phase of 
the medical curriculum,32;33;38 it might be interesting to investigate whether it can be used in daily 
prescribing practice by interns and registrars, for example, by incorporating elements of it into the 
medical record. This might help clarify the drug choices of students and their clinical teachers.     
Context learning (and expertise or expert development)
In the 1970s, context was recognized as playing an important role in learning, but then context was 
seen as the physical setting (e.g., class room) in which learning took place, which is a fairly simple 
and one-dimensional approach to the learning context.39;40
In 1998, Coles defined context learning as learning in a setting similar to that of the future 
profession. This approach increases the intrinsic motivation and willingness of students to 
invest in themselves and relies on four basic principles: setting, repetition, feedback, and 
responsibility for learning.41 Learning is an active process in which each student develops 
a particular knowledge network built on that student’s experience. This experience can be 
based on, for instance, fictional cases, patient demonstrations during lectures, or sitting next 
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to a specialist carrying out a consultation. In the early clinical experience concept, experiences 
should be real and legitimate in order to achieve optimal learning effects and engagement. 
Two reviews35;42 have shown there is a need for explorative studies on which to base the design 
of curricula with regard to teaching and training in the complex skill of prescribing. McLellan et al. 
suggested that the way forwards in teaching prescribing skills is to design interventions grounded 
in a real-life context.42 Medical students should be observed and evaluated in the context of the 
workplace. In order to develop an understanding of what works and under what conditions, we 
need to explore educational interventions that encourage the development of expertise.42 
Since 1998, the VU University Medical Center in Amsterdam has taught medical prescribing using 
a preclinical context-based pharmacotherapy education programme based on the WHO six-
step method.13;32;33;38 This three-year programme consists of weekly role-playing sessions in the 
form of consultations. The role-playing sessions consist of three phases, namely, consultation, 
argumentation, and feedback. Students alternately play the role of a ‘student doctor’, ‘student 
patient’, and  ‘student assessor’.32;33;38 
Vollebregt et al. found that this approach had a small but positive impact on the cognitive 
pharmacotherapeutic skills (namely, choice of drug therapy and the determination of patient 
information) of preclinical medical students directly after completion of the programme.32 
However, the long-term effect of this preclinical context-based pharmacotherapy programme 
remains to be established, and in particular its impact during the real-life context of internships.
Current prescribing training in clinical practice
The transition from medical student to junior doctor is often experienced as major and rather 
abrupt,43 particularly because of the sudden increase in responsibility, workload, and contact with 
other healthcare workers and patients.5 It is therefore not surprising that many studies report 
that junior doctors feel underprepared for their new prescribing responsibilities.1;4-7;9 Recently, 
Ashcroft et al. showed that junior doctors with 1 or 2 years in training were more than twice as 
likely as medical consultant to make prescribing errors.44 Their findings are in line with an error 
rate of up to 10.3% of all medication orders made by junior doctors, as described in the Equip 
study in 2009.9 The Equip study proposed mainly educational innovations, for example, regarding 
the transition from non-prescriber to prescriber, as a way to reduce the prescribing error rate.9;45 
This is consistent with the findings of a number of studies involving medical graduates that 
report that undergraduate education does not prepare graduates sufficiently for their prescribing 
responsibilities as junior doctors.1-3 
If we look at prescribing training, as currently taught in medical curricula, we can identify a 
number of reasons why junior doctors feel unprepared for their prescribing task. First, many 
clinical clerkships still place emphasis on establishing the diagnosis, with little time being devoted 
to therapeutic reasoning. Curriculum designers tend to assume that prescribing tasks are easy 
to learn and perform,45 and that medical students acquire their prescribing skills during regular 
clerkships,46 without being given actual and explicit training opportunities. For example, it is 
generally accepted practice for interns to watch other doctors prescribing, instead of getting 
opportunities to practise prescribing for real patients themselves. Celebi et al. showed that this 
13
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practice, of solely watching other doctors prescribing during clerkships, is not sufficient when 
it comes to the acquisition of reliable prescribing skills.46 Students are rarely presented with 
educational encounters that afford them the opportunity to practise the whole task of prescribing: 
meeting a patient, identifying a need for drug therapy, appropriately selecting a drug, completing 
a prescription, and being involved in the patient’s subsequent management.45 Recently, McLellan 
et al. performed a grounded theory study of how clerkship students learn to prescribe during 
clerkships, using audio diaries, interviews, and observations.45  One of their audio diary transcripts 
of a clerkship student perfectly illustrates the opportunities clinical teachers currently tend to 
overlook in teaching medical students during the clinical phase of the medical curriculum:   
‘‘So, while we were in an outpatient clinic I saw him [the resident] seeing a patient 
who had Bell’s palsy and he was going to prescribe him [the patient] a course of 
antivirals and steroids. At this point I thought, well, you know, it would be quite 
good for me to take this opportunity to get my prescribing competency signed 
off, which he agreed to (social space). However, it was a bit strange because I 
hadn’t really had a chance to speak to the patient and take a history, or do an 
examination. He told me what to prescribe and what doses to prescribe as well 
(process space) so, at no point did I ever really interact with prescribing. I was 
more of a secretary taking dictation from him, writing down what he said on the 
prescription sheet, which he said he’d be willing to sign off. It wasn’t at all like a real 
situation’’ (cognitive space). 45
Prescribing is a complex process that is often performed in a challenging, rapidly changing social 
environment and must therefore be practised as a complete task in an integrated and contextualized 
approach.42;47 McLellan et al concluded: “although students were motivated to learn to prescribe, 
opportunities to practice the whole, contextualised task of prescribing in advance of becoming a 
qualified doctor were limited. It is, therefore, unsurprising that the transition from non-prescriber 
to prescriber is a significant challenge, potentially resulting in clinical errors”.45 
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aims and ouTline of The Thesis
The main objective of the studies described in this thesis was to investigate and explore the possibilities 
of improving the rational prescribing of medical students within a context-based, pharmacotherapy 
learning programme based on the WHO six-step method. These studies focused mainly on the clinical 
phase of medical training (under- and postgraduate) and investigated two central components of the 
programme. Since these studies were based on the WHO six-step model, the logical order for improving 
the pharmacotherapy training programme would be to look at whether, why, what, and how the learning 
context influences the prescribing skills of interns. Another important feature of the WHO six-step model 
is that it provides structure to the therapeutic reasoning of students. There may be opportunities to offer 
students more structure in those parts of the WHO six-step method that they perceive as difficult, such 
as the setting of treatment goals and the recording of a treatment in the medical record.
To this end, three aims were formulated regarding the current situation in pharmacotherapy 
education, the learning context, and the structure of therapeutic reasoning. 
Aims part 1 (situation)
• To review the development of clinical pharmacology and therapeutics (CPT) education in the 
past 40–50 years, to describe what is currently known about general learning objectives in 
CPT and the therapeutic decision-making process of medical students and physicians, and to 
present context learning as an effective way to teach rational prescribing.
• In order to gain insight into the therapeutic decision-making process of inexperienced 
and experienced prescribers, we investigated whether there are differences in the factors 
contributing to the drug choices of final-year medical students and their teachers (general 
practitioners and clinical specialists).
Aims part 2 (context)
• To study the long-term effect of a preclinical context-based pharmacotherapy learning programme 
on the rational prescribing competence of medical students during clinical clerkships.
• To explore the effect of different levels of realism of the learning context on the prescribing 
competence of medical students during clinical clerkships.
• To determine the feasibility of incorporating structured therapeutic consultations with real 
patients in the clinical clerkship internal medicine.
Aims part 3 (structure)
• To study the effect of further structuring of one of the steps of the WHO six-step method 
(treatment goal) on the prescribing skills of medical students.
• To gain insight into the extent to which medical records are structured for therapeutic 
information in teaching hospitals in the Netherlands, and to determine which therapeutic 
data registrars and clinical consultants consider should be recorded in the medical record and 
to what extent registrars record this information themselves.
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Outline of the thesis
This thesis is divided into three main parts. In the first part, the ‘situation’, we describe the current 
international problem of the lack of rational prescribing skills in future doctors (chapter 2), and 
the possible causes for this (chapter 3). In the second and third parts, ‘context’ and ‘structuring’, 
respectively, we describe opportunities for improving the teaching of rational prescribing skills for 
future doctors. In part two, we looked at two aspects of the context in which rational prescribing 
skills are taught. First, the long-term effect of preclinical context-based pharmacotherapy education 
during internships is described (chapter 4), and then the ideal context for further training during 
internships (chapter 5). 
During internships, interns see lots of patients in hospital, and in particular in the context of the 
diagnostic process. However, it is not known whether this ideal form of context, i.e. practising in the 
future professional situation with real patients, is best way of training interns in pharmacotherapy. 
Until now, it is not common practice to train medical students in pharmacotherapy in daily real-
life practice. Therefore we investigated the feasibility of incorporating structured therapeutic 
consultations with real patients into the internal medicine clinical clerkship (chapter 6). We also 
investigated whether students are able to draw up treatment plans and carry out therapeutic 
consultations with real patients without compromising patient care, and whether students and 
their clinical supervisors consider this new form of context-based pharmacotherapy training 
workable and useful.
In part three, we investigated the potential of ‘structuring’ information for improving training in 
rational prescribing. First, we studied the effect of further structuring of one of the steps in the 
WHO six-step method, namely, treatment goal setting (chapter 7). According to the WHO Guide 
to Good Prescribing, setting treatment goals is an essential step in the six-step process of rational 
prescribing;13 however, medical students find this step difficult to perform in practice.
The pharmacotherapeutic training of our future doctors obviously does not stop after the 
preclinical phase of the medical curriculum and should be a structural part of their clinical training. 
The medical record has an important function in both daily clinical practice and clinical training. 
Structuring the diagnostic section of the medical record improves diagnosis and communication 
between doctors. However, little is known about the therapeutic section of the medical record. 
The aim of the study described in chapter 8 was to gain insight into the extent to which therapeutic 
information is structured in medical records, to determine which therapeutic data registrars 
and clinical consultants consider should be recorded in the medical record, and to what extent 
registrars record this information themselves. This multicentre observational study was a first 
step to discussing whether it is necessary to structure the therapeutic information recorded in a 
medical record, bearing in mind that a structured therapeutic section could also play an important 
role in the clinical training of medical students and in the postgraduate education of registrars, 
especially in the field of prescribing.
As the chapters of this thesis have been published as individual journal articles, some repetition 
and overlap of information across chapters is inevitable.
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Chapter 2
absTracT
Background 
The rational prescribing of drugs is an essential skill of medical doctors. Clinical pharmacologists 
play an important role in the development of these skills by teaching clinical pharmacology and 
therapeutics (CP&T) to undergraduate medical students. Although the approaches to teaching 
CP&T have undergone many changes over the last decennia, it is essential that the actual teaching 
of CP&T continues to be a major part of the undergraduate medical curriculum.
Objectives 
The learning objectives of CP&T teaching in terms of developing the therapeutic competencies of 
undergraduate medical students are described, with an emphasis on therapeutic decision-making. 
On the basis of current theories of cognitive psychology and medical education, context-learning 
is presented as an effective approach by which to achieve therapeutic competencies. An example 
of a CP&T curriculum is presented.
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inTroducTion
The field of modern clinical pharmacology began to develop in the second half of the 19th century 
when physicians began to realise that agents such as heavy metals and plant extracts, then in use, 
more often made diseases worse instead of better.1 In 1969, a study group on clinical pharmacology 
was convened by the World Health Organisation (WHO) in order to demarcate the scope of this 
relatively new discipline.2 They concluded that the tasks of the clinical pharmacologist include: (1) 
research into the action of drugs in humans, (2) services such as providing information on drugs 
and (3) teaching clinical pharmacology and therapeutics (CP&T) to medical students, hospital staff 
and physicians.2 While both research and services are important areas of clinical pharmacology, 
it is in their roles as teachers of CP&T to medical students that clinical pharmacologists have 
an extremely important effect on the development of rational prescribing by medical doctors. 
However, despite this importance, the undergraduate teaching of CP&T has not, in contrast to the 
two other functions of the clinical pharmacologist, achieved an international level of recognition.3, 
4 The lesser attention given to teaching CP&T is also reflected in the small number of scientific 
publications. For example, only about 20 articles on teaching CP&T were published in the European 
Journal of Clinical Pharmacology between 1980 and 2000. In many medical schools, undergraduate 
students learn little about the therapeutic use of drugs and even after graduation, some doctors 
read little on the subject and rely too much on the promotional efforts and information from 
the pharmaceutical industry. As indicated by a survey conducted under the auspices of the 
WHO in 1989, in European medical schools, an average of only 28 h was devoted to teaching 
clinical pharmacology, even though over 100 h were devoted to pharmacology.5, 6 However, the 
number of hours spent teaching CP&T is probably underestimated since clinical pharmacology 
and particularly therapeutics are taught implicitly during the clinical clerkships. The European 
Association of Clinical Pharmacology and Therapeutics (EACPT) was founded in 1993 to promote 
the field of CP&T. One of the important objectives of the EACPT was to develop CP&T in Europe 
by improving and harmonising the teaching of the rational use of drugs at the undergraduate and 
postgraduate levels. An Education Subcommittee of the EACPT was subsequently established in 
1997 to increase the amount of attention given to as well as the quality of teaching CP&T. The 
first task of this subcommittee was to identify the educational requirements of medical students 
in terms of CP&T. A positive consequence of the expanded attention for the teaching of CP&T has 
been the substantial increase of scientific publications on teaching CP&T during the past decade: 
there have been about 32 articles published between 2000 and 2007 in the European Journal of 
Clinical Pharmacology, which is twice as many as during the preceding two decades.
Unfortunately, despite the increasing amount of attention being given to the teaching of CP&T, 
CP&T educational programmes are still not optimal in many medical schools[7]. Nowadays, many 
graduates still feel insufficiently prepared to assume prescription responsibilities after graduation.7 
Therefore, it is important to improve the undergraduate teaching in CP&T.
In this review, we shall endeavour to indicate the essential aspects of teaching CP&T to undergraduate 
medical students. To this end, we first describe what is known about the general learning objectives 
in CP&T that medical students should master before graduation. Subsequently, we focus on an 
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essential (in our opinion) core learning objective: ‘therapeutic decision-making’. We go on to describe 
how medical students and physicians arrive at a therapeutic decision and discuss the possibilities 
of teaching medical students rational pharmacotherapy. Finally, we recommend approaches for 
organising, presenting and assessing CP&T in  the undergraduate medical curriculum.
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from core learninG objecTives To compeTencies
In many curricula, the teaching in clinical disciplines is centred on symptoms and diagnosis, 
and little or no time is given to the principles of drug treatment. In the past, CP&T was only 
taught as short courses in medical schools in which information was presented in the form of 
dogmatic indications of which drug to use and when. In some medical schools, however, clinical 
pharmacologists participated in basic pharmacology courses, usually given early in the clinical part 
of the curriculum.4 Notwithstanding, much of the postgraduate and continuing education of the 
practicing physician has been left to the persuasive methods of the pharmaceutical industry.1 It 
was only in 1989 that the Council for Medical Student Education in Clinical Pharmacology and 
Therapeutics stressed the importance of defining a core curriculum for clinical pharmacology 
in the medical curriculum. One year later, Nierenberg developed a core curriculum for medical 
students in CP&T.9 Based on consensus between 40 clinical pharmacology teachers, Nierenberg 
formulated a list of core knowledge, skills and attitudes that every medical student should master 
before graduation in order to be able to prescribe effectively and safely.8, 9 Core knowledge in 
clinical pharmacology deals with the facts that are necessary to make rational and optimal 
therapeutic plans; it includes the principles needed to organise these facts into useful information 
and to recognize when essential facts are missing.5, 8 Core skills are in many ways similar to core 
knowledge because knowledge must be learned and used as the medical student develops skill 
in practicing rational therapeutics. Core attitudes include attitudes about what constitutes valid 
information, what kind of information is likely to be in error and what new information must be 
continuously acquired from reliable sources.
Based on the learning objectives as formulated by Nierenberg, a questionnaire on core learning 
objectives was subsequently developed in the United Kingdom by Walley.10 Senior academic 
clinical pharmacologists who were active in teaching CP&T in the UK or Ireland assessed the 
relative importance of each learning objective as an element of a core curriculum. This resulted 
in a list of core knowledge, skills and attitudes11 that largely matched the learning objectives as 
formulated by Nierenberg.8 In addition to the approach of Nierenberg and Walley to defining the 
core curriculum in CP&T, Orme described two other approaches to developing a core curriculum 
for CP&T.12 First, based on the WHO concept of an ‘essential drug list‘, he developed two lists of 
drugs; one list consisted of approximately 120 essential drugs that students would be expected to 
know in detail, and a shorter list consisted of drugs that students would be expected to be familiar 
with but were not required to know in any detail. This list of essential drugs was then examined 
by the Education Subcommittee of the EACPT. The second approach to defining a core curriculum 
for CP&T was the disease-based approach. Three types of disease process were defined: (1) 67 
diseases that were common and that the student must know how to manage; (2) 158 diseases 
that were less common but that students must be able to diagnose, after which the appropriate 
therapy could be found in the literature; (3) 36 diseases that were rare but that students should 
be aware of. Defining a core curriculum for CP&T as presented by Nierenberg, Walley and Orme 
is important to defining the shape and boundary of the discipline and may be helpful as part 
of a medical student’s examination. However, in addition to knowledge, physicians must also 
have prescribing skills in order to prescribe rationally. Therefore, the WHO Action Programme 
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on Essential Drugs has developed, in collaboration with the University of Groningen, a manual 
for undergraduate medical students on the principles of rational prescribing, the so-called Guide 
to Good Prescribing (GGP). This manual provides a normative model for therapeutic reasoning 
and prescribing and provides a six-step guide to the process of rational prescribing that will be 
necessary throughout the clinical career of the medical student (Table 1). All six steps are based 
on the core learning objectives, knowledge, skills and attitudes as formulated by Nierenberg and 
Walley and on positive experience in the Netherlands.13, 14 In addition, the content is based on an 
observational study among general practitioners and clinicians in the Netherlands and on 10 years 
of experience with pharmacotherapy courses for medical students in Dutch medical faculties and 
abroad. The GGP has also been reviewed and examined by a large body of international experts in 
the teaching of pharmacotherapy. As reported by De Vries et al., a short interactive training course 
in pharmacotherapy, using the GGP, was evaluated in a controlled study among 219 undergraduate 
international medical students.15  This study indicated that undergraduate students who used the 
GGP performed significantly better than students who did not used the GGP. In addition, students 
not only remembered how to solve old problems, but they could also apply their skills to new 
problems, a so-called transfer effect.
A new framework for the innovation of medical curricula has been recently introduced, called the 
Can- MEDS. The CanMEDS framework describes aspects of competence related to seven roles 
of a clinical specialist: the role of Medical Expert, Communicator, Health Advocate, Collaborator, 
Manager, Scholar and Professional.16  Despite the fact that many doctors agree with the importance 
of these aspects of competence and that many countries have already adopted the CanMEDS roles 
in their curricula, there is limited information on how these roles can be applied in an international 
context and in different specialities, such as CP&T. Therefore, before clinical pharmacology as a 
discipline can adopt the CanMEDS competencies, the core learning objectives as determined in 
the last decades will have to be translated into the CanMEDS competencies.
In conclusion, in order to improve the competency of future doctors to prescribe effectively and 
safely, several clinical pharmacologists have attempted to determine what every medical student 
should master before graduation. A common feature of all of the competencies formulated is that all 
students must acquire a knowledge of the clinical pharmacology of essential drugs and diseases and 
must master prescribing skills in order to become competent in the rational prescription of drugs.
Table 1 | WHO 6-steps model of rational prescribing 18
Step 1 Define the patient’s problem
Step 2 Specify the therapeutic objective
Step 3a Choose your standard treatment (P-drug)
Step 3b Verify the suitability of your treatment (P-drug)
Step 4 Start the treatment
Step 5 Give information, instructions and warnings
Step 6 Monitor (and stop?) treatment
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THerAPeuTIC DeCISIOn-MAkInG
Although, as described previously, there are many essential therapeutic skills, the final choice of 
a (drug) treatment for a patient can be looked upon as a core skill in therapeutics. In order to find 
effective ways to teach our future doctors, it is important to explore how expert doctors arrive at 
this final therapeutic decision.
Therapeutic decision-making or therapeutic reasoning is, together with diagnostic reasoning, an 
important part of the process of clinical reasoning. Therapeutic reasoning can be defined as the 
step in clinical reasoning that pertains to the choice of therapy. 17 However, in contrast to the 
process of diagnostic reasoning, which has been investigated extensively, little is known about the 
process of therapeutic reasoning. To our knowledge, the first attempt to investigate therapeutic 
reasoning in real practice was a small observational study carried out in 1984 in the Netherlands. 
The results of this unpublished study constituted the basis for the development of the WHO six-
step model.18 Over 500 patient consultations by 25 general practitioners and 25 clinical specialists 
were observed and recorded. In addition, all doctors were interviewed about their therapeutic 
reasoning. Based on this study, it became evident that doctors generally based their choice of 
(drug) treatment on two steps: (1) doctors initially used treatment guidelines or drug formularies 
as a starting point; (2) this was followed by a verification of the suitability of this treatment for the 
individual patient and a modification of the choice of treatment if necessary (for example, in case 
of co-morbidity or co-medication). Moreover, it was also observed that the more experienced 
physicians knew more standard treatments by heart compared to less experienced physicians.
The first study that described the process of how therapeutic decisions are made in practice in 
greater detail was performed by Denig.19  By interviewing 169 different general practitioners 
and 72 hospital physicians, she studied how doctors arrive at a choice of drug and what factors 
influence this drug choice.19, 20 This study indicated that when a doctor is confronted with a 
diagnosis – for example, a patient with both essential hypertension and a renal disorder – he or she 
immediately thinks of a number of pharmacotherapeutic possibilities, referred to as the ‘evoked 
set’. Depending on the diagnosis, the ‘evoked set’ consists of 1.7–5 different pharmacotherapeutic 
options that are influenced by many factors, such as refresher courses, the literature, experience 
and advertisements from the pharmaceutical industry. The ultimate choice out of the ‘evoked 
set’ for an individual patient may be either ‘unreasoned’ (routine) or ‘reasoned’ (evaluation of 
the different options). However, how the final choice of treatment is made is still unknown. In 
contrast to the scarcity of information available on therapeutic decision-making, much research 
has been done on diagnostic reasoning. When an experienced doctor is confronted with a patient 
with certain symptoms and signs, so-called illness scripts are called up from memory. Illness 
scripts contain clinically relevant information on diseases, their consequences, the context in 
which diseases develop, including the personal circumstances, and the experience of the doctor 
with previous patients. These scripts are generated by the frequent solving of diagnostic clinical 
problems.21, 22 Based on recognition, experienced doctors are able to choose the right script for 
solving a specific diagnostic problem efficiently, particularly in routine cases.23 In order to verify 
whether this is the right script for the individual patient, two types of diagnostic reasoning may be 
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used – analytical and non-analytical. Analytical reasoning is characterised as a slow and relatively 
time-consuming process that is carried out consciously and systematically and, if possible, 
evidence-based. Less or inexperienced doctors, such as medical students, mostly use this type of 
reasoning, mainly because they do not possess the ability to call up so-called ‘illness scripts’. In 
contrast to analytical reasoning, non-analytical reasoning is carried out rapidly and subconsciously 
and is based on experience and pattern recognition. This type of reasoning is used especially by 
experienced doctors. However, when an experienced doctor is confronted with a complex patient 
case, he or she will also use analytical reasoning.
Based on the similarities between therapeutic and diagnostic reasoning, it is possible to construct 
a hypothetical model of therapeutic reasoning (Fig. 1).24 When the diagnosis has been determined, 
one or more treatment scripts will be called up from the memory. In order to determine the 
right treatment, an analytical or nonanalytical process, or a combination of both, will start. This 
process is similar to the process of diagnostic reasoning. The chosen treatment and its effect will 
contribute to the modification of the existing treatment scripts or may result in a new treatment 
script. However, in order to validate this hypothetical model, further research should be performed, 
particularly in terms of how experienced doctors arrive at their choice of treatment. In addition, 
we need to find out how these experienced doctors differ from less-experienced doctors, such 
as medical students and interns. The answers to these questions will provide more insight into 
how we should teach therapeutics to students although it can already be stated that early clinical 
practice will support the development of treatment scripts by undergraduate medical students.
Analytic
slow, conscious, 
systematic, evidence 
based, novice
Non-analytic
fast, unconscious, 
heuristic, experience 
based, expert
Diagnosis Treatment
Therapie scriptTreatment script
Figure 1 | Hypothetical model of therapeutic reasoning.24 
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how To Teach and learn TherapeuTics
Gaining knowledge and at the same time applying this knowledge in practice is essential for learning 
in general and, presumably, also for the development of treatment scripts by medical students. This 
so-called context-learning seems to be more effective in many ways than sequential learning, in 
which learning and applying knowledge is separated.22, 25,26 The positive effect can be explained by 
theories from cognitive psychology and medical problem-solving.22, 26–28 These theories suggest that 
the way in which knowledge is stored in the brain is essential for its recall and application. Therefore, 
storing pharmacotherapeutic knowledge in combination with the situation in which this knowledge 
will be applied benefits the speed and quality with which the information is recalled.21, 22, 29
Context-learning is defined as learning in a setting that is similar to the setting of the future 
profession.30 Context-learning is based on four basic principles: setting, repetition, feedback and 
responsibility.30 The setting in which therapeutics is taught or learned should be the same as or as 
similar as possible to the setting of the future profession; for medical students, this is the clinical 
setting, such as in primary health care, hospitals or nursing homes. This clinical setting gives students 
the opportunity to gain experience the same way doctors do, allowing them to generate networks of 
organised knowledge in their memory and to develop illness and treatment scripts.31 Subsequently, 
students should be given the opportunity to repeat the therapeutic problem-solving process as 
much as possible. Repetition allows students to generate networks of organised knowledge in the 
brain. Frequent exposure to patients and pharmacotherapeutic problems gradually condense these 
networks into readily accessible therapeutic scripts. Furthermore, students should also receive 
feedback immediately after their performance to assure the condensation of correct therapeutic 
scripts. Argumentation and motivational feedback may be a rapid way to reveal the process of 
therapeutic thinking and its possible errors. Finally, students should be responsible for their own 
learning. It is the student’s own responsibility to repair any lack of knowledge or skills discovered 
during their clinical work and feedback sessions. Apart from the most extreme form of context-
learning, which is the clinical setting, different variations with lower levels of concreteness of the 
context are possible, varying from role-playing sessions with standardised patients in a simulated 
practice setting to the solution of written patient problems in small working groups and patient 
demonstrations during lectures. However, there are many ways to improve the setting, such as by 
using real case histories instead of written patient problems or through the use of video materials, 
laboratory test results or roentgenograms. One possible approach to organising a context-learning 
programme in therapeutics is described by Vollebregt et al.32 These authors described a context-
learning programme consisting of weekly-organized, role-playing sessions in the form of consulting 
hours. The role-playing sessions consist of three phases: consultation, argumentation and feedback. 
First, a ‘student’ doctor must carry out three therapeutic consultations of 10 min each. Before the 
start of a consultation, the doctors are given a written patient case. Subsequently, the ‘student’ 
patient and ‘student’ assessor enter the consultation room, and the doctor has to choose and 
prescribe the (drug) treatment interactively with the patient. The second phase (argumentation) 
starts immediately after the consultations. In this phase, the doctor has to substantiate the chosen 
therapy. Finally, during the third phase, all students sit together and discuss the various (drug) 
treatments and the performance of the doctors, guided by a clinical pharmacologist.
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In addition to teaching therapeutics, assessing students’ therapeutic knowledge and skills is an 
essential component of the medical curriculum. In 1990, Miller suggested a framework for clinical 
assessment (Fig. 2).33 According to this framework, students, residents or physicians must have 
knowledge in order to carry out the required professional functions effectively. Students must also 
know how to use the knowledge that they have accumulated. For example, they must develop the 
skill that is needed to acquire information from a variety of human and laboratory sources, to analyse 
and interpret data and, finally, to translate such findings into a rational diagnostic or therapeutic plan. 
When this quality is functionally adequate, it is defined as a competence. Furthermore, students 
must not only be able to demonstrate that they know and know how, but also to show how they do it 
when confronted with a patient, which is called performance. Finally, it is important what a graduate 
actually does when functioning independently in clinical practice. According to Miller, this action 
component of professional behaviour is the most difficult to measure.
Figure 2 | ‘Pyramid’ by Miller as an illustrative framework for discussing the assessment of clinical skills, 
competence and performance.33
The Objective Structured Clinical Examination (OSCE) and structured clinical examinations in 
general are well known and approved methods for assessing competence and performance.34 As 
far as the OSCE is concerned, this has also been shown to be useful for assessing therapeutic 
competence. Nevertheless, it is important that the manner in which the students are assessed is 
as similar as possible to the approach used in teaching them.
In conclusion, based on theories as to how physicians arrive at their therapeutic decisions, context-
learning seems to be an effective way to teach CP&T to medical students. It is obvious that the 
ideal situation, i.e. real practice with real patients, is not always attainable, but various suboptimal 
forms of context-learning and assessment can be applied.
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conclusions and recommendaTions 
In this document, the learning objectives of teaching CP&T to undergraduate medical students 
have been described, with an emphasis on therapeutic decision-making. Based on current theories 
of cognitive psychology and medical education, we have also discussed context-learning as an 
effective approach to teaching medical students how to prescribe rationally.
Until recently, there were only two groups of people who were permitted to prescribe drugs – 
registered medical practitioners and registered dental practitioners. Since 2006, some nurses, 
pharmacists and physician assistants have also been able to prescribe drugs for medical conditions 
within their area of competence.35 Consequently, given this increasing number of registered 
prescribers with different qualifications, it has become increasingly important to train prescribers 
sufficiently in how to choose and prescribe drugs rationally. In addition, most curricula are 
changing from discipline- and subject-based teaching to competence and integrated or problem-
based learning, resulting in less visibility of CP&T. The importance of teaching CP&T is further 
supported by the fact that many graduates still feel insufficiently prepared to assume prescribing 
responsibilities after graduation.7 Furthermore, many hospital admissions and even deaths 
are caused by possibly avoidable medication errors.36 Clinical pharmacologists should play an 
important role in the development of prescribing skills by teaching CP&T to undergraduate medical 
students. It is recommended that they formulate a CP&T context-learning curriculum within the 
medical curriculum – of course, in collaboration with physicians. This curriculum must be based 
on the final learning objectives of the CP&T education programme in which the required level of 
therapeutic competence of medical graduates has been determined. In addition, the curriculum 
must fulfill the criteria of context-learning, i.e. gaining knowledge and skills simultaneously in a 
(simulated) clinical practice setting. Furthermore, for the sake of clarity, it is stressed that the CP&T 
curriculum should be a visible part of the medical curriculum and that students must know, from 
the beginning, the required level of competence when they graduate. Current medical students 
often do not recognise the various CP&T teaching activities since they are scattered through the 
medical curriculum.
Figure 3 | A design of a clinical pharmacology and therapeutics (CP&T) context-learning curriculum (adapted 
from HJM van Rossum)
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A draft of a CP&T context-learning curriculum is presented in Fig. 3. At the start of the curriculum, 
the emphasis lies on gaining CP&T knowledge and simultaneously learning to apply this knowledge 
by training skills in therapeutics. During this phase, little attention is given to the prescription of 
drugs in clinical practice. In the following study years, as CP&T knowledge and therapeutic skills 
increase, increased emphasis is given to prescribing in
clinical practice, while the acquisition of knowledge and skills diminish. An example of a more 
specific CP&T curriculum is presented in Box 1.
In conclusion, effective undergraduate teaching of CP&T is essential to improve rational prescribing 
and will immunize students against factors that may induce irrational prescribing after graduation. 
Therefore, based on current knowledge about learning, cognitive psychology and research in 
therapeutic teaching, a CP&T curriculum should be a prominent part of the medical curriculum. 
The CP&T curriculum should also be linked to postgraduate and continuing education in order 
to maintain an optimal competence in rational prescribing after graduating. Finally, to achieve a 
CP&T curriculum, allies should be found because clinical pharmacologists can and should not work 
on this alone. Medical students are already allies; they are interested in clinical pharmacology 
and really want to learn how to prescribe drugs rationally. Physicians should also become allies, 
since they can provide the clinical context for teaching and can prevent students from copying 
the bad prescribing habits of some of the physicians that train medical students. Associate 
clinical pharmacologists must collectively determine the current state and perspectives of the 
undergraduate education of CP&T in Europe. To this end, a European research project, which is 
organised jointly by the EACPT and British Pharmacological Society, has recently been started. 
Ultimately, clinical pharmacologists, students and physicians collectively may be able to convince 
the policy-makers, such as the faculty boards, of the need for a CP&Tcurriculum. Such a joint effort 
is truly necessary because, unfortunately,
the following words, spoken by Miller in 1990, are, to a great extent, still valid: 
“It will not be easy to convince conservative medical faculties, reasonably 
comfortable with the current conventions that allow clinical impressions to 
substitute for systematic accumulation of behavioural evidence, that change (in 
teaching, ed.) is in order”.
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BOx 1. IlluSTrATIOn OF A CP&T CurrICuluM
Figure 4 | Outline of a CP&T curriculum. 
Figure 4 shows the different learning activities and their mutual relations. The horizontal lines 
represent the three learning components: knowledge [upper line: basic pharmacology, clinical 
pharmacology, therapeutics (1) and therapeutics (2), clinical practice (middle line: video patients, 
patient demonstrations, observation of consultations and prescribing drugs) and skills [lower line: 
prescription, drug formulary, prescribing (6-steps) and CP&T literature]. The vertical lines describe 
the simultaneous use of these three components in order to realise a context-learning curriculum.
Let us use the example of a clinical pharmacology department that provides a course of lectures 
in basic and clinical pharmacology during the first three years of a classical medical curriculum. 
The aim of the department is to expand its teaching activities and use the context-learning 
methodology as much as possible. Therefore, the lectures in basic and clinical pharmacology must 
be transformed according to the criteria of context-learning, i.e. by adding patient cases (clinical 
practice) and prescription writing (skills). For example, the lecture about ‘P-450-dependent 
oxidation’ is placed into the clinical context by presenting a video of a patient case illustrating 
a drug interaction as the result of a wrong drug choice (WHO step 3b). The lecture concludes 
by discussing the patient case according to the six-step approach, including how to write a new 
prescription.18 The clinical pharmacology lectures in the second and third year can be transformed 
in a similar way by presenting real patients, followed by lectures on different classes of drugs. 
Simultaneously with the clinical pharmacology lectures, students must develop a personal drug 
formulary by, for example, using an E-learning programme.3 In the fourth year, students start on 
their clinical clerkships. In collaboration with their clinical colleagues, the clinical pharmacology 
department introduces a therapeutic assignment during these clerkships. Students must observe 
several consultations by clinicians in a structured way according to the WHO six-step approach 
and discuss these in small groups during therapeutic sessions with a clinical pharmacologist and/
or physician. Concurrently, students must follow a skills training programme in order to learn 
how to prescribe rationally (six steps). During the clinical clerkships in the fifth and sixth years, 
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prescriptions written by the students are evaluated by a clinical pharmacologist in collaboration 
with a physician and pharmacist during therapeutic sessions. Finally, students must attend a 
course on how to evaluate CP&T literature and how they must apply this knowledge in practice.
It is evident that in an integrated or problem-based medical curriculum it will be difficult to organise 
lectures. However, an advantage of this type of curriculum is that teaching is already centred on 
patient cases. As a result, clinical pharmacologists can introduce learning tasks with respect to 
basic and clinical pharmacology and therapeutics. In such a curriculum, it will probably be easier to 
train students in the six-step approach in small group-teaching sessions and practice prescribing in 
a clinical setting. Obviously, there are various possibilities for context-learning teaching activities, 
and the above-mentioned are just a few examples of these. More detailed information on how 
to determine learning objectives for therapeutics and on methods for teaching and assessing 
therapeutics can be found in the WHO Teacher’s Guide to Good Prescribing.37 In addition, this 
guide also provides information on how to mobilise support for changing and implementing a 
CP&T curriculum and how to perform research in this field.
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Chapter 3
absTracT
Purpose
Although the importance of rational prescribing is generally accepted, the teaching of 
pharmacotherapy to undergraduate medical students is still unsatisfactory. Because clinical 
teachers are an important role model for medical students, it is of interest to know whether 
this extends to therapeutic decision-making. The aim of this study was to find out which factors 
contribute to the drug choices made by medical students and their teachers (general practitioners 
and clinical specialists).
Methods 
Final-year medical students (n=32) and medical teachers general practitioners (n=29), lung 
specialists (n=26), orthopaedic surgeons (n= 24), and internists (n=24)] from all eight medical 
schools in the Netherlands participated in the study. They were asked to prescribe a treatment 
(drug or otherwise) for uncomplicated (A) and complicated (B) written patient cases and to 
indicate which factors influenced their choice of treatment, using a list of factors reported in the 
literature to influence drug prescribing.
results 
Final-year medical students primarily based  their drug choice on the factors ‘effectiveness of the 
drugs’ and ‘examples from medical teachers’. In contrast, clinical teachers primarily  based their 
drug choice on the factors ‘clinical experience’, ‘effectiveness of the drugs’, ‘side effects of the 
drugs’, ‘standard treatment guidelines’, and ‘scientific literature’.
Conclusions 
Medical teachers would appear to base their drug choice mainly on clinical experience and drug-
related factors, whereas final-year medical students base their drug choice mainly on examples 
provided by their medical teachers. It is essential that medical teachers clearly explain to their 
students how they arrive at a specific choice of medication since medical students tend to copy the 
therapeutic drug choices from their teachers, mainly because of a lack of experience. Presenting 
students with clinical therapeutic problems early during undergraduate training will not only give 
them a chance to gain experience in solving medical problems but will also give meaning to what 
they are studying as opposed to merely reproducing what they learn or copying what they are told.
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inTroducTion 
Unlike diagnostic reasoning ,1, 2 little is known about therapeutic reasoning, the process by which 
doctors make a choice of treatment.3 This part of the consultation is often regarded simply as a 
matter of knowing which drug to prescribe for a certain condition rather than as a reasoned choice.4 
Experienced doctors rely on their knowledge when prescribing drugs for common ailments,4, 5 often 
having two to five potential drug and non-drug treatments for the disease or symptom(s) in  their 
mental ‘standard treatment guideline’. They make their choice of these options heuristically.6 This 
means that doctors may not be conscious of the assumed value judgement and logic underlying 
their therapeutic decision. In turn, this lack of awareness may make it difficult for medical teachers 
to explain to medical students how they arrive at a certain therapeutic choice. In addition, teaching 
in clinical disciplines tends to be focussed on symptoms and making an appropriate diagnosis, and 
relatively little  attention is paid to the principles of drug treatment or pharmacotherapy.3 This may 
explain in part why many graduates feel under-prepared to take on prescribing responsibilities 
after graduation. 7 
In order to gain insight into the therapeutic decision-making process, we investigated whether 
there are differences in the factors contributing to the drug choices of final-year medical students 
and their teachers (general practitioners and clinical specialists).
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maTerials and meThods
Final-year medical students and medical teachers in four clinical specialities (General Practice, 
Pulmonology, Orthopaedics, and Internal Medicine) from all eight medical schools in the 
Netherlands  participated in this study. The heads of the above-mentioned departments were 
asked to select five specialists to participate and in addition the heads of the departments of 
general practice were asked to select randomly eight final-year medical students (because general 
practice medicine is the last  clerkship before graduation).
Three clinical patient cases (bronchial asthma, osteoarthritis, and essential hypertension) with 
two levels of complexity (A and B) were developed in consultation with clinical specialists and 
clinical pharmacologists from the VU University Medical Center in Amsterdam, the Netherlands 
(Table 1).  A was an uncomplicated case, whereas B was a more complicated version of A involving 
comorbidity and comedication. The participants recorded their choice of drug and/or non-drug 
treatment on a form. The pulmonology, orthopaedics, and internal medicine specialists completed 
the patient cases for their own specialism only, whereas the general practitioners and the final-
year medical students completed all three patient cases.
After the participants had made their treatment choice, they were given a list of drug choice-
related factors (Table 3, left column) that are mentioned in the literature as contributing to 
therapeutic decision-making. 5, 6, 8-11  The participants were asked to indicate to what extent each 
of the 14 factors had contributed to the choice of  treatment for each patient case (0= to no extent 
at all, 1= to some extent, 2= to a considerable extent, 3= to a decisive extent) (Table 3). 
Data collection and statistical analysis
The generic names of drugs were used and prescribed drugs were classified into groups according 
to the Dutch Pharmacotherapy Compendium.12 The primary outcome scores on drug choice 
related factors were described by means including 95 % confidence intervals. A one-way ANOVA in 
combination with a least-squared difference test was performed to investigate the differences in 
each drug choice-related factor among the students, general practitioners, and clinical specialists. 
We also compared the students versus medical teachers (i.e. gp’s and specialists).  The model 
assumptions were investigated by residual analysis. A p-value <0.05 was considered statistically 
significant. Statistical analyses were performed using SPSS 15.0 (SPSS Inc, Chicago, IL).
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Table 1 | Summary of the written patient cases presented to the participants for choosing a (drug) treatment. 
A = Uncomplicated case, B = Complicated case. 
Patient case Situated in general practice or the outpatient clinic
Bronchial
Asthma
a Woman, age 22. History: - 
Currently: Acute asthma attack a few hours ago, lasting about 5 minutes. Works 
in pet shop. Working diagnosis: bronchial asthma.
b Woman, age 22. History: Migraine since 6 months. Takes acetaminophen 2x500 
mg and metoclopramide supp. 20 mg during migraine attack. No attacks since 
using propranolol tab. 80 mg daily. 
Currently: Acute asthma attack a few hours ago, lasting about 5 minutes. Works 
in pet shop. Working diagnosis: bronchial asthma.
Osteoarthritis a Woman, age 63. History: -  
Currently: Increasing pain right knee since a few weeks. Working diagnosis: 
osteoarthritis.
b Woman, age 61. History: Osteoarthritis in right knee since 10 years. Ibuprofen 
tab. 400 mg when necessary since 1 year; no pain. 
Currently: Stomach pain since 7 days. Working diagnosis: NSAID-related gastric 
symptoms.
essential 
Hypertension
a Woman, age 52. History: - 
Currently: High blood pressure detected during a sports physical examination. No 
complaints. Now: BP 160/105 mmHg. Working diagnosis: essential hypertension.
b Man, age 62. History: myocardial infarction in 1999. Since then: atenolol 50 mg 
daily, acetosal 80 mg daily. Six weeks ago: recurrent high blood pressure 170/105 
mmHg; diet and exercise advice. 
Currently: Control visit: BP 170/100 mmHg. Working diagnosis: essential 
hypertension; after 6 weeks of not responding to diet, exercise advice and 
atenolol
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resulTs 
Thirty-two final-year medical students, 29 general practitioners, and 74 clinical specialists (26 lung 
specialists, 24 orthopaedic surgeons, and 24 internists) participated in the study. They prescribed 
128, 116, and 148 drug and non-drug treatments, respectively (see Table 2). In general, the drugs 
prescribed by medical students and general practitioners were similar, whereas clinical specialists 
prescribed relatively more potent drugs out of a broader range of drug classes.    
The contribution of the various factors to the drug choice of the students, general practitioners, 
and clinical specialists is shown in Table 3. Since there was no difference in the factors influencing 
the choice of treatment for A and B  cases,  the scores of the two versions were pooled. Students 
based their drug choice to a considerable extent (mean score ≥2 on a scale of 0-3) on the factors 
‘effectiveness of the drugs’ and ‘examples from clinical teachers’. In contrast, both general 
practitioners and clinical specialists based their drug choice to a considerable extent on the factors 
‘clinical experience’, ‘effectiveness of the drug(s)’, and ‘side effects of the drug(s)’. In addition, 
general practitioners based their drug choice to a considerable extent on ‘standard treatment 
guidelines’ and clinical specialists on ‘scientific literature’. 
Students attached significantly more importance to ‘examples from clinical teachers’ when making 
their treatment choice than did the general practitioners and clinical specialists, whereas general 
practitioners and clinical specialists placed more emphasis on three practice-related factors (‘own 
clinical experience’, ‘patients’ convenience’ and ‘compliance of the patient’) and two drug-related 
factors (‘side effects of the drug(s)’ and ‘therapeutic spectrum of the drug(s)’). Besides this the 
general practitioners attached significantly more importance to the drug choice-related factors ‘costs 
of the drug(s)’ and ‘education and postgraduate education’ compared to the students, whereas the 
clinical specialists rated the drug-related factors ‘effectiveness of the drug(s), ‘scientific literature’, 
and ‘information from the pharmaceutical industry’ significantly higher than the students. 
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discussion
We found that medical teachers base their drug choice mainly on the factors ‘clinical experience’, 
‘effectiveness of the drug(s)’, ‘side effects of the drug(s)’, ‘standard treatment guidelines’, and 
‘scientific literature’, whereas final-year medical students base their drug choice mainly on the 
factors ‘effectiveness of the drug(s)’ and ‘examples from clinical teachers’. That medical teachers 
base their choice mainly on ‘clinical experience’ is consistent with theories from cognitive psychology 
about how clinical (diagnostic) expertise is achieved.2, 3, 13 During everyday practice, doctors build up 
so-called cognitive networks of organized (therapeutic) knowledge and expertise,3 generating readily 
accessible treatment scripts. When a doctor is presented with a patient with one or more ailments, 
a specific treatment script is selected, depending on the level of complexity of the problem and the 
doctor’s prior experience. This selection is done subconsciously when the medical problem is simple, 
but  occurs in a conscious and analytical way when the medical problem is complex.  
While both medical teachers and medical students based their choice of treatment on the 
‘effectiveness of the drug(s)’, students’ knowledge of drug effectiveness is mainly theoretical, 
since they have little or no prescribing experience, whereas medical teachers’ knowledge of 
drug effectiveness is both theoretical and practical, based on the response of other patients to 
the medication in question. The same also holds for drug side effects: students have theoretical 
knowledge whereas medical teachers have both theoretical and practical knowledge. This 
practical knowledge gained through experience is probably why medical teachers rated this factor 
significantly higher than medical students.
Clinical specialists ,in contrast to the general practitioners, rated the drug choice-related factor 
‘scientific literature’ significantly higher than medical students. This might reflect a difference 
in patient populations seen by the two groups of medical teachers. Clinical specialists are 
accustomed to treating more complicated and severely ill patients who are, for the most part, 
referred by the general practitioner. In these cases, they frequently prescribe more potent and 
newer drugs.14 Clinical specialists learn about these new drugs (mostly before their launch) 
from drug company advertising, the literature, or at meetings.15 This could account also, at least 
partly, for the significantly higher value assigned by clinical specialists to the drug choice-related 
factor ‘information from the pharmaceutical industry’. General practitioners, in contrast to 
clinical specialists, based their drug choice to a considerable extent on  the drug choice-related 
factor ’standard treatment guidelines’. These guidelines, which have been formulated for many 
common ailments and diseases, provide evidence-based recommendations for the treatment of 
‘standard’ patients. In the Netherlands, general practitioners have a so-called gatekeeper function 
with regard to specialist care, and the use of national guidelines ensures a more uniform referral 
practice. Conversely, clinical specialists might possibly adhere more to international guidelines.
That nearly graduating students based their treatment choices on the example of their medical 
teachers is consistent with the copying behaviour of medical students.16, 17  Medical students 
have little opportunity to gain therapeutic experience, and so their reliance on  the example of 
their teachers is not surprising. This means that clinical teachers need to explain the arguments 
underlying their treatment choice explicitly to their students.18, 19 
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Before interpreting the results, the strengths and limitations of this study need to be addressed. 
As far as we know, this is the first nationwide study to investigate whether there are differences 
between medical students and their teachers in how they choose a medication. While we included 
103 clinical teachers, we had only 32 final-year nearly graduating students. This was unfortunately 
inevitable because data collection occurred at one moment during the students’ final clerkship, 
general practice.  However, the students were recruited from all eight medical schools in the 
Netherlands, and since there were no significant differences in baseline characteristics (i.e., 
gender, age etc) or mean examination score during training, it is very likely that the included 
population was representative. Lastly, it may not be possible to generalize these results to medical 
students and teachers in other countries because of differences between medical curricula in 
various countries. However, our findings may be generalizable to medical students in countries 
that have a sequentially designed medical curriculum as in the Netherlands.
In conclusion, we found that final-year medical students base their prescribing choices on the 
examples of their teachers. To improve rational prescribing, medical curricula should pay more 
attention not only to diagnostic reasoning, but also to therapeutic reasoning. Incorporation of 
specific clinical pharmacology and therapeutics courses into the medical curriculum20 may 
help students bridge the gap between (pre-clinical) theoretical learning and (clinical) practical 
learning, and between undergraduate and postgraduate training. Presenting students with clinical 
therapeutic problems early during undergraduate training will not only give them a chance to gain 
experience in solving medical problems but will also give meaning to what they are studying as 
opposed to merely reproducing what they learn, or copying what they are told.21, 22  Replication of 
our findings in further studies might provide more insight into the process of therapeutic reasoning 
and contribute to optimization of the therapeutic training of our future doctors. 
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absTracT
The irrational prescribing of drugs seems to be a general problem in medical practice, occasionally 
leading to serious consequences. In order to improve the drug prescribing performance of medical 
students, a compulsory context-learning pharmacotherapy module was implemented in 1998 in 
the medical curriculum of 2nd–4th-year medical students at the VU University Medical Center 
(VUmc), Amsterdam, the Netherlands. As part of this program, preclinical medical students are 
taught how to select, prescribe, and evaluate a drug regimen rationally. The aim of this study was 
to investigate the effect of this preclinical pharmacotherapy program on the quality of rational 
prescribing during the ensuing clinical clerkship of these students in internal medicine. The results 
of this study indicate that preclinical contextlearning in pharmacotherapy leads to the use of 
more rational prescribing modalities by medical students during their ensuing clinical clerkship 
in internal medicine. This effect was obtained not only with respect to the clinical topics in which 
training had been given as part of the pharmacotherapy curriculum, but also for other disease 
situations that the students dealt with. This implies that students not only remember the specific 
information they have learned during the training, but are also able to apply the acquired skills in 
new situations (transfer effect). 
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inTroducTion 
The prescribing of drugs is an essential skill for medical doctors. Given that ~50% of all consultations 
end with a prescription, it is essential that medical doctors prescribe drugs effectively, safely, and 
on the basis of an understanding of the disciplines of pharmacology, clinical pharmacology, and 
therapeutics. However, despite the generally accepted importance of rational prescribing, the 
teaching of pharmacotherapy to undergraduate medical students is still unsatisfactory.1 Many 
graduates feel underprepared to take on prescribing responsibilities after graduation.2 Moreover, 
as shown recently by Garbutt and co-workers, the prescribing performance of house staff and 
medical students is poor, partly because of inadequate training.3
Indeed, in many curricula, the teaching in clinical disciplines has been centered on symptoms 
and diagnosis, and little or no time has been given to imparting the principles of treatment with 
drugs. In order to improve rational prescribing, the authorities in many countries are now giving 
increased attention to the teaching of pharmacotherapy.4–7
In the Netherlands, the medical curriculum consists of two phases: a preclinical phase (years 1–4) 
and a clinical phase (years 5 and 6). Ninety percent of the curriculum is designed in the form 
of thematic “blocks.” The knowledge acquired in these blocks is then applied in the so-called 
problem-based learning. In 1998, an obligatory context-learning pharmacotherapy program was 
implemented in the preclinical medical curriculum of the VU University Medical Center (VUmc), 
Amsterdam, The Netherlands. This program comprises organized, once-a-week role-play sessions 
for 2nd-, 3rd-, and 4th-year medical students, and an Objective Structured Clinical Examination 
in the outpatient clinic for 4th-year medical students, as described in the Methods section.8 It 
has been shown recently that this preclinical pharmacotherapy program has a positive effect on 
improving the cognitive pharmacotherapeutic skills (i.e., the process of selecting the relevant 
information relating to the patient and choosing a drug treatment regimen) of medical students 
during the preclinical phase of their medical education.8 This finding is encouraging, no doubt, 
but it is still not known what effect this pharmacotherapy program would have on improving 
the rational prescribing performance of medical students during the ensuing clinical phase of 
their study. The aim of this study, therefore, was to investigate the effect of a preclinical context-
learning program in pharmacotherapy on rational prescribing performance of medical students 
during their first clinical clerkship in internal medicine. 
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meThods
Study design
Between 1998 and 2006, medical students who were performing their clinical clerkship in Internal 
Medicine at the VUmc, Amsterdam, The Netherlands, were included in the study. Depending on 
the year of their inclusion, these students had received the contextlearning pharmacotherapy 
program for periods ranging from 0 to 3 years (2nd to 4th year) (Figure 1). The participating 
students had to formulate (within 15 min) a pharmaco-therapeutic treatment plan for two 
randomly selected patients who visited the outpatient clinic in internal medicine. The students’ 
suggested treatment plans were based on the WHO six-step plan as described by de Vries and 
co-workers in the WHO Guide to Good Prescribing.16 The study was approved by the educational 
research committee of the VUmc, Amsterdam, The Netherlands. 
Preclinical context-learning pharmacotherapy education program
The pharmacotherapy context-learning program consists of organized, once-a-week role-play 
sessions in the form of consulting hours. The role-play sessions consist of three phases: consultation, 
argumentation, and feedback. First, a student “doctor” must carry out three therapeutic 
consultations of 10 min each. Before the start of a consultation, the student “doctors” are given 
a written patient case. Subsequently, the student “patient” and student “assessor” enter the 
consultation room and the “doctor” has to choose and prescribe the (drug) treatment interactively 
with the patient. The second phase (argumentation) starts immediately after the consultations. In 
this phase, the “doctor” has to substantiate the chosen therapy. Finally, during the third phase, 
all the students sit together and discuss the various (drug) treatments and the performances 
Figure 1 | Study population
The first group of students (1998, n=33) that started their clinical clerkship in internal medicine had not followed 
the pharmacotherapy education program. The second group (1999, n=31) followed 1 year (4th year) of the 
pharmacotherapy program. From 2001 onward, all included students had followed the complete preclinical 
pharmacotherapy program. OPC, outpatient clinic. 
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of the “doctors,” guided by a multidisciplinary team consisting of a clinical pharmacologist, a 
clinician, and a pharmacist. Each student had to attend 15 role-play sessions during the 2nd–4th-
year (five times each as “doctor,” “patient,” and “assessor”). Finally, each 4th-year student had to 
take the Objective Structured Clinical Examination. The form of the Objective Structured Clinical 
Examination was similar to the role-play sessions. The main differences were that the students 
now had to treat three standardized patients in the outpatient clinic, and that they were assessed 
by clinical pharmacologists, clinical specialists, pharmacists, and medical psychologists.
WHO six-step plan
The WHO six-step plan is a normative model for therapeutic reasoning and prescribing and 
provides a six-step guide to the process of rational prescribing. All six steps are partly based on the 
core learning objectives, namely, knowledge, skills, and attitudes as formulated by Nierenberg and 
Walley.17,18 The six steps described are: Step 1, define the patient’s problem; Step 2, specify the 
therapeutic objective; Step 3, choose a (drug) treatment, taking all relevant patient characteristics 
into account; Step 4, “write a prescription;” Step 5, give information to the patient; and Step 6, 
take monitoring measurements.
Scoring and analysis
All six steps of the treatment plans were scored by a clinical specialist in internal medicine. In 
order to evaluate the reliability and validity of the score, a clinical pharmacologist scored a random 
selection (50%) of the treatment plans for all 9 years of the study. The clinical pharmacologist 
was blinded as to the year of inclusion, name of the student, and score of the clinical specialist. 
Thereafter, agreement on the rationality of the treatment plans was calculated by a weighted 
kappa coefficient (Kw). The Kw between the clinical specialist and clinical pharmacologist for each 
of the six steps was between 0.55 and 0.85, thereby indicating a large extent of agreement. Both 
the clinical specialist and the clinical pharmacologist scored the different treatment plans using a 
four-point Likert scale (0, insufficient; 1, moderate; 2, sufficient; and 3, excellent). The results were 
presented as a percentage of the level required for graduation. That is, each student’s score was 
divided by the highest possible score and multiplied by 100. In addition to the separate scores 
relating to the six steps, the total rationality of the treatment plans was defined as the mean 
score of Steps 1–6. Also, because the students had received training in dealing with various clinical 
problems during their preclinical pharmacotherapy program, we investigated whether there was 
a difference in the levels of rationality between the treatment plans for clinical problems in which 
the student had already been trained and those for new clinical problems.
The data were analyzed using SPSS 14.0 (SPSS, Chicago, IL). Differences were analyzed by means of 
a one-way analysis of variance. A P value <0.05 was considered statistically significant.
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A total of 292 undergraduate medical students were included in this study (Figure 1). The mean score 
on the six steps of the World Health Organization (WHO) six-step plan presented by the medical 
students is shown in Figure 2. The scores on Step 1, “define the patient’s problem,” increased 
significantly (P < 0.001) depending on the duration of training in the preclinical pharmacotherapy 
program, from 90.2% for students who had not received the pharmacotherapy training at all to 
97.8% for students who had completed the entire 3-year program. Similarly, the scores on Step 2, 
“specify the therapeutic objective,” increased significantly (P < 0.001), from 65.9 to 89.7%; those on 
Step 3, “choose a (drug) treatment, taking all relevant patient characteristics into account,” increased 
significantly (P < 0.001), from 74.8 to 96.3%; those on Step 4, “write a prescription,” increased from 
62.7 to 72.1%; those on Step 5, “give patient information,” increased significantly (P < 0.001), from 
47.75 to 68.8%; and those on Step 6, “take monitoring measurements,” increased significantly (P 
< 0.001), from 52.9 to 75.3%. No significant differences were found between the groups that had 
received the entire 3-year program, with regard to the scores on the six steps. The total rationality of 
the treatment plans is shown in Figure 3. The total rationality increased significantly (P < 0.001), from 
55.2% for students who had not undergone the pharmacotherapy program to 87.1% for students 
who had completed the entire preclinical pharmacotherapy program. As shown in Figure 3, there 
was no significant difference between the scores for rationality of the treatment plans for “new” 
clinical problems (55%) and clinical problems in which the students had already been trained during 
the preclinical pharmacotherapy program (45%).
  
Figure 2 | Score on the six steps of the World Health Organization (WHO) six-step plan. Data are presented as 
mean percentage of the maximum. Unbroken lines, P < 0.001.
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Figure 3 | The total rationality of the treatment plans and the total rationality in trained and new cases. Data 
are presented as percentage of the maximum. Unbroken lines, P < 0.001.
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discussion
This study shows that the context-learning program improves the level of rational prescribing by 
medical students during their clinical clerkship in internal medicine. Moreover, this effect was obtained 
not only for clinical problems in which the students had been trained during the pharmacotherapy 
program, but also for “new” clinical problems, a so-called transfer effect of the training.
Strengths and limitations
Before interpreting the results, the strengths and limitations of this study need to be addressed. 
As far as we know, this is the first study to investigate the effect of a preclinical teaching program 
on rational prescribing during the clinical phase of the medical curriculum. The effect was 
measured in a large group of students who underwent the whole program (n = 197); however, 
the control group that had not followed the pharmacotherapy program was relatively small (n = 
33). This was unfortunately inevitable because the pharmacotherapy program was implemented 
simultaneously in the 2nd to 4th study year of the medical curriculum. Next, this study was an 
observational study rather than a randomized controlled trial. For “ethical” reasons, it was not 
possible to withhold the pharmacotherapy program from any group of students. Furthermore, 
the effect on rational prescribing was measured only during the clinical clerkship in internal 
medicine, which is the students’ first clerkship. Therefore, we do not know the effect of the 
preclinical program on rational prescribing performance just before graduation, which is ~2 years 
later. Finally, because the preclinical pharmacotherapy program covered a relatively small part of 
the whole curriculum(1% of the study load), the measured impact may not be ascribable to this 
program alone. However, during the course of this study, no substantial changes were made in the 
medical curriculum, which contained hardly any other training in pharmacotherapy.
In line with this, the persistent effect on rational prescribing in a relatively large group of students 
who had followed all 3 years of the program testifies to the validity and reliability of the results. 
This finding of an increase in the level of students’ therapeutic skills after the context-learning 
program is in accordance with the results of earlier studies, thereby lending more credence to 
our results.5,8,9 Finally, generalization of these results to students in other faculties and countries 
may be questionable, given the differences between the various curricula. However, a majority of 
the medical curricula are, like ours, of a sequential design, and it is therefore likely that the same 
results would be obtained with medical students from other faculties and countries.
Interpretation of the results
Taking these strengths and limitations into account, the positive effect on the level of rational 
prescribing could, at least partly, be explained by the fact that the preclinical pharmacotherapy 
program fulfilled the requirements for context-learning and those for the enhancement of the 
transfer effect. The pharmaco-therapy program was based on the principles of context-learning.10 
These principles are: (i) the setting is similar to the setting of the future profession, (ii) the number 
of repetitions is optimal, (iii) the students receive feedback immediately after their performance, 
and (iv) the students are responsible for their own learning progression. Obviously, many variations 
are possible in respect to the concreteness of the setting of the future profession. This concreteness 
may vary from the most realistic form, that is, actual clinical practice with real patients, through role-
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play sessions with standardized patients in a simulated practice setting, solving written problems 
in small problem-based learning groups, and observing practical demonstrations with patients 
during teaching sessions, to reading case descriptions in clinical textbooks. The role-play sessions as 
organized in the preclinical pharmacotherapy program in this study were the maximum attainable 
form of concreteness, taking into account the practicability and possibilities within the curriculum 
of our university medical center. Apart from the context, the preclinical pharmacotherapy program 
covered only 1% of the total study load of the medical curriculum, as a result of which only a 
restricted number of repetitions and feedback sessions could be held. In spite of this, the results 
indicate that even a suboptimal context and study load contribute significantly to an improvement 
in rational prescribing performance during the ensuing clerkship in internal medicine.
In addition to finding that the rationality of prescribing improved among medical students, this 
study also indicated that students not only prescribed rationally for clinical problems in which 
they had already been trained during the preclinical pharmacotherapy program, but were also 
able to apply the acquired skills in new situations. The phenomenon of using a previously learned 
concept to solve a new problem is called the “transfer effect”11 and has been reported in several 
studies.5,12,13 In order to stimulate transfer behavior, some important requirements of the teaching 
program must be fulfilled: (i) some knowledge from the initial training has to be retained by the 
student; (ii) the initial learning must be perceived by the student as meaningful; (iii) the new 
situation must be perceived by the student as being similar to the initial learning situation; (iv) 
the general principles must have been emphasized to the student; and (v) sufficient opportunities 
must have been provided to the student to apply the methods.13–15 The pharmacotherapy 
program as presented in this study satisfies these requirements sufficiently, which may explain the 
demonstrated transfer effect. Another possible explanation for the transfer effect could be that, 
before starting the pharmacotherapy program, it was clearly stated to all the students that only 18 
of the 68 core diseases8 could be taught during the preclinical program, but that they should learn 
by themselves the management of the other 50 diseases before graduating.
remarkable findings
Studying the scores on each of the six steps singly, it is noteworthy that students who did not 
undergo the pharmacotherapy program were able to perform more adequately (90.2%) in defining 
the patient’s problem (Step 1) than in the other steps. Given the fact that this first step is intimately 
associated with the diagnostic process and that, in many curricula, the teaching in clinical disciplines 
is centered on symptoms and diagnoses, this result is not surprising. In contrast to Step 1, the score 
on Step 5, “patient information,” started at a relatively low level (47.8%) and increased relatively little 
to 68.8%. Conceivably, this aspect of the consultation is underestimated and requires more attention, 
for example, by increasing the number of exercises. Another reason could be that practicing with 
fellow students, which occurs during the preclinical program, may not be the best technique.
Conclusions and recommendations
Taking these considerations into account it can be concluded that, in a sequential curriculum, a 
preclinical context-learning pharmacotherapy program improves the level of rational prescribing 
by medical students during the ensuing clinical clerkship, and that the students are able to apply 
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this ability to new clinical situations, thereby demonstrating the so-called transfer effect. This 
could possibly indicate that, in order to teach students an adequate level of rational prescribing, 
only a limited number of disease situations need to be taught.
Because we do not know the optimal number of different disease situations that should be 
taught in order to achieve a transfer effect, further research is recommended. Further, in order 
to evaluate the effect of the clinical phase of the medical curriculum, it is recommended that the 
level of performance with regard to rational prescribing by medical students be studied just before 
graduation. It would also be interesting to study whether optimizing the context or increasing the 
study load would lead to a further improvement in rational prescribing performance. 
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Chapter 5
absTracT
Purpose 
To evaluate the effect of different levels of realism of context learning on the prescribing 
competencies of medical students during the clinical clerkship internal medicine. 
Methods 
Between 2001 and 2007, 164 medical students took part in the prospective explorative study 
during their clinical clerkship Internal Medicine at the VU University Medical Center, Amsterdam, 
the Netherlands. In a fixed order, each student had to formulate a treatment plan for a real patient 
in three situations of increasing realism: a minimal level (studying a patient record), medium level 
(preparing for a therapeutic consultation), and optimal level (preparing for and performing a 
therapeutic consultation with the patient). 
results 
In comparison to studying a patient record (minimal context level), preparing a therapeutic 
consultation (medium context) improved four of the six steps of the WHO 6-step plan. Preparing 
and performing a therapeutic consultation with a real patient (optimal context) further improved 
three essential prescribing competencies, namely, checking for contraindications and interactions, 
prescription writing, and instructions to the patient. 
Conclusion and recommendations  
The results of this first explorative study suggest that enrichment of the learning context 
(responsibility for patientcare) might be an important factor to improve the training of rational 
prescribing skills of medical students during their clinical clerkship in internal medicine.  Clinical 
(pharmacology) teachers should be aware that seemingly small adaptations in the  learning 
context of prescribing training during clinical clerkships (i.e. with or without involvement with and 
responsibility for patient care) may have relatively large impact on the development of prescribing 
competencies of our future doctors.
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inTroducTion 
Many medical curricula focus on symptoms and diagnosis, with little or no explicit teaching of the 
principles of drug treatment or to the process of therapeutic reasoning.1,2  This despite concern 
about the high number of preventable prescribing errors and their adverse consequences.3,4 
As described recently by Brennan and coworkers, the transition from medical student to junior 
doctor is often experienced as a major and even too abrupt change 5, particularly because of 
the sudden increase in responsibility, workload, and contacts with other healthcare workers 
and patients.2 Various studies have reported that junior doctors feel underprepared for their 
prescribing responsibilities2,6-10, are not adequately prepared to prescribe safely,4,9,11,12 and fail to 
demonstrate adequate prescribing skills.13 All of these factors could contribute to the finding that 
10.3% of medication orders made by foundation year 2 doctors contain prescribing errors.9 That 
junior doctors feel underprepared for their prescribing responsibilities is not surprising, because in 
many clinical clerkships emphasis is on establishing the diagnosis, with little time being devoted to 
therapeutic reasoning. It is currently generally accepted practice for interns to watch other doctors 
prescribing,14 a practice that does not appear to be adequate when it comes to acquiring reliable 
prescribing skills.15
It has been suggested that interns should be more actively involved in therapeutic decision-
making, in order to make the student–junior doctor transition less abrupt.2 As stated in the WHO 
teachers guide to good prescribing, students should have the opportunity to treat real patients 
under supervision,16  to prepare them better for their prescribing responsibilities as junior doctors. 
Mainly based on research about diagnostic competencies, it has been suggested previously that 
medical students should best be prepared for their role as therapeutic decision makers by involving 
them in decision-making during daily clinical practice.1,17-24  The theory behind this device is that 
optimization of the learning context leads to improvement of rational prescribing. However,  recent 
studies investigating the effect of different levels of realism of context learning on prescribing 
competencies are not available. This paper describes the findings from an exploratory study on 
the effect of different levels of realism of the learning context on the prescribing competencies of 
medical students during their clinical clerkship internal medicine.
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meThods
Study design
Additional to the regular clerkship internal medicine, we introduced in this prospective exploratory 
study three learning situations in the form of an assignment. In a fixed order, each student had 
to formulate a treatment plan in three situations of increasing realism: a minimal level (studying 
a patient record), medium level (preparing for a therapeutic consultation), and optimal level 
(preparing and performing a therapeutic consultation with a real patient). The treatment plans 
were the same in all three learning situations and were structured according to the WHO 6-step 
plan (see left column table 1).25 Step 3 “choosing a drug treatment” and step 5 “give information 
to the patient” are essential and difficult steps when preparing and performing a therapeutic 
consultation with real patients. For this reason, we subdivided these two steps into five and three 
sub steps, respectively. Step 3 (choosing a drug treatment) was subdivided into a, drug choice; 
b, contraindication; c, drug administration; d, dosage; and e, duration of therapy. Step 5 (give 
information to the patient) was subdivided into a, giving information about the drug; b, giving 
instructions how to use the drug; and c, warning about the hazardous effects of the drug.
Population
Participants were randomly selected medical students who did their clinical clerkship in Internal 
Medicine at the VU University Medical Center, Amsterdam, the Netherlands, between 2001 and 
2007. All included students had received a 3-year context-learning pharmacotherapy program as 
described previously. 26;27 In short, this program consists of weekly pharmacotherapeutic role-play 
(doctor–patient) sessions in the second to fourth years of the preclinical medical curriculum. 
Intervention
Additional to the regular clerkship internal medicine, three different levels of realism of the learning 
context were designed, a minimal, medium, and optimal level. In the minimal context, students 
received the medical record of a patient who had already been treated by a resident or clinical 
specialist. In this medical record, the treatment plan had been removed. The students had to draw 
up a treatment plan based on the patient file, according to the WHO 6-step plan. This treatment 
plan had no consequences for the patient and the student was not involved in the preparation and 
performance of the therapeutic consultation with the patient. In the medium context, students had 
to prepare a treatment plan based on the medical record of a patient who had not yet been treated 
before by a resident or a clinical specialist. The students had to draw up a treatment plan, with the 
knowledge that their treatment plan would be used during the therapeutic consult. However, they 
knew in advance they would not perform the therapeutic consultation themselves. In the optimal 
context, students had to prepare a therapeutic consultation, based on the medical record of a 
patient who had to be treated by the students themselves under supervision of an internal medicine 
specialist. Again, the students had to draw up a treatment plan, however in this context they knew 
beforehand they would be involved in both the preparation phase of the therapeutic consultation 
and would perform this consult themselves. Although, the three situations differed in level of realism 
of the learning context, there was no difference in the assignment of formulating a treatment plan.
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Scoring and analysis
The treatment plans were blinded for the name of the student and level of realism of the learning 
context. All six steps and sub steps were assessed on a 10-point scale by one specialist in internal 
medicine with special interest in pharmacotherapy education. Students’ scores are expressed as a 
percentage of the highest possible score (10). Data were analyzed using SPSS 15.0 (SPSS, Chicago, 
IL). Differences were analyzed by means of a one-way ANOVA in combination with a least-squared 
difference test . A P value <0.05 was considered statistically significant.
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resulTs
A total of 164 undergraduate medical students were considered eligible for this study. Fifty students 
were excluded because they did not complete all three assignments, mainly for practical reasons (illness, 
absence etc). Remaining 114 were evaluable for the analysis. The students’ mean scores for the six steps 
for the minimal, medium, and optimal levels of context are shown in Table 1. 
Compared with the minimal context , preparing a therapeutic consultation (medium context) 
improved four of the six steps of the WHO 6-step plan. The scores for step 3 “choose a (drug) 
treatment, taking all relevant patient characteristics into account,” increased significantly from 
63.8% for the minimal context to 95.1% for the medium context. Scores for step 4, “write 
a prescription”, increased significantly from 69.5% to 84.6%, and for step 5, “give patient 
information”, increased significantly from 71.5% to 87.7%. The scores for step 6, ”take monitoring 
measurements”, increased significantly from 61.8% to 77.7%. Compared with the medium 
context, preparing and performing a therapeutic consultation with a real patient (optimal context) 
further improved scores for step 4 “write a prescription” (from 84.6% to 90.6%) and two substeps, 
namely, step 3b “checking for contraindications and interactions” (from 91.3% to 98.7%) and step 
5b “giving instructions to the patient” (from 89.9% to 93.3%). 
Table 1 | Scores of treatment plans scored according to the WHO six-step model at different levels of context. 
Data expressed as means % of maximum score (with SD)
Minimum Context (n=114) Medium Context  (n=114) Optimal Context (n=114)
1. Problem definition 94.8 (15.4) 97.0 (13.6) 97.5 (11.0)
2. Therapeutic objective 76.3 (28.4) 80.5 (25.4) 82.2 (25.8)
3. Therapy choice 66.6 (17.1) 95.0 (9.8) * 95.3 (8.8) #
     a. Drug choice 90.9 (19.4) 93.6 (19.1) 94.9 (16.5)
     b. Contra-indication 59.1 (23.5) 91.5 (24.7) * 98.7 (10.3) #§
     c. Drug administration 60.0 (21.2) 98.7 (10.3) * 98.3 (13.0) #
     d. Dosage 60.9 (20.7) 97.9 (13.7) * 97.5 (15.8) #
     e. Duration of therapy 62.1 (22.6) 92.8 (21.0) * 87.1 (32.4) #
4. Prescription 69.6 (17.0) 84.3 (18.3) * 90.7 (14.5) #§
5. Patient information 71.3 (10.4) 87.3 (14.5) * 90.2 (9.5) #
     a. Information 69.6 (13.3) 85.6 (19.1) * 85.6 (16.4) #
     b. Instruction 72.4 (14.4) 89.3 (18.0) * 93.7 (13.3) #§
     c. Warnings 72.0 (15.6) 87.4 (19.5) * 91.4 (14.4) #
6. Therapy monitoring 61.7 (16.7) 77.7 (20.4) * 78.1 (20.5) #
* =  P < 0.001 vs Minimum context.  # = P < 0.001 vs Minimum context. § P < 0.001 vs Medium context
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discussion
The results of this explorative study suggest that increasing the realism of context learning, by 
allowing students to use real medical records and to let them prepare for and carry out real 
therapeutic consultations, improves the rational prescribing skills of medical students during 
their clinical clerkship in internal medicine. Compared with the minimal context, preparing a 
therapeutic consultation (medium context) improved four of the six steps of the WHO 6-step plan, 
while preparing and performing a therapeutic consultation with a real patient (optimal context) 
further improved three essential prescribing competencies’, i.e. checking for contraindications and 
interactions, prescription writing, and giving instructions to the patient. This result is in line with 
previous studies on the advantages of learning in the clinical context 23;24 and with real patients.28  
The aim of this study was to investigate the effect of different levels of realism of the learning 
context on the prescribing competencies of medical students during their clinical clerkships. In 
medical education research,  the clinic is seen as the most important contextual factor in the design 
of the learning task. However, concerns have been raised because of the reduced availability of 
patients to students in clinical settings during the clerkships, due to increased patient turnover, 
shorter hospital stays and a diminishment of the number of hospital beds 23. The results of this first 
explorative study suggest that enrichment of the learning context improves the level of rational 
prescribing of medical students. The students’ perceived increased feeling of responsibility for 
patient care,  might be an important contributive factor to this finding and is consistent with 
previous research in clinical teaching.29-33 It is also consistent with current theories about context 
learning in medical education.34 Creating efficient learning contexts is not as straightforward 
as is often thought 34,35 and might have to go much further than, for example, simply changing 
the physical learning environment from medical faculty to the clinic. Koens et al presented a 
three-dimensional framework for analyzing the effects of learning context in medical education: 
a physical, semantic and commitment dimension, which can be adjusted independently.34 This 
provides educational reseachers the opportunity to investigate much more subtle differences in 
learning context.34   In accordance with this model, the three different contexts in our study can 
be ordered from reduced in the minimal context (providing few cues, little meaning, and little 
commitment because of low responsibility for patient care) to medium and optimal context 
(providing many cues, much meaning, and high commitment because of the high responsibility 
for patient care and or physical contact with the patient). 
In the minimal context, students had to formulate a treatment plan based on a randomly received 
case history of a patient. The medical students were aware that the patient already had been 
treated, so they knew that the treatment plan they drew up would not contribute to the care of 
the patient. This lack of participation in the patients’ treatment30 and the less “authentic” learning 
situation34 might have decreased motivation and commitment, thereby decreasing students’ 
willingness to invest effort and time in learning the task, namely, rational prescribing.29,34,36 
The optimal context, in which students had to prepare and perform a therapeutic consultation with 
a real patient, further improved three essential prescribing competencies, namely, checking for 
contraindications and interactions, prescription writing, and giving instructions to the patient. This 
72
Chapter 5
improvement is comprehensible since these are precisely the competencies which are essential 
when performing a therapeutic consultation. In contrast, the other prescribing competencies did 
not improve further relative to those attained in the medium context-learning situation. This might 
be because there is an optimum level of commitment for learning tasks,34 and this had already 
been reached with the medium learning context. As long ago as 1960, it was recognized that there 
is an optimal level of arousal or tension for task performance, such that unrestrained increase in 
the level of arousal or tension does not result in an ever further increase in performance.37 There 
is an inverted-U relationship between arousal and task performance, with performance being 
optimal at intermediate levels of arousal.34 An alternative explanation is that the already relatively 
high scores for the medium context did not leave much room for improvement in the optimal 
context. Scores for most of the prescribing competencies were already close to the maximum 
(ceiling effect), which makes the further improvement in the three prescribing competencies all 
the more remarkable. Alternatively, the improvement in four of the six steps of rational prescribing 
might be explained by the fixed order of the three assignments, which may have created a 
possible ‘learning effect’ from the 1st to the 2nd and 3rd intervention. This is known as ‘testing’ in 
educational research.38 However, all the students had already completed a 3-year context-learning 
pharmacotherapy program and were therefore already familiar with formulating these particular 
treatment plans (approximately 50 times) based on the WHO six-step plan.26,27 These 50 treatment 
plans did not differ from the three treatment plans used in this study in the minimal, medium 
and optimal context. We acknowledge that if the three treatment plans in the study were the 
first three treatment plans made by these students in their career, there would be a substantial 
risk of a ‘testing’ or learning effect between the three levels of context. This effect however will 
be very small or even negligible in the case of treatment plan number 51 to 53. Moreover the 
‘testing’ effect is mainly described for knowkledge tests instead of skills learning. The effect on 
skills learning has only been studied in one study,39 however their participants were trained in 6 
standardized, 5-minute cardiac arrest scenarios. One of these six scenarios was also used for the 
outcome assessment 2 weeks later, making the effect of testing a logical finding in their study. 
In our study there were no standardized scenarios, because of the real patients we used. Our 
patients all differed in characteristics, disease and relevant patient related factors for therapy 
choice such as comorbidity and co-medication. In this situation ‘testing’ has never been reported.
In addition, this ‘learning effect’ or ‘testing’ should apply for all 6 steps, which was not the case. 
Interestingly, the context learning situations did not influence the scores for steps 1 and 2 of the 
WHO 6-step plan for rational prescribing, respectively “define the patients problem” and “specify 
the therapeutic objective”, possibly because the scores for these steps were already high, as 
reported earlier.26,27  In addition, steps 1 and 2 could be seen as diagnostic steps compared with 
the more therapeutic four remaining steps.  As medical curricula traditionally focus on diagnosis 
rather than treatment principles,1 students would have been better trained in this aspect. 
Study limitations
Our findings should be discussed in the context of potential limitations in our study, such as the fact 
that the dropout (50 students) was substantial. As far as we know, this is the first study to investigate 
the effect of different levels of realism of context learning on rational prescribing competencies 
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during clinical clerkships. In the 1970s, it was assumed that context played an important role in 
learning, but then context was seen as the physical setting (e.g., class room) in which learning 
took place, which is a fairly simple and one dimensional approach to the learning context.39 The 
three different levels of realism of the learning context described in our study were much more 
consistent with the more comprehensive and especially for medical education designed three-
dimensional model of context learning described by Koens et al. This model was also designed to 
help in selecting appropriate contexts when researching the significance of context for learning.34
An important limitation of learning in an enriched context (real clinical practice) is that the quality 
of the learning environment is difficult to control because such contexts are not primarily designed 
to meet educational demands.34,40 However, in this experimental study we designed the three 
levels of context and the fixed order of the assignments to be as analogous as possible to the 
normal sequence and rhythm of the clinical clerkship internal medicine. In this way, we ensured 
maximum feasibility 41 and controlled contexts with the least interference in other existing activities 
of the clinical clerkship internal medicine. For the same reason and ethical reasons concerned with 
withholding a portion of the interns the prescribing practice oportunities with real patients, we 
did not choose for a three-armed study design. Finally, the clerkship in internal medicine is the 
first clinical clerkship that students experience, and thus we do not know whether the enriched 
learning context would have a similar effect if given later, for example, just before graduation. 
Conclusion and recommendations
The results of this first explorative study suggest that enrichment of the learning context 
(responsibility for patientcare) might be an important factor to improve the training of rational 
prescribing skills of medical students during their clinical clerkship in internal medicine. Clinical 
(pharmacology) teachers should be aware that seemingly small adaptations in the  learning 
context of prescribing training during clinical clerkships (i.e. with or without responsibility for 
patient care) may have relatively large impact on the development of prescribing competencies 
of our future doctors.
Therefore we should change the current often convenient way for clinical teachers of teaching 
medical students how to prescribe during the clinical clerkships. Medical students should not 
passively observe other doctors prescribing but instead be actively involved in the therapeutic 
decision-making process with responsibility for  real patients. As this study was performed during 
the internal medicine clerkship of medical students, similar studies should be performed during 
other clerkships or even earlier during  the medical curriculum.
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Objective
To determine the feasibility of incorporating structured therapeutic consultations (TCs) into the 
clinical clerkship Internal Medicine. TCs were considered feasible if students were able to draw 
up a therapeutic plan and carry out a TC, and if students and their supervisors considered TCs 
workable and useful.
Method
From March 2008 to October 2009, medical students carried out a ‘diagnostic’ and subsequent 
‘therapeutic’ consultation with the same patient during their clinical clerkship Internal Medicine at 
the VU University Medical Center. After the diagnosis was established, the student had to formulate 
a therapeutic plan and then carry out a TC with the patient, supervised by a clinician. The supervisor 
assessed the therapeutic plan and how the student conducted the TC. Both the student and the 
supervisor received a questionnaire about the workability and usefulness of the TC.
results
On average, the students’ performance in drawing up a therapeutic plan was awarded a score 
of 4.4 on a 5-point scale, and the TC performance of 96% of the students was considered amply 
sufficient or better. Eighty-three percent of the supervisors agreed or strongly agreed with the 
statement that the TC is a worthwhile addition to the clerkship and 67% of the students indicated 
that they would like to perform more TCs.   
Conclusion
This study shows that incorporating a structured TC with a real patient into the clinical clerkship 
Internal Medicine is both feasible and worthwhile. This may be an important step to improving the 
prescribing skills and attitudes of junior doctors and residents, and to reducing their prescribing 
errors after graduation.
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inTroducTion
The main objective of medical curricula is to provide graduates with diagnostic and therapeutic skills 
and competencies. Broadly speaking, medical curricula are divided into two phases, a preclinical 
phase followed by a clinical (clerkship) phase. During the preclinical phase, emphasis is usually 
on the acquisition of theoretical knowledge and skills in the diagnosis and treatment of diseases, 
while during the clinical phase this knowledge and these skills are put into practice. However, 
especially during the clinical phase, attention tends to be on the acquisition of diagnostic, rather 
than therapeutic, skills. In this phase of their training, medical students perform consultations 
with new patients in the outpatient departments, take a detailed history, perform a physical 
examination, and determine the differential diagnosis and formulate a diagnostic plan. However, 
they seldom work out a therapeutic plan during the initial consultation and are rarely involved in 
the next step, the therapeutic consultation (TC), during which the diagnosis is discussed with the 
patient and a therapeutic strategy is chosen and started. Students also rarely carry out the follow-
up consultations, in which the effect of therapy is monitored. To our knowledge, this situation 
applies to most Dutch medical schools and probably also to most medical schools abroad.
It is therefore not surprising that many junior doctors feel that they are not prepared for their 
responsible roll as house officers regarding therapeutic treatments 1-4 and that they make many 
prescribing errors.5;6  Also, there is no clear reason why more time cannot be devoted to therapeutic 
aspects during the clinical clerkship. Often-heard reasons for not doing this are that students will 
learn about therapy later during their registrar period and that they are not yet ready to treat real 
patients. We doubt this, and this is why we developed a pharmacotherapy training assignment at 
the outpatient department of Internal Medicine at the VU University Medical Center, Amsterdam, 
the Netherlands, during which students carry out a diagnostic and a therapeutic consultation with 
the same patient. The aim of this study was to determine the feasibility of incorporating structured 
TCs into the clinical clerkship Internal Medicine. TCs were considered feasible if students were able 
to draw up a therapeutic plan and carry out a TC, and if students and supervisors considered the 
TC workable and useful.
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Population
From March 2008 to October 2009, all medical students who performed their clinical clerkship in Internal 
Medicine at the VU University Medical Center were included in the study. Prior to this clerkship, all 
included students had completed a preclinical context-learning pharmacotherapy training programme 
during the 2nd to 4th years of their study, as described previously.7 In short, this programme consisted 
of weekly role-playing sessions in the form of a consultation during which ‘student’ doctors perform 
therapeutic consultations with ‘student’ patients. These consultations are observed by and discussed 
with ‘student’ assessors. After the consultations, and under the supervision of a clinical pharmacologist, 
the students discuss the various (drug) treatment options and how they performed as doctors.
Pharmacotherapy training assignment
The pharmacotherapy training assignment consisted of carrying out a diagnostic and a therapeutic 
consultation with the same patient who visited the outpatient clinic of Internal Medicine for the first time 
(see box 1). After the student had performed the diagnostic consultation, an appointment was made for 
the TC. A few days before the TC, the student and the supervising clinician determined the diagnosis, 
based on the results of diagnostic tests, and the student formulated a therapeutic plan, based on the 
WHO 6-step plan.8 Since this was the patients first visit to the outpatient clinic, there were no existing 
therapeutic plans available. Therefore, all students had to formulate their own therapeutic plan. The 
therapeutic plan involved the written completion of the following 6 steps: Step 1, define the indication 
for the treatment; Step 2, specify the therapeutic objective; Step 3, specify the standard treatment for the 
diagnosis; Step 4, choose a preliminary (drug) treatment, taking all relevant patient characteristics into 
account; Step 5, “write a prescription” in the case of drug treatment and determine what information 
should be given to the patient; and Step 6, determine what should be measured and when, in order 
to monitor the progress of treatment. The therapeutic plan was discussed with and evaluated by the 
supervisor. Because it is known that clinical supervisors tend to overestimate performance scores and 
hardly fail a student during clerkships (Williams 2003), step 4 (choose treatment) and step 5 (write 
prescription and determine patient information) were also assessed by an independent assessor not 
involved in the supervision of these students. Subsequently, the student carried out the TC and together 
with the patient determined the definite therapeutic plan, again supervised by the clinician. The 
supervisor then evaluated (both orally and in writing) the student’s performance during the TC. Lastly, 
student and supervisor completed a questionnaire on the workability and usefulness of the TC (Table 2).
Scoring and analysis
Performance on each step of the therapeutic plan was scored 1 to 5 (1= lowest attainable score and 
5= maximum attainable score), as was TC performance (1= inadequate; 2= doubtful; 3= sufficient; 
4= amply sufficient; 5= good). The students were asked to indicate how long they took to prepare 
for the TC (1= 1-3 hours; 2= 4-6 hours; 3= 7-10 hours; 4= >10 hour). In the questionnaire evaluating 
the workability and usefulness of the TC, agreement with a number of statements was scored on a 
5-point scale (1= strongly disagree; 2= disagree; 3= neutral; 4= agree; 5= strongly agree). 
The data were analyzed using SPSS 15.0 (SPSS, Chicago, IL). Differences were analyzed using a 
Wilcoxon Signed Rank test. A P value <0.05 was considered statistically significant.
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Box 1 | The pharmacotherapy training assignment (diagnostic + therapeutic consultation) during the clinical 
clerkship internal medicine.
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From March 2008 to October 2009, 50 of 86 eligible students completed the diagnostic and 
therapeutic consultations with the same patient. Thirty-six (42%) students did not carry out the 
TC. Twelve clinical specialists supervised and evaluated the students. An overview of the diagnoses 
that were subject of the therapeutic plans is given in Table 1. 
Table 1 | Overview of the diagnoses for which a therapeutic plan was made during the  training assignment.
Diagnosis no. of therapeutic plans
Gastrointestinal diseases 10
Hypertension 9
Hypo- / hyperthyroidism 9
Infectious diseases 5
Iron-deficiency anemia 5
Diabetes Mellitus 4
Osteoporosis 3
Hypercholesterolemia 2
Atrial fibrillation 1
Depression 1
Diabetes insipidus 1
Total 50
Students’ mean scores for drawing up a therapeutic plan and carrying out a TC, and the preparation 
time are shown in Table 2. The supervisors gave the overall therapeutic plan (steps 1 to 5) a score 
of 4.4, with treatment choice (step 4) being scored 4.3, and prescription and patient information 
(step 5) being scored 4.4. The independent assessor gave step 4 a score of 3.7 and step 5 a score 
of 4.4. TC performance was assessed as doubtful in 4% of students, amply sufficient in 48% of 
students, and good in 48% of students. Seventy-one percent of the students needed 1-3 hours to 
prepare for the TC, 24% 4-6 hours, and 5% 7-10 hours.
Forty-five (90%) students who carried out both consultations completed the questionnaire, as did 
all 12 supervisors (Table 3). Regarding the workability of this approach, 84% of the students agreed 
or strongly agreed that they had enough preparation time, and 71% agreed or strongly agreed 
that they could easily carry out a TC in combination with their other clinical activities. Seventeen 
percent of the supervisors thought that the TC approach involved too much work, whereas 66% 
were neutral about the work involved, and 17% thought that it did not cost them too much time. 
With respect to the usefulness of this approach, 93% of the students agreed or strongly agreed 
that they liked being able to consult the patient for a second time, and 67% indicated that they 
would like to perform more TCs. Eighty-three percent of the supervisors agreed or strongly agreed 
that the TC is a worthwhile addition to the clerkship Internal Medicine. 
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Table 2 | Scores for the therapeutic plan (max = 5; n=50), for the therapeutic consultation (n=50), and for the time 
taken to prepare for the consultation (n=45).
Preparation therapeutic plan
Average score   (95% C.I.)
Supervisor
Score independent assessor
Step 1: Define indication 4.4 (4.2 - 4.6)
Step 2: Specify therapeutic 
objective
4.3 (4.1 - 4.5)
Step 3: Specify standard 
treatment
4.3 (4.1 - 4.5)
Step 4: Choose a (drug) 
treatment
4.3 (4.1 - 4.5) 3.7 (3.5 – 3.9)*
Step 5: Write prescription and 
determine information
4.4 (4.2 - 4.6) 4.4 (4.2 – 4.6)
Step 6: Determine monitoring 
parameters
4.4 (4.2 - 4.6)
Performance therapeutic 
consultation
in adequate doubtful sufficient
amply
sufficient
good
Performance of therapeutic 
consultation
0% 4% 0% 48% 48%
Preparation time students 1-3 hours 4-6 hours 7-10 hours > 10 hours
Preparation time 71% 24% 5% 0%
* p<0.001
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Table 3 | Supervisor (n=12) and student (n=45) ratings of the workability and usefulness of the therapeutic consultation.
Workability 
strongly 
disagree
disagree neutral agree
strongly 
agree
supervisors
Supervision of the consultation involved too 
much work
0% 17% 66% 17% 0%
The instructions were clear 0% 0% 8% 50% 42%
My role was clear 0% 0% 17% 33% 50%
sTudenTs
I had enough time to prepare for the consultation 0% 4% 16% 50% 34%
The therapeutic consultation can easily be 
combined with other activities
4% 7% 18% 51% 20%
The instructions were clear 0% 2% 14% 62% 22%
Usefulness
supervisors
Carrying out a therapeutic consultation is a good 
addition to the clerkship
0% 0% 17% 47% 36%
sTudenTs
I liked seeing a patient for a second time 0% 0% 7% 36% 57%
I was satisfied with the clinician’s supervision 0% 4% 16% 39% 41%
I would like to perform other therapeutic 
consultations
2% 7% 24% 31% 36%
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discussion
This study shows that it is feasible to incorporate a structured TC with a real patient into the clinical 
clerkship Internal Medicine. On average, the students’ performance in drawing up a therapeutic plan 
and carrying out a TC was more than sufficient. Both clinicians and students considered the extra 
work and effort involved worthwhile and students appreciated the opportunity to carry out a TC. 
The uniformly high scores (>4) for the therapeutic plan are remarkable but are consistent with 
an earlier report of scores for therapeutic performance of about 80% of the maximum attainable 
score.9 We are aware that clinical supervisors tend to overestimate performance scores and hardly 
fail a student during clerkships,10 so the scores must be interpreted carefully. The independent 
assessor scored the treatment choice of students (step 4) significantly (p<0.001) lower than did 
the supervisors, although the score was still sufficient. This difference might be due to the context 
in which the assessments took place. The supervisors knew the patients from the diagnostic 
consultation and had access to the patients’ medical records, which might have influenced their 
evaluation of the students’ choice of treatment. Despite this difference, the results show that 
supervising clinicians agree that trained medical students are sufficiently competent to carry out 
supervised TCs with real patients. Regarding the appreciation for the TC, earlier studies have also 
shown that students appreciate supervised interaction with real patients.11;12 Furthermore, TCs 
with real patients constitute an optimal form of context learning, which is an effective learning 
method.7;9;13-16  According to Coles,17 a criterion for context learning is repetition. In this study, 
the students performed only one consultation at the start of their clerkship. Thus for optimal 
learning, students should have the opportunity to carry out other TCs during subsequent 
clerkships. Moreover, the preparation time might become shorter if students perform more TCs. 
At the moment, 29% of the students needed 4 hours or longer to prepare for the TC. This might be 
because they were confronted with diseases that had not been dealt with during the preclinical 
phase of the medical curriculum; however, subsequent analysis revealed that the preparation time 
was similar for clinical problems that had been covered during the preclinical pharmacotherapy 
programme (data not shown). This so-called transfer effect has been described earlier 9. Since it 
was the first time that students carried out a TC with a real patient, they probably did not know 
what to expect and wanted to leave nothing to chance. 
Another benefit of performing TCs during outpatient clinics is that students have to carry out 
the TC within the time available, and thus learn to cope with time pressure. Since time pressure 
is a recognized cause of prescribing errors,18;19 early exposure to time pressure might prevent 
medication errors later during the junior doctor period. 
In spite of the optimal context and the fact that students appreciated the consultations, 36 (42%) 
students did not manage to see a patient a second time for a TC. Possible reasons for this are that 
diagnostic test results were not back before students rotated to another clerkship, or the second 
appointment could not be made within this 4-week period. These results suggest that other forms 
of TCs are needed to enable all students to carry out a TC. An alternative is for students to carry 
out TCs with patients they have not seen in a diagnostic consultation, or for students to carry out 
follow-up consultations, during which therapy is monitored.
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Recently, Celebi et al.20 showed that medical students do not acquire adequate prescribing skills by 
merely watching other doctors prescribe during clerkships. Instead, this might encourage undesired 
copying behaviour.21 So, despite the above-mentioned limitations, allowing students to carry out 
TCs with real patients in the clinical phase of the medical curriculum is a valuable component 
of clinical clerkships. According to our knowledge, this is the first study that investigated if it is 
feasible that students carry out a TC with real patients during the clinical phase of the medical 
curriculum. Future studies should focus on the effect of this pharmacotherapy training assignment 
on the confidence of junior doctors and, more importantly, the prevention of prescribing errors. 
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Purpose
Determining treatment goals is an important part of the treatment decision-making process, but 
medical students are not trained in a structural way on how to define these goals. ‘SMART’ criteria 
are widely used in non-medical professions for determining goals and may improve treatment 
goal setting. The aim of this study was to assess the effect of implementation of SMART criteria 
on medical students’ ability to set treatment goals and to analyse the effects on treatment choice 
and monitoring. 
Methods
We performed a prospective, randomized controlled minimal intervention study with one control 
and two intervention groups (WHO group and SMART group). Second-year medical students had to 
complete a WHO six-step treatment plan for four written case reports of patients with asthma. The 
treatment plans were assessed using a standard scoring sheet developed by a Delphi procedure 
among respiratory physicians from all eight university medical centres in the Netherlands.
results
A total of 251 second-year medical students participated. The SMART group had significantly 
higher scores for setting treatment goals than the WHO and control groups (68.5% versus 29.6% 
and 30.8%, respectively; both p < 0.001). The SMART group also had significantly better scores 
for treatment monitoring than the WHO and control groups (34.2% versus 19.3% and 24.6%, 
respectively; both p<0.001). There were no between-group differences in treatment choice. 
Regardless of the study group, better setting of treatment goals was associated with better 
treatment monitoring, an association not reported earlier. 
Conclusion
SMART criteria improve the setting of treatment goals and treatment monitoring.
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inTroducTion
 
New prescribers require training to ensure that they act safely and rationally. The WHO six-step 
plan was developed to improve rational and safe prescribing by junior doctors.1  It is a normative 
model for therapeutic reasoning and starts by establishing the indication for treatment and 
ends with monitoring treatment. It has been shown to improve rational prescribing by medical 
students and junior doctors.1-7 However, there have been few studies of the second step, 
determining treatment goals, even though medical students find this difficult in practice. Setting 
treatment goals is an essential step of the WHO Guide to Good Prescribing, 1 and improved goal 
setting might contribute to the prevention of avoidable medication errors and unnecessary high 
medication costs, and might improve the follow-up of patients. There is little or no information or 
a generally applicable guideline about how to set treatment goals, even though doctors do this 
daily, consciously or unconsciously, when treating patients. While a number of studies describe 
treatment goals for specific diseases,8-10 even the WHO Guide to Good Prescribing provides little 
support, stating only the importance of setting treatment goals without providing practical tools 
on how to do so. Moreover, goal setting has received relatively little attention in the medical 
literature,11 in contrast to research in other disciplines, such as psychology, organizational 
behaviour, management, and education.11-13 
A well-known and frequently used method to optimize the process of goal setting in general is ‘SMART’.14 
According to SMART, goals have to be Specific, Measurable, Acceptable, Realistic, and Time-bound, 
but other interpretations of the letters can also be found. SMART criteria have been used effectively in 
rehabilitation medicine,15;16 but it is not known whether SMART criteria are effective in terms of setting 
treatment goals and rational prescribing. Therefore, the aim of this minimal intervention study was 
to assess the effect of implementation of SMART criteria on the setting of treatment goals by medical 
students and to analyse how these criteria influence the choice of treatment and treatment monitoring. 
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Study design
We performed a prospective, randomized controlled intervention study with one control group 
and two intervention groups (WHO group and SMART group). 
Study population
All second-year undergraduate medical students from the VU University Medical Centre in 
Amsterdam, the Netherlands, were included when they attended a mandatory pharmacotherapy 
training programme. These students had not previously received pharmacotherapy training and 
were therefore relatively homogeneous in their knowledge. The students were randomly divided 
into three study groups for their first pharmacotherapy training session, given on 3 consecutive 
days depending on their education schedule. The first group, the control group, which attended 
training on the first day, received no specific further instructions about setting treatment goals. 
The second group, the WHO group, received general instructions obtained from the WHO Guide 
to Good Prescribing on day 2, 1 day after the control group. This one-page information leaflet 
indicated only the relevance of setting treatment goals to rational prescribing without providing 
practical tools. The third group, the SMART group, received a one-page information leaflet with 
specific instructions regarding the use of SMART criteria to set treatment goals on day 3. These 
instructions consisted of an explanation of the acronym SMART and some examples on how to use 
these criteria to set treatment goals. It took students 1–2 minutes to read the English WHO and 
SMART instructions, but they were free to use them during the rest of the training. 
Materials
In the training session, students had to set treatment goal(s), choose appropriate medications, and 
determine what measures to monitor for four different cases of patients with bronchial asthma. 
These patient cases, developed by a respiratory physician, consisted of common patient information 
(e.g., name, birth date, sex etc.), a summary of the medical history, allergies and intoxications, 
comedication and/or comorbidities, a description of the current indication (containing anamnesis, 
physical examination, and if necessary results of peak flow analysis for instance), and the final 
diagnosis. All cases were of comparable difficulty and suitable for the level of experience of our 
study population and could be solved with the help of generally accepted clinical guidelines.
Besides the patient case and instructions on treatment goals (WHO and SMART groups), all 
students received a form, based on the six-step from the WHO Guide to Good Prescribing, on 
which to record their treatment plan. The students were allowed to use a pharmacotherapeutic 
reference book to look up specific drug information. 
Scoring template by Delphi procedure
A standard scoring sheet for the four patient cases was developed by using a Delphi procedure 
among pulmonary physicians from all eight university medical centres in the Netherlands. This 
Delphi procedure consisted of three consecutive rounds to establish the best treatment plan for 
the patient cases. In the first round, 25 pulmonary physicians gave their own treatment plan. In 
the second round, all summarized items from round one were scored by 22 participants, with 
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scores ranging from 1 (total disagreement) to 5 (total agreement). In the third round, 18 remaining 
members of the Delphi panel reviewed their previous scores, in relation to the average scores of 
all participants, and were given the opportunity to decide whether or not to adjust their scores. 
Then all items with an average score of > 3.5 were included in the scoring template. This model 
thus consisted of the best items for treatment goal, treatment choice, and treatment monitoring 
according to the nationwide Delphi expert panel.
Scoring and statistical analysis
The treatment plans were scored blind to study group. The number of items matching the scoring 
template were counted and expressed as a percentage of the maximum attainable score. Scores 
for treatment goal, choice, and monitoring were transferred to a database. Data management 
and statistical analyses were performed in SPSS (IBM SPSS Statistics, v20). A one-way ANOVA with 
Least Significant Difference (LSD) was used to test for differences in scores among the control, 
WHO, and SMART groups. Spearman’s correlation analysis was used to test for associations 
between treatment goals, treatment choice, and treatment monitoring. For statistical analysis no 
distinction was made between the four different patient cases. Significance level was set at 5%.
This study falls outside the scope of the Dutch Law on Medical Research (WMO), and when the study 
started the Dutch Ethical Review Board of Medical Education, which could provide study approval, was 
not yet operational. All participants were included during their first training session in a mandatory 
and regular pharmacotherapy training programme in the second year of the medical curriculum. 
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In total, 251 second-year medical students were included over the 3 consecutive days. The control, 
WHO, and SMART groups consisted of 100, 69 and 82 students, respectively. The mean scores for 
setting treatment goals, treatment choice, and treatment monitoring of the three groups are given 
in table 1. The SMART group had significantly higher scores for setting treatment goals than the 
WHO group (68.5 % versus 29.6%, p<0.001) and the control group (68.5 % versus 30.8 %, p < 0.001). 
Treatment monitoring was also significantly better in the SMART group than in the WHO group 
(34.2% versus 19.3%, p<0.001) and the control group (34.2% versus 24.6%; p=0.004). There were 
no significant differences in the scores for treatment choice between the three groups (52.2%, 
53.0%, and 49.3%, respectively; p=0.463). The relationships identified remained significant even 
if a more conservative approach than Fisher’s LSD were used (Games-Howell, multicomparison).
Table 2 shows the associations between the scores for setting treatment goals, treatment choice, 
and treatment monitoring. There was a significant association between the scores for setting 
treatment goals and the scores for treatment monitoring (p=0.001), but not between the scores 
for setting treatment goals and the scores for treatment choice (p=0.069). Subgroup analysis 
showed a similar pattern for each group which means that these associations were not significantly 
different between the three groups.
Table 1 | Average scores for treatment goal, treatment choice and monitoring of the three study groups (Control, 
WHO, SMART)
Control (N=100)
Mean in %(95% CI)
WHO (N=69) SMART (N=82)
Mean in %(95% CI) Mean in % (95% CI)
Treatment goal 30.8 (28.4-33.2) 29.6 (26.8-32.4) 68.5 (63.9-73.2)#
Treatment choice 49.3 (45.1-53.4) 53.0 (48.2-57.9) 52.2 (47.4-57.1)
Monitoring 24.6 (20.6-28.6) 19.3 (14.7-23.9) 34.2 (28.5-39.9)*
Significant differences (calculated with ANOVA LSD analysis) are bold and highlighted with #(better therapeutic 
goals for the SMART group, compared with the WHO and control group, both P < 0.001) and*(better treatment 
monitoring for the SMART group, compared with the WHO and control group, P < 0.001 and P = 0.004)
Table 2 | Correlation (Spearman’s) between treatment goal, treatment choice and treatment monitoring, 
independent of study group
Treatment goal
Correlation coefficient P-value
Treatment choice 0.115 0.069
Monitoring 0.212 0.001#
Significant correlations are bold and highlighted with #
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discussion
This study shows that use of the SMART criteria by medical students improved their ability to set 
treatment goals and monitor treatment. Moreover, regardless of whether WHO, SMART, or no criteria 
were used, improved goal setting was found to be associated with better treatment monitoring, an 
association not reported earlier. This is consistent with the claim of the WHO Guide to Good Prescribing 
that setting treatment goals is an essential step in the six-step process of rational prescribing.1
Previous studies involving students in the preclinical and clinical phases of the medical curriculum 
have shown that students have relatively low scores for step 6 (treatment monitoring) compared 
with the other five steps of the WHO guide6;7;17,18 and is usually perceived as a difficult step to 
perform by medical students. Thus it would appear that the currently used WHO six-step method 
does not help students sufficiently to acquire this skill. For this reason, it is interesting that use of the 
SMART criteria by students prescribing for the first time not only improved their setting of treatment 
goals (both quality and number of goals) but also treatment monitoring (not the primary target 
for the intervention in this study). This might be because with the SMART criteria treatment goals 
are explicitly stated, which might make it easier for medical students to determine what measures 
should be used to monitor treatment. As far as we know, this is the first study to investigate the effect 
of use of the SMART criteria by medical students on setting goals for treatment, making treatment 
choices, and monitoring treatment, which makes it difficult to compare our results with previous 
studies. However, research on goal setting in other fields, such as psychology and management, 
suggests that setting explicit and specific goals is fundamental to goal achievement,11-13 and has a 
positive effect on behaviour and work productivity.12;13 In medical literature, pharmacy students have 
shown to be capable to write SMART learning objectives after following a continuing professional 
development training program19  and in allied health clinicians a 50 minute education programme 
also improved SMART goal-writing skills.20 In view of generalizability of our results, we have therefore 
no reason not to assume that encountering SMART criteria in another discipline or later phase of the 
study Medicine might also improve (treatment) goal setting.
The association between goal setting and treatment monitoring was similar in all three groups, and 
thus it appears that every improvement in treatment goal setting improves treatment monitoring. 
However, use of the SMART criteria did not improve treatment choice, and setting treatment goals 
was not significantly associated with treatment choice. In contrast with our findings, it is generally 
assumed that the quality of treatment goals is related to therapy choice. A possible explanation is 
that in treatment guidelines, for example, those for bronchial asthma used in our study, therapy 
choices are explicitly ordered, taking into account relevant treatment goals for a specific condition, 
so that defining the correct indication leads automatically to the recommended therapy choice. 
This is in line with the fact that although goals are a critical component of making choices, people 
are often not aware of the goals they have when making a specific choice.21 The WHO Guide to 
Good Prescribing claims that treatment goals determine the choice of P(ersonal) drug (i.e., the 
most effective, safe, suitable, and cheap treatment, which is comparable with a guideline) for a 
condition rather than for a specific patient.1  The latter is affected indirectly. For example in the case 
of choosing a P-drug for angina pectoris which can be prevented and treated,1  if the treatment 
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goal is to stop an attack as soon as it starts, effective drugs might be sublingual short acting nitrates 
or nitro-glycerine. If the treatment goal is prevention, effective drugs are β-blockers, long acting 
nitrates and calcium channel blockers. In this example the treatment goal is decisive for choosing 
the list of effective treatment options from the P-drug or guideline. 
If treatment guidelines are not available, then treatment goals are important when it comes to 
choosing the appropriate drug out of all the drugs available. Specifying treatment goals structures 
thinking,1  forcing a person to concentrate on the real problem, thereby limiting the number of 
treatment possibilities and making the final choice much easier.1  In this way, only information 
relevant to the goal is used to determine the drug choice – information is processed in a manner 
that facilitates the evaluation of options relative to active goals.21 Moreover, setting treatment 
goals might be especially relevant to drug choices when there are potentially multiple treatment 
goals that are not necessarily linked to each other. For example, when pain and infection in a 
patient both need to be treated. 
The SMART criteria are a widely and effectively used goal setting technique that is easy to use (it 
takes maximally 2 minutes to read the instructions), even for first-time users. This makes these 
criteria a highly appropriate educational intervention for second-year medical students without 
prior training or experience in prescribing. Providing students with simple but specific instructions 
on how to set treatment goals as a structural part of the pharmacotherapy curriculum might be a 
promising and easily implementable improvement, but this should be evaluated in future studies. 
We had a relatively large study population of 251 second-year medical students, randomly divided 
into three study groups. This student population, with no specific prior pharmacotherapy training, was 
relatively homogeneous in terms of  knowledge and experience and therefore ideal for assessing the 
effect of an experimental educational intervention. However, it was not possible to include a quantitative 
comparison of the students’ academic performance which is a limitation of the study. While we do 
not know whether the SMART criteria would be equally effective in more trained prescribers, such as 
interns and junior doctors, there is probably room for improvement in the goal setting skills of these 
more experienced groups, although this should be addressed in future studies. 
Bronchial asthma was suitable as ‘target’ disease because students had already had lectures on 
the pathology and ethology of the disorder. Moreover, the availability of well-defined treatment 
guidelines for asthma, without compromising the opportunity for personal interpretation of 
treatment goals, treatment choice, and treatment monitoring, makes it a very good subject for a 
first-time training session. Whether the SMART criteria are equally effective when used for other 
diseases remains to be established.
Taking the strengths and limitations of our study into consideration, we can conclude that the 
SMART criteria improve the setting of treatment goals and the monitoring of treatment, and that 
improved goal setting is associated with improved treatment monitoring. The SMART criteria 
might be an effective way to improve the setting of treatment goals. The WHO six step method of 
the Guide to Good Prescribing is used both in the Netherlands22 and worldwide by many young, 
beginning prescribers and has proven effective in pharmacotherapy training.23  To further improve 
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the prescribing skills of future prescribers, and more specifically their setting of treatment goals 
and treatment monitoring, the next revision of the Guide should not only stress the importance 
of setting treatment goals but also provide practical tools, such as the SMART criteria, to structure 
and improve the process of goal setting by inexperienced prescribers.
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rationale, aims and objectives
Structuring the diagnostic section of the medical record (MR) improves diagnosis and communication 
between doctors. However, little is known about the therapeutic section of the MR. The aim of this 
study was to gain insight into the extent to which MRs are structured for therapeutic information, 
to determine which therapeutic data registrars and clinical consultants consider should be recorded 
in the MR and to what extent registrars record this information themselves.
Methods
 A multicentre observational study was carried out in the internal medicine outpatient clinics of five 
teaching hospitals in the Netherlands. Preformatted structure, importance and actual recording of 
therapeutic information was compared with a reference list of 35 therapeutic items based on the 
WHO Guide to Good Prescribing (e.g. drug name, indication for drug).
results
The preformatted structure of four paper MRs and one electronic MR was assessed. Eight of the 
35 therapeutic items were listed in the paper MRs and 18 items in the electronic MR. Registrars 
and consultants agreed on the importance of recording most of the therapeutic items in the MR, 
25 and 27 out of the 35 items, respectively; however, registrars recorded only 11 of the 35 items 
in the paper MR and 20 of the 35 items in the electronic MR.
Conclusions
The structure and content of paper and electronic MRs are not adequate. While both registrars 
and consultants agree on the importance of recording therapeutic items in the MR, registrars fail 
to record most of this information in practice. The results of this study can be used as starting point 
for the discussion regarding the necessity of structured recording of therapeutic information in the 
MR and its possible benefits with regard to medication safety and training of the new generation 
of prescribers.
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inTroducTion
Medication errors are common and a major concern internationally.1-4 Errors can cause adverse 
drug events, resulting in ineffective treatment, unnecessary hospital admissions, and serious harm 
to the patient.3,5-7 Almost half of these events are considered preventable and hence an important 
target for improvement.5,8-10 Medication errors have multiple potential causes and can occur 
throughout the prescribing–dispensing process.11-13 Although several interventions to improve 
prescribing have been developed, their effect has yet to be established. 14-17
The lack, or poor quality, of therapeutic information recorded in the medical record (MR) is 
frequently mentioned as a cause of medication errors.7,18-23  It is known that a structured section 
(pre-formatted templates containing clear headings in bold) for diagnostic information (e.g., 
medical history, physical examination, clinical tests) leads to better documentation of information 
24,25 and improves the quality of diagnosis, communication between doctors, patient satisfaction 
with treatment, and patient care.24 Several studies in a clinical educational setting likewise indicate 
that recording of information in a structured manner improves the (perceived)performance of 
trainees.26-28 Also Duggan et al.29 conclude that recording of information and performance of 
healthcare providers can be changed by manipulation of the medical record format. The emphasis 
of all these studies, however, was mainly on the recording of diagnostic information. Regarding 
pharmacotherapy, it is known that structure (WHO 6-step) improves therapeutic competences 
of pre-clinical medical students.30  There have been no studies of whether a structured section 
for therapeutic information in the MR, using pre-formatted templates, has an equally beneficial 
effect as seen with diagnostic information. We therefore carried out a multicentre observational 
study to gain insight into the extent to which the section for recording therapeutic information is 
preformatted in paper and electronic MRs. We also investigated which therapeutic data registrars 
and consultants in internal medicine consider essential to record in the MR and to what extent 
they actually record this information. 
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Study design
We performed a multicentre observational study in the internal medicine outpatient clinics of 
the VU University Medical Center in Amsterdam and four affiliated teaching hospitals in the 
Amsterdam region. The study was divided into three subsequent phases between September 
2009 and December 2009. First, we analysed the structure of empty MRs (phase I: Structure). We 
then investigated which therapeutic data registrars and consultants in internal medicine thought 
should be recorded in the MR (phase II: Important to record), and subsequently evaluated to what 
extent registrars actually record this information (phase III: Recording). For the assessments, we 
used a therapeutic item (reference) list based on the WHO 6-step31 in all three phases. 
Therapeutic items 
For this study, we created a list of 35 therapeutic items (see left column table 1) based on the WHO 
6-step guide to rational prescribing.31 The items were deemed to represent the minimal information 
needed by physicians to get a complete overview of the chosen drug treatment and why it was 
chosen (e.g., indication, checking contraindications, and interactions). The 35 therapeutic items 
were classified into three subgroups (see left column table 1): patient characteristics (13 items); 
rational prescribing (12 items); and prescribed drug information (10 items). The subgroup ‘patient 
characteristics’ consisted of general patient data that is usually recorded in the diagnostic section 
of the MR and is necessary to choose an appropriate treatment for the patient (e.g., comorbidity 
and comedication). The subgroup ‘rational prescribing’ emphasizes the process of rational 
prescribing (e.g., checking for contraindications and interactions). The subgroup ‘prescribed drug 
information’ consisted of items regarding specific information about the chosen drug (e.g., name 
of drug and drug dosage).  
Data collection 
Phase I: Structure  
The empty MRs (paper and electronic) of patients attending the internal medicine outpatient clinic 
were collected, and two researchers (PF and RU) checked, using a 2-point scale, whether the 35 
therapeutic items were listed (1= listed, 2=not listed). The assessment covered all sections of the 
outpatient MR.
Phase II: Important to record
To investigate which therapeutic items are important to record in the MR, an Internet-based 
questionnaire (Survey Monkey®) was sent to the registrars and consultants of each participating 
clinic. The questionnaire contained the same list of 35 therapeutic items, and the clinicians were 
asked to indicate, on a 4-point Likert scale ((1= very important, 2= important, 3= unimportant, 4= 
very unimportant), how important they thought it was to record information about each item in a 
MR. An item was considered  ‘important to record’ when ≥80% of the respondents gave it a score 
of 1 or 2 (i.e., very important or important). Participants also had the opportunity to propose new 
therapeutic items themselves.
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Phase III: Recording 
A random selection of MRs used during consultations by registrars were collected from each 
clinic. MRs were included if they were completed by internal medicine registrars working in the 
outpatient clinic, if they were scheduled for a consultation during the week of the data collection 
(cross sectional study design) and only if there was a recording of the start of a drug treatment 
(less than 1 year ago). The same two researchers (PF and RU) checked, using a 3-point scale (1= 
recorded, 2= partly recorded, 3= not recorded), whether each therapeutic item was listed in the 
MR. The items ‘rational prescribing’ and ‘prescribed drug information’ were based on the last 
consultation recorded in the MR, when drug treatment was started (less than 1 year ago). All 
sections of the MR were used to assess ‘patient characteristics’. An item was considered adequately 
recorded if it was recorded in ≥80% of the MRs. 
Scoring and analysis
If the two researchers disagreed about scoring, they discussed their differences to reach consensus. 
During analysis, no items were scored as ‘partly recorded’ and so a 2-point scoring scale was used 
(1= recorded, 2= not recorded). All study results are collected in Excel and SPSS version 18.0 (SPSS, 
Chicago, IL). The data were analysed using SPSS 18.0. In phase I of the study descriptive analysis 
was used to analyse the data regarding the preformatted structure of empty MRs. In phase II of the 
study descriptive analysis was used to analyse the data regarding the therapeutic items considered 
important to record in the MR. In phase III of the study descriptive analysis was used to analyse the 
to what extent registrars actually record therapeutic information in the MR.
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Phase I: Structure
Each hospital provided one MR (response rate of 100%) from the internal medicine outpatient 
clinic to assess the preformatted structuring of therapeutic items. In total, four paper MRs and 
one electronic MR were assessed. The results are shown in column A of table 1. Of the 13 ‘patient 
characteristics’ items, 6 were listed in 75% of the paper MRs, 1 was listed in 50% of the paper 
MRs, and 6 were not listed as separate headings. In the electronic MR, 11 of the 13 items were 
listed. Of the 12 ‘rational prescribing’ items, 1 (control appointment) was listed in one paper MR, 
but no items were listed separately in the electronic MR. None of the 10 items of ‘prescribed drug 
information’ were listed in the paper MRs, whereas 7 were in the electronic MR (name drug, drug 
dose, drug dosage, dosage form, duration of treatment, start date, and patient instructions).  
Phase II: Important to record
Thirty-one internal medicine clinicians (16 registrars and 15 consultants) completed the 
questionnaire. The link for the survey was distributed by the heads of the departments of internal 
medicine to all employed registrars and consultants internal medicine. Registrars and consultants 
agreed on the importance of recording most of the therapeutic items in the MR (see column 
B, table 1). All ‘patient characteristics’ items were scored by all respondents as important to 
record, except the item ‘evaluation of comedication’, which was scored as important by 63% by 
the registrars. Six of the 12  ‘rational prescribing’ items were considered important to record by 
both registrars and consultants; in addition, registrars considered 3 more items important and 
clinical consultants 1 extra item. Of the 10 ‘prescribed drug information’ items, 4 were considered 
important by both registrars and consultants; the consultants also considered 3 additional items 
relevant (dosage form, duration of treatment, and stop date).  
Phase III: recording 
In total, 305 outpatient MRs (265 paper MRs and 40 electronic MRs) completed by internal 
medicine registrars were collected. This means 100% inclusion of the MRs that met the following 
inclusion criteria: MRs were included if they were completed by internal medicine registrars 
working in the outpatient clinic, if they were scheduled for a consultation during the week of the 
data collection (cross sectional study design) and only if there was a recording of the start of a drug 
treatment (less than 1 year ago). The results are shown in column C of table 1. Of the 13 ‘patient 
characteristics’ items, 7 were recorded in more than 80% of the paper MRs and 11 were recorded 
in all electronic MRs (see column c, table 1). Of the 12 ‘rational prescribing’ items, 3 were recorded 
in more than 80% of the paper MRs and only 2 in electronic MRs. Five items were not recorded in 
either type of MR. Of the 10 ‘prescribed drug information’ items, 1 was recorded in more than 80% 
of the paper MRs and 7 in electronic MRs. 
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Table 1 | Results of study phase I, II and III separated in subgroups 
a b c
Phase I.
Structure 
Phase II.
Important to record 
Phase III. 
recording
 PMR 
(n=4)
EMR 
(n=1)
Registrars 
(n=16)
Consultants 
(n=15)
PMR 
(n=265)
EMR              
(n=40)
Patient characteristics 
1. Year of birth 3 (75) 1 (100) 16 (100) 15 (100) 265 (100) 40 (100)
2. Gender 3 (75) 1 (100) 16 (100) 15 (100) 265 (100) 40 (100)
3.  Allergy and 
hypersensitivity
2 (50) 1 (100) 16 (100) 15 (100) 191 (72) 39 (98)
4. Intoxication(s) 3 (75) 1 (100) 16 (100) 15 (100) 228 (86) 39 (98)
5. Pregnancy and lactation 0 0 15 (94) 13 (87) 19 (7) 14 (36)
6. Medical history 3 (75) 1 (100) 16 (100) 15 (100) 262 (99) 39 (98)
7. Co-morbidity 3 (75) 1 (100) 16 (100) 15 (100) 262 (99) 39 (98)
8. Co-medication 3 (75) 1 (100) 16 (100) 15 (100) 265 (100) 40 (100)
9. Name of drug 0 1 (100) 16 (100) 15 (100) 260 (98) 40 (100)
10.  Drug dose 0 1 (100) 16 (100) 15 (100) 151 (57) 40 (100)
11. Drug dosage 0 1 (100) 16 (100) 14 (93) 106 (40) 40 (100)
12. Dosage form 0 1 (100) 16 (100) 13 (87) 5 (2) 40 (100)
13. Evaluation of co-
medication
0 0 10 (63)  15 (100) 0 0
rational prescribing
14. Complaint(s) and   
symptoms of  patient 
0 0 16 (100) 15 (100) 239 (90) 31 (78)
15. Indication for treatment 
(diagnosis and clinical 
findings)
0 0 16 (100)  15 (100) 21 (8) 8 (20)
16. Therapeutic goal 0 0 14 (88) 12 (80) 0 0
17. When to achieve 
therapeutic goal 
0 0 4 (25) 8 (53) 0 0
18.  Non-drug treatment 0 0 14 (88) 11 (73) 34 (13) 3 (8)
19.  Drug treatment 0 0 16 (100) 15 (100) 265 (100) 40 (100)
20. Treatment based on 
guideline  
0 0 4 (25) 5 (33) 0 0
21. Whether there has been 
deviated from guideline 
0 0 13 (81) 10 (67) 0 0
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Phase I.
Structure 
Phase II.
Important to record 
Phase III. 
recording
 PMR 
(n=4)
EMR 
(n=1)
Registrars 
(n=16)
Consultants 
(n=15)
PMR 
(n=265)
EMR              
(n=40)
22. Check contra-indication(s) 
and interaction(s)
0 0 15 (94) 11 (73) 0 0
23. Control appointment 1 (25) 0 12 (75) 12 (80) 223 (84) 39 (98)
24. Control method(s) 0 0 14 (88) 12 (80) 188 (71) 27 (68)
25. Control parameter(s) 0 0 15 (94) 13 (87) 66 (25) 15 (37)
Prescribed drug information
26. Name of drug 0 1 (100) 16 (100)  15 (100) 257 (97) 40 (100)
27. Drug dose 0 1 (100) 16 (100) 14 (93) 193 (73) 40 (100)
28. Drug dosage 0 1 (100) 15 (94) 12 (80) 101 (38) 40 (100)
29. Dosage form 0 1 (100) 11 (69) 13 (87) 0 40 (100)
30. Duration of treatment 0 1 (100) 10 (63) 13 (87) 13 (5) 40 (100)
31. Start date 0 1 (100) 13 (81) 13 (87) 0 40 (100)
32. Stop date 0 0 12 (75) 13 (87) 0 0
33. Patient information 0 0 8 (50) 11 (73) 8 (3) 2 (5)
34. Patient instructions 0 1 (100) 3 (19) 9 (60) 8 (3) 40 (100)
35. Approval of patient for 
treatment
0 0 5 (31) 9 (47) 0 0
The results are shown as numbers (%). 
EMR, electronic medical record; PMR, paper medical record.
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discussion
The principal aim of this study involving five Dutch teaching hospitals was to gain insight into the 
extent to which paper and electronic MRs are preformatted to record therapeutic information. The 
results show that the majority of the 35 therapeutic items are not given as headings/subheadings 
in either paper or electronic MRs, although electronic MRs were slightly better than paper MRs. 
Both registrars and consultants in internal medical agreed about the importance of recording 
information about most of the therapeutic items in the MR. Surprisingly, registrars often failed to 
record this therapeutic information in practice.
Strengths and limitations 
Before interpreting the results, the strengths and limitations of this study need to be addressed. 
This is the first observational study to investigate the extent to which preformatted templates 
for therapeutic information are used in written and electronic MRs, which makes it difficult to 
compare with the results of previous studies. The study was conducted in more than one medical 
centre and included a large number of MRs used by registrars. However, the present study had 
several limitations. First, only the MRs from the outpatient clinic of internal medicine were 
used, which makes the generalizability of findings to other clinics questionable. The reason why 
the Department of Internal Medicine was chosen for this study is because treatment is often 
medication based. Secondly, there were fewer electronic MRs than paper MRs, so results must 
be interpreted carefully. Thirdly, because we found no literature on which specific therapeutic 
information should be recorded, we composed a list of 35 items based on the WHO 6-step,31 and 
participants were asked to assess the importance of these items. Although, the participants did 
have the opportunity to propose new therapeutic items themselves, none of them did. Lastly, as 
this was an observational study rather than a randomized control trial, we could not evaluate the 
effect of structuring therapeutic information on the completeness of documentation.
There was a lack of templates for recording therapeutic information not only in the paper MRs, 
but also in the relatively new electronic MRs. This was surprising, because it is recognized that 
structuring the MR can improve patient outcomes and doctors’ performance.24 Nevertheless, it is 
in line with the lack of attention for recording treatment data in the MR that has been seen since 
MRs were first introduced, when their function was primarily educational.24,32,33 Both registrars 
and consultants agreed that it was important to record information on the majority of the 35 
therapeutic items. This is perhaps not surprising because modern healthcare is complex and 
patients are often seen by more than one doctor,34 which makes it important to have extensive 
information available in the MR. Surprisingly, the registrars did not themselves record all the 
information they thought important. This is in line with other studies, which  found that not all 
prescribed medication is recorded in the MR or discharge notes.35,36 Furthermore, doctors tend to 
think they record more information than they actually do.37 
A remarkable finding in this study is the fact that in particular the 12 items related to rational 
prescribing (e.g., indication, therapeutic goal setting, guideline used, deviated from guideline  and 
checking contraindications and interactions) are not preformatted to record in either paper or 
electronic MRs. This is in line with the research of Tully et al which mentioned the incompleteness 
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of the patient’s records as a complicating factor in the development of explicit indicators of 
appropriateness of longterm prescribing. This was particularly the case for the indication, an 
essential piece of information to judge many aspects of the appropriateness of the medication.38
Moreover these items are recorded poorly by residents in both types of MR, although they are 
considered as important items in the process of rational prescribing 31,39 and partly by the residents 
and consultants in this study. These not preformatted and not recorded items are all related to 
personalizing a (drug) treatment and argumentation for the treatment choice.  
Not recording these items, of course does not mean they have not been taken into consideration 
during the actual treatment choice. Future research should reveal the reason for not recording 
the argumentation and the desirability of this current lack of information in the MR. It might be 
preferable that another doctor is not only familiar with the prescribed drug (e.g., name of drug 
and drug dosage) but also with the argumentation for a specific drug treatment, especially when 
a patient is handed over or during the training period of residents. Particularly since, the lack 
of therapeutic information recorded in the medical record (MR) has been mentioned as a cause 
of medication errors7,18-23 and better documentation of therapeutic information may potentially 
contribute to the improvement of the quality of care. A second remarkable finding is the fact that 
even the most basic patient characteristics (such as for example gender, date of birth, allergy and 
hypersensitivity) are not 100% preformatted to record in the MRs. The absence of a preformatted 
structure for gender and date of birth of course does not mean these characteristics are not 
recorded in the MRs. For example, some hospitals use self-adhesive stickers with basic patient 
characteristics in the MR.
Taking these strengths and limitations into account, we can conclude that (1) most MRs do not 
have a designated structure (headings/sub-headings) for recording therapeutic information 
(2) registrars and consultants prefer extensive therapeutic information to be recorded, and (3) 
registrars actually record little therapeutic information. Future research is needed to investigate 
the optimal structure of the MR for recording therapeutic information. It is of importance that 
MR users are involved and that essential therapeutic items are identified. It should also be borne 
in mind that MRs could also play an important role in the postgraduate education of registrars,32 
especially in the field of prescribing. Obviously, the optimal content and effect of having a 
structured section of the MR for therapeutic information needs to be determined.
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Figure 1 | Summary of conclusions and recommendations of this thesis
Figure 1 Summary of conclusions and recommendations of this thesis
1. 
Situation
2. 
Context
3. 
Structuring
Conclusions: The teaching of clinical pharmacology and therapeutics (CPT) 
has undergone many changes over the last decades. It is essential that 
CPT teaching continues to be major part of the undergraduate medical 
curriculum. Final-year medical students tend to copy the drug treatment 
choices of their teachers. 
recommendations: On the basis of current theories of cognitive psychology 
and medical education, contextual learning is an effective way to achieve 
therapeutic competencies. Presenting students with clinical therapeutic 
problems early during undergraduate training will not only give them the 
opportunity to gain experience in solving medical problems, but will also 
give meaning to what they are studying as opposed to merely reproducing 
what they learn or copying what they are told.
Conclusions: A preclinical context-based learning programme in 
pharmacotherapy improves the rational prescribing of medical students during 
their clinical clerkships (long-term effect). This improvement was seen not only 
with previously studied clinical conditions but also with new clinical conditions 
(transfer effect). Enrichment of the learning context (responsibility for patient 
care) might be  important for improving the training of rational prescribing 
skills during the internal medicine clerkship of medical students. Incorporating 
structured therapeutic consultations with real patients into clinical clerkships 
is both feasible and valuable.  
recommendations: The transfer effect could indicate that, in order to teach 
students rational prescribing adequately, only a limited number of diseases 
need to be taught in a preclinical context-based learning programme in 
pharmacotherapy. Clinical (pharmacology) teachers should be aware 
that seemingly small adaptations to the learning context of prescribing 
training during clinical clerkships (i.e. with or without involvement with and 
responsibility for patient care) could have a relatively large impact on the 
development of prescribing competencies of future doctors.
Conclusions: Use of SMART criteria improves the setting of treatment goals 
and treatment monitoring. Medical records in teaching hospitals in the 
Netherlands do not have a designated structure (headings/sub-headings) 
for recording therapeutic information. Registrars and consultants indicate 
that extensive therapeutic information should be recorded, but registrars 
tend not to do this in pratice.
recommendations: To further improve prescribing skills in future 
prescribers, and more specifically their ability to set treatment goals and to 
monitor treatment, the next revision of the WHO Guide to Good Prescribing 
should not only stress the importance of setting treatment goals but also 
provide practical tools, such as the SMART criteria, to structure and improve 
the process of goal setting by inexperienced prescribers. The optimal 
structure for recording therapeutic information in the medical record needs 
to be determind with all stakeholders. It should also be borne in mind that 
medical records could play an important role in the postgraduate education 
of registrars, especially in the field of prescribing.
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1. SuMMAry
Doctors should be able to prescribe rationally, and this is especially true for junior doctors, who 
are responsible for the bulk of prescriptions for patients in hospital.1-3  Therefore, medical curricula 
should prepare undergraduate medical students for this important and difficult task. However, 
many studies have reported that junior doctors feel particularly unprepared for their new and 
challenging prescribing responsibilities.4-10  Furthermore, according to their clinical teachers (i.e. 
consultants and specialist registrars), first-year junior doctors in the UK ‘were deemed not well 
prepared for prescribing’. 11 Moreover, a study from 2015 showed that junior doctors (one or two 
years in training) were more than twice as likely to prescribe erroneously than more experienced 
medical consultants. 3 This is consistent with an error rate of up to 10.3% of medication orders 
made by junior doctors reported in the Equip study in 2009.1 
Several studies have reported that medical graduates considered that their undergraduate education 
did not prepare them sufficiently for their prescribing responsibilities as junior doctors.7;12-14  The Equip 
study suggested that educational innovations should be introduced to ease the transition from non-
prescriber (undergraduate student) to prescriber (junior doctor), as a way to reduce the prescribing 
errors of junior doctors.1;15 Unfortunately, little is known about what these innovations should be in 
practice. Two reviews 16;17 suggested that there is a strong need for explorative studies on which to 
base the design of curricula for teaching and training prescribing skills. McLellan et al. suggested that 
the way forward for teaching prescribing skills is to design interventions based on a real-life context. 
18 Medical students should be observed and evaluated in the context of their future workplace. In 
order to develop an understanding of what works and under which conditions, we need to investigate 
educational interventions that encourage the development of expertise in rational prescribing.18
This was the motivation for the studies described in this thesis, the main objective of which was 
“to investigate and explore the possibilities of improving the rational prescribing behaviour of 
medical students in a context-based pharmacotherapy learning programme based on the WHO 
6-step method”. The following research questions were derived from this main objective:
1. What is the current situation regarding the development of clinical pharmacology and 
therapeutics (CPT) education and are there differences in the therapeutic decision-making 
process of inexperienced and experienced prescribers?
2. Does a preclinical context-based pharmacotherapy learning programme have a long-term 
and transferable effect on the rational prescribing competencies of medical students? What 
is the influence of the level of realism of the learning context during clinical clerkships on the 
prescribing competencies of medical students, and is it feasible to incorporate structured 
therapeutic consultations with real patients into clinical clerkships?
3. Does further structuring of one of the steps of the WHO 6-step method (treatment goal) affect 
the prescribing skills of medical students? To what extent are medical records structured for 
therapeutic information in teaching hospitals in the Netherlands, which therapeutic data do 
registrars and clinical consultants consider important to record in the medical record, and to 
what extent do registrars record this information themselves?
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This chapter summarizes and discusses the answers to these questions, placing them in a broader 
perspective. Figure 1 shows the main findings and recommendations. On the basis of the current 
literature and the findings of this thesis, we also present a composite theoretical/conceptual model 
which describes the relationships between the normative rational pharmacotherapeutic process 
in clinical practice (WHO 6 step), therapeutic reasoning (by experienced and non-experienced 
prescribers), and context-based learning, a model which can form the basis for future research and 
educational innovations. We conclude this chapter with some practical implications and future 
perspectives, based on our findings. 
Situation
Chapter 2
In order to describe the current situation in clinical pharmacology and therapeutics (CPT) education, 
we reviewed the literature on CPT teaching of the last 40–50 years, with emphasis on the therapeutic 
reasoning of undergraduate medical students. The rational prescribing of drugs is an essential skill that 
medical doctors should have acquired by the time they practise medicine. Clinical pharmacologists 
have an important role in the development of these skills, by teaching undergraduate medical students 
CPT. Even though CPT teaching has undergone many changes over the last decades, it is essential that 
it continues to be a major part of the undergraduate medical curriculum. This chapter describes the 
learning objectives for teaching therapeutic knowledge and skills to undergraduate medical students, 
with emphasis on therapeutic decision-making. Subsequently, on the basis of current theories of 
cognitive psychology and medical education, context-based learning is presented as an effective way 
to teach/train therapeutic skills. Lastly, an example of a CPT curriculum is presented.
Chapter 3
In order to investigate possible differences in the therapeutic decision-making process of 
inexperienced and experienced prescribers, we performed a nationwide study of the therapeutic 
decision-making process of medical students and their teachers (GPs and clinical specialists). 
We found that medical teachers mainly based their drug choice on clinical experience and drug-
related factors, whereas final-year medical students mainly based their drug choice on examples 
provided by their medical teachers. It is therefore essential that medical teachers clearly explain 
to their students how they arrive at a specific drug choice since medical students tend to copy 
the therapeutic drug choices of their teachers, mainly because of a lack of experience. Presenting 
students with clinical therapeutic problems early during undergraduate training will not only give 
them a chance to gain experience in solving medical problems, but will also give meaning to what 
they are studying, as opposed to merely reproducing what they learn or copying what they are told.
Context
Chapter 4
In order to investigate whether a preclinical context-based learning programme in pharmacotherapy 
has a long-term and transferable effect on the rational prescribing competence of medical students, 
we performed an observational study during the clinical phase of the medical curriculum. A large 
group of students followed the entire programme (n = 197), a control group did not follow the 
programme (n = 33), one group followed the programme for one year, and another group followed 
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the programme for two years. Preclinical pharmacotherapy context-based learning was found 
to improve the rational prescribing of medical students during their clinical clerkship in internal 
medicine (long-term effect). This improvement was seen not only for the clinical diseases taught 
during the pharmacotherapy curriculum, but also for other diseases. This implies that students 
not only remember the specific information they have learned during training but are also able to 
apply the acquired skills to new situations (transfer effect). 
Chapter 5
In order to explore the possible effect of the level of realism of context-based learning on the prescribing 
competence of medical students during clinical clerkships, we investigated, in an exploratory study, the 
optimal learning context for prescribing competencies in the clinical phase of the medical curriculum. 
We found that increasing the realism of context-based learning improved the rational prescribing 
skills of medical students during their clinical clerkship in internal medicine. Clinical (pharmacology) 
teachers should be aware that seemingly small adaptations to the learning context of prescribing 
training during clinical clerkships (i.e. with or without involvement in and responsibility for patient 
care) might have a relatively large impact on the prescribing competence of future doctors.
Chapter 6
We studied the feasibility of incorporating structured therapeutic consultations into the clinical 
clerkship internal medicine. These consultations were considered feasible if students were able 
to draw up a therapeutic plan and carry out a consultation, and if students and their supervisors 
considered therapeutic consultations workable and useful. This study showed that incorporating a 
structured therapeutic consultation with a real patient into the clinical clerkship internal medicine 
was both feasible and valuable. This may be an important step to improving the prescribing skills and 
attitudes of junior doctors and residents and to reducing their prescribing errors after graduation.
Structure
Chapter 7
In order to study the effect of further structuring of one of the steps of the WHO 6-step method 
(treatment goal) on the prescribing skills of medical students, we performed a prospective, randomized 
controlled minimal intervention study with one control and two intervention groups (WHO group and 
SMART group). Second-year medical students were asked to complete a WHO 6-step treatment plan for 
four written case reports of patients with asthma. The treatment plans were assessed using a standard 
scoring sheet developed by a Delphi procedure among respiratory physicians from all eight university 
medical centres in the Netherlands. Use of the SMART criteria improved the ability of students to set 
treatment goals and to monitor treatment. Better setting of treatment goals was associated with better 
treatment monitoring. SMART criteria might be an effective way to improve the setting of treatment 
goals and could be included in the next edition of the WHO Guide to Good Prescribing.
Chapter 8
Lastly, to investigate to what extent medical records are structured (i.e. preformatted with relevant 
headings) in terms of therapeutic information, which therapeutic data registrars and clinical 
consultants consider should be recorded, and to what extent registrars record this information 
themselves, we carried out a multicentre observational study in the internal medicine outpatient 
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clinic of five teaching hospitals in the Netherlands. What was considered relevant information and 
actual recording of therapeutic information were compared with the information provided for 
a reference list of 35 therapeutic items based on the WHO Guide to Good Prescribing (e.g. drug 
name, drug dosage, indication for drug, check for contraindications). The structure and content of 
current paper and electronic medical records was found not to be adequate. While both registrars 
and consultants agreed on the importance of recording most of the 35 therapeutic items, registrars 
failed to record most of this information in practice.
2. COMPOSITe THeOreTICAl MODel OF (PHArMACO) THerAPeuTIC 
PrACTICe, reASOnInG, AnD leArnInG
In order to improve our understanding of successful educational strategies to ease the transition 
from medical student to junior doctor with regard to prescribing responsibilities, we need to 
broaden the way we look at CPT teaching. Prescribing is a complex task in which doctors need 
to combine various high-level cognitive processes. We argue that the development of successful 
strategies to teach prescribing is more complex than just providing a 6-step normative model of 
therapeutic reasoning (WHO 6 step). We think that, in addition to the WHO 6-step model, a strategy 
for teaching prescribing should incorporate the hypothetical model of therapeutic reasoning and 
the concept of contextual learning. Such a strategy or model could serve as a framework for future 
research and educational innovations. It would combine current knowledge of the normative 
WHO 6 step model, knowledge (and hypotheses) of the differences in therapeutic reasoning 
between experienced and inexperienced prescribers, and knowledge of essential components of 
the learning context. This type of composite model would enable us to understand the relationship 
between those three (hypothetical) models.
Description of the three individual models
Model 1: WHO 6-step
The WHO 6-step method is a normative model for therapeutic reasoning and prescribing and 
provides a six-step guide to the process of rational prescribing (see table 1). All six steps are partly 
based on the core learning objectives formulated by Nierenberg and Walley, namely, knowledge, 
skills, and attitudes.19;20 The six steps are: Step 1, define the patient’s problem; Step 2, specify the 
therapeutic objective; Step 3, choose a (drug) treatment, taking all relevant patient characteristics 
into account; Step 4, “write a prescription;” Step 5, give information to the patient; and Step 6, take 
monitoring measurements. After step 6, the therapeutic process begins again after monitoring 
results have been obtained. The WHO 6-step method is used worldwide, 16;21;22 and in all eight 
medical schools in the Netherlands,23 to stimulate the rational prescribing of medication. The 
WHO 6-step has been shown to improve prescribing.16;22
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Table 1 | World  Health  Organization  6-step  model  of  rational prescribing 24
Steps Description
Step 1 Define the patient’s problem
Step 2 Specify the therapeutic objective
Step 3a Choose your standard treatment (P-drug)
Step 3b Verify the suitability of your treatment (P-drug)
Step 4 Start the treatment
Step 5 Give information, instructions and warnings
Step 6 Monitor (and stop?) treatment
Model 2: Therapeutic reasoning
Given the similarities between therapeutic and diagnostic reasoning, it is possible to construct a 
hypothetical model of therapeutic reasoning (Figure 2).25;26 Once the diagnosis has been established, 
one or more treatment scripts will be called up from memory. In order to determine the right treatment 
and based on the amount of experience the doctor has, an analytical or non-analytical process will 
start. This process is similar to the process of diagnostic reasoning. The chosen treatment and its effect 
will contribute to the modification of the existing treatment scripts or may result in a new treatment 
script. In psychological studies of judgement and choice, the non-analytic and analytic processes 
are termed system 1 (non-analytical) and system 2 (analytical), respectively. 27;28 Experts often make 
decisions based on the non-analytical system 1, which is characterized by fast, unconscious, intuitive, 
experience-based, effortless, and implicit judgements governed by habit and recognition. 25;27 In 
contrast, non-experts often make decisions based on the analytical system 2, which is characterized 
by the fact that it is slow, conscious, systematic, theory-based, effortful, and explicit. 25;27
Analytic
slow, conscious, 
systematic, evidence 
based, novice
Non-analytic
fast, unconscious, 
heuristic, experience 
based, expert
Diagnosis Treatment
Therapie scriptTreatment script
Figure 2 | Hypothetical model of therapeutic reasoning 25;26
126
Chapter 9
Model 3: Contextual learning 
Contextual learning is defined as learning in a setting that is similar to the setting of the future 
profession.29 Gaining and simultaneously applying knowledge in practice is essential for learning 
(figure 3). In many ways, contextual learning seems to be more effective than sequential learning, 
in which learning and applying knowledge are distinct activities.30;31 The greater effectiveness of 
contextual learning can be explained in terms of cognitive psychology and medical problem-solving 
theory,30;32 by which the way in which knowledge is stored in the brain is essential for its recall and 
application. Therefore, storing knowledge in combination with the situation in which this knowledge 
will be applied benefits the speed and quality with which the information is recalled.30;33;33
Contextual Learning
Clinical practice Theory (books,etc)
Specific experiences Abstract theoratical concepts
Memory networks
 
Evoked sets/ therapy 
scripts 
Figure 3 | Model of contextual learning in which knowledge is gained and at the same time applied in clinical practice
Description of our composite theoretical model
Drawing on the literature and our findings, we developed a composite theoretical/conceptual model 
(figure 4) that describes the relationships between the normative rational pharmacotherapeutic 
process in clinical practice (WHO 6 step), therapeutic reasoning (in experienced and non-experienced 
prescribers), and contextual learning. With minor modification of the three hypothetical models, 
the composite model provides insight into the relationship between the three (hypothetical) 
models and can form a framework for future research and educational innovation. 
Modifications and new insights based on this thesis
Normative therapeutic process (WHO 6 step) (yellow box)
The horizontal core of the composite model consists of model 1, the WHO 6-step (yellow box), which 
describes the normative pharmacotherapeutic process in clinical practice.24 As described earlier, 
inexperienced prescribers as non-experts make therapeutic decisions based on a slow analytical 
process of reasoning. However, our brains always try to create shortcuts to make decision-making 
easier and faster. This is perfectly illustrated by the findings presented in chapter 3, which showed 
that during clinical clerkships students tended to copy the therapy choices of their clinical teachers
127
Summary and General discussion
9
Contextual Learning
Clinical 
structure 
WHO-6 step
Clinical/
Therapeutic 
reasoning
1.Diagnosis 2.Ther goal
Non analytic (expert/system 1)
Fast, unconscious, intuitive, 
experience-based, effortless, implicit 
(not available to introspection), 
governed by habit
4.Start 
treatment 
choice
5.Patient 
information
6.Monitoring 
treatment
Clinical practice
Specific experiences
Theory (books,etc)
Abstract theor. concepts
Responsibility
for patient care
Treatment scripts
diagnosis and solution
3a. P(ersonal) treatment
set of relevant therapies 
for common conditions 
and complaints 
 
3b. Analytic (novice/system 2)
Slow, systematic, theory-based, 
effortful, relatively flexible, potentially 
rule governed, more likely to be 
consciously monitored 
+
M
etacognition
Memory networks
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Figure 4 | Current understanding of how students and junior doctors learn to prescribe drugs can be summarized 
in a composite model based on three separate models, namely, the normative rational pharmacotherapeutic 
process in clinical practice (WHO 6 step), therapeutic reasoning (in experienced and non-experienced prescribers), 
and contextual learning
as a way to creating a shortcut in the therapeutic process. Although this might speed up the 
therapeutic process, it might be dangerous if students do not know the reason why a specific therapy 
was chosen and could lead to inappropriate therapeutic decisions when students treat new patients 
with the same disease but with other patient characteristics (such as age, pregnancy, comorbidity, 
and comedication) in the future. It is essential that clinical teachers clearly explain why they chose a 
specific treatment, so as to prevent students from storing incorrect or incomplete treatment scripts 
in their memory. Experts may find it difficult to explain the arguments underlying their therapy 
choices because they probably made their decision unconsciously and non-analytically. This problem 
might be resolved by using the ‘backward reasoning’ technique, whereby experts try to formulate 
and reconstruct the arguments for their decision afterwards. ‘Backward reasoning’ has been added 
to the composed model as a purple arrow (figure 4). Another way to prevent copying behaviour 
is to present students with clinical therapeutic problems early during undergraduate training (for 
example, role play sessions), to give them a chance to gain experience in solving medical problems. 
In the study presented in chapter 4, we found that a preclinical training programme based on the 
WHO 6-step method not only had a short-term effect directly after programme completion 34 but 
also had a long term and transfer effect – the improvement in rational prescribing persisted during 
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ensuing clinical clerkships (long-term effect), showing that students could apply this ability to new 
clinical situations (transfer effect). 
Lastly, the studies described in chapters 6 and 7 showed that providing additional structure, 
for example, SMART criteria in treatment goal setting (step 2 of the WHO 6 step) and 
structuring the recording of therapeutic information in the medical record, might facilitate the 
pharmacotherapeutic reasoning of inexperienced prescribers in clinical practice.
Therapeutic reasoning (brown box)
The first minor but important difference in the composite model compared with the earlier 
described hypothetical model of therapeutic reasoning (figure 2) is that ‘P(ersonal) treatments’ are 
specifically linked to analytical system 2, and ‘treatment scripts’ to the non-analytical and intuitive 
system 1. In the hypothetical model of Bissessur et al,25 treatment scripts are linked to both 
systems. However, a ‘treatment script’ can be defined as the intuitive recognition of a combination 
of diagnosis, specific patient factors (e.g. age, comorbidity, etc), and the best pharmacotherapy 
in that specific situation/case. Therefore, treatment scripts do not fit in the analytical system 
in which therapeutic options are explicitly compared to each other. This is in line with previous 
psychological research on the intuitive decisions taken by experienced decision-makers working 
under pressure in real-life situations (fire commanders, paramedics, and others making split-
second decisions on the job).35 These studies show that experienced decision-makers rarely need 
to choose between options because in most cases only a single option (solution) comes to their 
mind.27;35 Although it has not been studied extensively,36 we have no reason to believe that the 
situation is different when doctors make intuitive therapeutic decisions. 
As our brains have a limited overall capacity for mental effort, intuitive decision-making is essential 
to enable a person to function in a professional environment with complex tasks that need to be 
performed under time pressure. Moreover, it has been argued that skilled decision-makers often 
do better when they trust their intuition than when they engage in slow analytical reasoning 
processes.27;37 However, intuitive decision-making is not always flawless and is sometimes influenced 
by cognitive errors or bias.38;39 Therefore, one of the important tasks of system 2 (effortful) is to 
monitor the quality of both systems, including the correction of cognitive errors.27;40;41 In cognitive 
psychology, this process of monitoring is known as metacognition (added to our model and 
indicated with a blue arrow between system 1 and 2) 17;42 or ‘slowing down when you should’.17;43
Being aware of the characteristics of systems 1 and 2, it is of course the question whether 
pharmacotherapy education should focus on system 1 or system 2. We, as well as McLellan et 
al, argue that medical education should ensure that students become, as much as possible, 
experts in prescribing before they enter medical practice.17 Until now, most pharmacotherapeutic 
educational interventions have focused on the development of analytical reasoning processes 
(system 2: slow, conscious, systematic), for example as part of the worldwide used WHO 6-step 
method,16;22;24 instead of focusing on creating the learning conditions that support and accelerate 
the acquisition of therapeutic reasoning as an expert. 
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Contextual learning (blue box)
The contextual learning framework is ideal for understanding which learning conditions encourage 
the development of expertise (i.e. rich and easily accessible treatment scripts). As described in 
chapter 5, context is much more than just the physical environment in which learning takes place, 
and (clinical) teachers can enrich the learning context with subtle adjustments. For example, as 
illustrated in figure 4 by the green arrow (between the WHO 6 step and the treatment scripts), one 
way to create treatment scripts is by the frequent training of prescribing skills (e.g. during role play 
sessions) and thereby analytical completion of the WHO 6-step process. However, we argue that the 
most effective way to create rich and easily accessible treatment scripts is by training in real practice 
with real responsibility for patient care (added to the contextual learning model). In chapter 5, we 
described the added value of this real responsibility during the clinical training of prescribing skills. 
Finally, in chapter 6, we showed that incorporating structured therapeutic consultations with real 
responsibility for patient care into the clinical clerkships is both feasible and valuable.
Conclusion
The overlap of the three models shows that treatment scripts and P-(ersonal) treatment play a 
crucial role in how a student learns to choose a treatment for individual patients, both analytically 
and non-analytically. We argue that the most efficient way to develop rich and easily accessible 
treatment scripts is by gaining experience in prescribing in real clinical practice as early as possible 
during medical training. Teachers should be aware that seemingly small adaptations to the 
learning context of prescribing training during clinical clerkships (i.e. with or without responsibility 
for patient care) could have a relatively large impact on the development of prescribing 
competencies. Medical education should promote the development of students’ prescribing skills 
and competence as early as possible, at least by the end of the undergraduate curriculum, because 
recently graduated doctors write a large proportion of prescriptions in hospitals. This requires 
rich and easily accessible therapy scripts, which can only be achieved by gaining experience in 
prescribing for real patients. 
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3. PrACTICAl IMPlICATIOnS AnD FuTure PerSPeCTIveS FOr eDuCATIOn 
(In ClInICAl PrACTICe), reSeArCH, AnD OrGAnIzATIOn
The studies described in this thesis investigated the possibilities of improving the rational prescribing 
of medical students by means of a context-based learning programme in pharmacotherapy based 
on the WHO six-step method. Many of the studies highlighted the importance of understanding 
successful contextual educational strategies and differences in the therapeutic reasoning of 
inexperienced and experienced prescribers, in order to ease the transition from medical student 
to junior doctor with regard to prescribing responsibilities. We conclude the thesis with a summary 
of the practical implications and future perspectives of our findings for CPT education (in clinical 
practice), research, and organization.
education 
1. Clinical teachers should be aware that medical students copy their drug choices during 
clinical clerkships. Teachers should therefore explicitly discuss the arguments underlying 
their choice of drug, even though as experts they probably did not make their choice 
consciously or analytically. Backward reasoning might help them to explain their ‘intuitively 
made’ choices to students. This can ensure that fewer ‘false’ or ‘incomplete’ therapy scripts 
are stored in memory, which might lead to fewer prescribing errors in the future.
2. Medical education should promote the development of therapeutic (and diagnostic) 
reasoning in students. To date, most pharmacotherapeutic educational interventions have 
focused on the development of analytical reasoning (system 2: non-expert, slow, conscious, 
effortful, systematic) instead of focusing on the creation of learning conditions that encourage 
therapeutic reasoning as an expert.
3. Students should be given the opportunity to train the whole task of prescribing medications 
17 in the complex context of real practice and with responsibility for patient care. This leads 
to an earlier and better development of richer and more easily accessible treatment scripts 
before medical students have prescribing responsibilities as junior doctors. Teachers should 
be aware that seemingly small adaptations to the learning context of prescribing training 
during clinical clerkships (i.e. with or without responsibility for patient care) could have 
a relatively large impact on the prescribing competencies of future doctors. While the 
studies of this thesis focused in particular on training during clinical clerkships, we think 
that training pharmacotherapeutic skills with real responsibility for patient care should start 
as early as possible (from the first year of the medical curriculum). An interesting method 
to achieve this might be learner-centred student-run clinics (LC-SRC), in which teams of 
medical students (1st–5th year) are responsible for the therapeutic care of real patients.44 A 
recent systematic review of student outcomes after participation in student-run clinics (SRC), 
which are common in North America, where they provide care for uninsured patients,45 
showed that students appreciated the early training opportunity, and that the quality of care 
provide in SRCs was adequate. However, little is known about the effect of SRC participation 
on students’ skills/knowledge.45;46 The LC-SRC project started in 2013 at the VU University 
Medical Center, in an internal medicine outpatient clinic (the first SRC with insured patients), 
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is feasible, based on the opinions of students, patients, and clinical supervisors.44;46 On the 
basis of this preliminary success, the LC-SRC project has recently been extended to include 
other initiatives: a student-run cardiovascular risk management programme, carried out in 
a general practitioner’s office, student-led management and treatment of thyroid diseases, 
and student-led assessment of adverse drug reaction reports in collaboration with the 
Netherlands Pharmacovigilance Centre Lareb.46 The effects of these LC-SRCs are currently 
being investigated.
4. Where necessary, additional structure should be provided to help inexperienced prescribers 
prescribe rationally, for example, by setting treatment goals and recording therapeutic 
information in the medical record. SMART criteria might be an effective way to improve 
treatment goal setting and could be included in the next edition of the WHO Guide to Good 
Prescribing. The recording of therapeutic information in the medical record in a structured 
manner might improve medication safety and the training of new generations of prescribers. 
Therefore, the necessity, optimal content, and effect of having a structured section in the 
medical record for therapeutic information needs to be determined.
Future research 
5. In this chapter, we presented a composite theoretical/conceptual model (figure 4) that 
describes the relationships between the normative rational pharmacotherapeutic process in 
clinical practice (WHO 6 step), therapeutic reasoning (in experienced and non-experienced 
prescribers), and context-based learning to prescribe. This framework, which could be 
used for future research and educational innovations, not only provides insight into the 
relationships and the overlap between the three existing models, but also helps us to 
identify gaps in our understanding of the conceptual model. This leads, among others, to the 
following research questions that need to be answered in the future: 
• To what extent does learning in real practice with responsibility for patient care (for example 
in a LC-SRC) accelerate the development of rich and easily accessible treatment scripts?
• What is the influence of learning with responsibility for patient care in the earliest 
phases of the medical curriculum (for example the 1st year)?
• What are the differences in therapeutic reasoning between non experienced, medium 
experienced, and experienced prescribers of medication?
• Is metacognition or ‘slowing down when you should’ trainable in therapeutic decisions?
• To what extent will a structured discussion of drug choices between trainee doctors 
and their supervisors (e.g. GPs in training) lead to better (rich and easily accessible) 
therapy scripts?
• What is the optimal content and effect of having a structured section for therapeutic 
information in the medical record? And is this structure helpful for inexperienced 
prescribers, such as interns and physicians in training?
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Organization
6. As described in chapter 2, it is difficult to get sufficient support from policy-makers, such as 
faculty boards, for a CPT curriculum. To achieve a successful, longitudinal (years 1–6) and 
integrated CPT curriculum, the input of other professionals, such as doctors, pharmacists, and 
the local Institute of Education and Training, is needed because clinical pharmacologists cannot 
and should not work on this alone. But the most important input is that of medical students. 
Therefore our main recommendation concerning the organization of CPT education is to enable 
students to play a significant role in organizing, conducting, and investigating CPT education.  
In many European medical schools, the department of pharmacology and clinical pharmacology is 
often small and staff may think they are not able to deliver a relatively labour-intensive contextual 
learning programme in pharmacology (i.e. role-play sessions, working groups, student run clinics, 
etc). This ‘problem’ can be resolved by actively involving students in CPT teaching. The section 
Pharmacotherapy, of the department Internal Medicine, at the VU University Medical Center 
has 20 years of experience with active student involvement. Student assistants play a crucial 
role in providing the energy and ideas for constant change and innovation, and the section 
Pharmacotherapy organizes a master class in pharmacotherapy. The master class is for students 
who have shown particular aptitude during pharmacotherapy training sessions and is led by three 
student coordinators (who have previously followed the master class). Participants are trained 
to teach according to the WHO 6-step method 47 and receive additional training for small-group 
teaching from the Department of Teacher Professionalization of the VUmc School of Medical 
Sciences. These participants then give pharmacotherapy training to younger (at least one year 
below them) students, under the supervision and coaching of experienced teachers. The student 
teachers are also trained by clinical experts (such as clinical pharmacologists, clinical specialists and 
pharmacists) to deepen their knowledge and therapeutic reasoning skills with regard to specific 
clinical cases. Besides explicit training for teaching sessions, other activities are organized for 
master class participants, such as in-depth sessions on interesting topics such as drugs, toxicology, 
drug dosing in patients with renal impairment, and visits to drug development facilities. 
The central role of students in organizing, conducting, and investigating CPT education is a win-
win venture for both students and faculty (departments). It allows students to gain a deeper 
understanding of clinical pharmacology and teaching (including research and development of 
education), and it provides the department with a constant supply of new energy and willingness 
to develop and improve education with and for students. Lastly, the involvement of students in 
this way in all facets of education gives them the responsibility for dealing with real (educational) 
problems, which hopefully will lead to a generation of doctors who remain intrinsically motivated 
teachers throughout their careers.
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samenvaTTinG
Artsen moeten rationeel geneesmiddelen kunnen voorschrijven. Dit geldt in het bijzonder voor 
net afgestudeerde artsen, die verantwoordelijk zijn voor het grootste deel van de recepten voor 
patiënten in het ziekenhuis. Daarom is het belangrijk dat medische curricula medisch studenten 
goed voorbereiden op deze belangrijke en ingewikkelde taak. Desondanks wordt in veel 
wetenschappelijke studies gerapporteerd dat net afgestudeerde artsen zich onvoorbereid voelen 
op hun nieuwe en uitdagende taak als voorschrijver. Ook volgens specialisten in de kliniek zijn 
net afgestudeerde artsen in het Verenigd Koninkrijk niet goed voorbereid op het voorschrijven 
van medicatie. Een studie uit 2015 toonde aan dat jonge afgestudeerde artsen (een of twee jaar 
in opleiding) meer dan twee keer zo vaak een fout maakten bij het voorschrijven van medicatie. 
Dit is in lijn met de EQUIP studie uit 2009 waarbij een foutenpercentage tot 10,3% gezien werd 
bij net afgestudeerde artsen. In verschillende studies wordt beschreven dat afgestudeerde 
basisartsen vinden dat de geneeskunde opleiding hen niet voldoende voorbereid heeft op 
hun  voorschrijf verantwoordelijkheden. In het rapport van de EQUIP studie wordt voorgesteld 
om onderwijsinterventies te ontwikkelen die de transitie van niet voorschrijver (medisch 
student) naar voorschrijver (basis arts) vergemakkelijken waardoor het aantal voorschrijffouten 
wordt gereduceerd. Helaas is er weinig bekend over hoe deze onderwijsinnovaties er in de 
praktijk uit zouden moeten zien. Twee review artikelen gaven aan dat er een sterke behoefte 
is aan exploratief onderzoek waarop het ontwerp van curricula voor het trainen van voorschrijf 
vaardigheden gebaseerd kan worden. Om artsen beter te laten voorschrijven stelde McClellan 
voor dat er interventies ontwikkeld moesten worden die gebaseerd zijn op de ‘real life’ context. 
Medisch studenten zouden geobserveerd en geëvalueerd moeten worden in de context van hun 
toekomstige werkplek. Om te begrijpen welke methode werkt en  onder welke condities, moeten 
we onderwijsinterventies onderzoeken die de ontwikkeling van expertise op het gebied van 
medicatie voorschrijven stimuleren. Dit was de motivatie voor de studies die beschreven staan 
in dit proefschrift. Het belangrijkste doel van dit proefschrift was het ‘onderzoeken en exploreren 
van mogelijkheden om het rationeel voorschrijfgedrag van medisch studenten te verbeteren 
tijdens een context gebonden farmacotherapie onderwijsprogramma gebaseerd op het WHO 
6-stappenplan’. De volgende onderzoeksvragen werden geformuleerd:
1. Wat is de huidige situatie met betrekking tot de ontwikkeling van het klinische farmacologie 
en farmacotherapie onderwijs en zijn er verschillen in het therapeutisch beslissingsproces 
van onervaren en ervaren voorschrijvers van medicatie?
2. Heeft een preklinisch context-gebonden farmacotherapie onderwijsprogramma een lange 
termijn en transfer effect op het rationeel voorschrijfgedrag van medisch studenten? 
Wat is de invloed van de mate van realiteit van de leer context tijdens coschappen op de 
voorschrijfvaardigheden van medisch studenten, en is het mogelijk om gestructureerde 
therapeutische consulten met echte patiënten toe te voegen aan de coschappen?   
3. Beïnvloedt een verdere structurering van een van de stappen van het WHO 6 
stappenplan (therapeutisch doel) de voorschrijfvaardigheden van medisch studenten? 
In hoeverre zijn patiënten dossiers voor-gestructureerd voor therapeutische informatie 
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in opleidingsziekenhuizen in Nederland, van welke therapeutische gegevens vinden arts-
assistenten en specialisten het essentieel dat ze genoteerd worden in de patiënten status, en 
in welke mate wordt deze informatie ook door arts-assistenten zelf genoteerd?
Dit hoofdstuk vat de antwoorden op deze vragen samen en bediscussieert deze door ze in een 
breder perspectief te plaatsen. Op basis van de huidige literatuur en de bevindingen in dit 
proefschrift wordt tevens een samengesteld theoretisch/conceptueel model gepresenteerd. 
Dit model beschrijft de relaties tussen het normatieve rationele farmacotherapeutische proces 
(WHO 6 step), therapeutisch redeneren (door ervaren en onervaren voorschrijvers), en context 
gebonden leren en kan een basis vormen voor toekomstig wetenschappelijk onderzoek van 
farmacotherapie onderwijs en onderwijs innovaties. We besluiten dit hoofdstuk met een aantal 
praktische implicaties en toekomst perspectieven gebaseerd op de  bevindingen in dit proefschrift.
Huidige situatie
Hoofdstuk 2
Om de huidige situatie in het klinisch farmacologisch en therapeutisch (CPT) onderwijs te 
beschrijven, hebben we een review gemaakt van de literatuur over CPT onderwijs van de afgelopen 
50 jaar waarbij de nadruk ligt op het therapeutisch redeneren van medisch studenten. Het 
rationeel voorschrijven van geneesmiddelen is een essentiële vaardigheid die medisch studenten 
zich eigen moeten hebben gemaakt voordat ze het beroep van arts gaan praktiseren. Klinisch 
farmacologen spelen een belangrijke rol bij het ontwikkelen van deze vaardigheid, middels het 
geven van CPT onderwijs aan medisch studenten. Ondanks dat het CPT onderwijs de afgelopen 
decennia veel veranderingen heeft ondergaan, is het essentieel dat het een belangrijk onderdeel 
blijft van het medisch curriculum. Dit hoofdstuk beschrijft de leerdoelen voor het onderwijs in 
farmacotherapeutische kennis en vaardigheden aan medisch studenten, met de nadruk op het 
farmacotherapeutisch besluitvormingsproces. Daarnaast wordt, op basis van de huidige theorieën 
in de cognitieve psychologie en medisch onderwijs, context gebonden leren gepresenteerd als een 
effectieve manier om therapeutische vaardigheden te trainen. Tot slot wordt een voorbeeld van 
een CPT curriculum beschreven.   
Hoofdstuk 3
Om mogelijke verschillen aan te tonen in het therapeutisch beslissingsproces tussen onervaren 
en ervaren voorschrijvers, hebben we een landelijke studie uitgevoerd naar het therapeutisch 
beslissingsproces van medisch studenten en hun docenten (huisartsen en klinisch specialisten). 
We vonden dat de docenten hun medicatie keuze met name baseerden op klinische ervaring en 
medicatie gerelateerde factoren, terwijl zesde jaar medisch studenten hun medicatiekeuze met 
name baseerden op de voorbeelden van hun opleiders. Het is daarom van essentieel belang dat 
medisch docenten  duidelijk uitleggen aan hun studenten hoe ze hun specifieke medicatie keuze 
gemaakt hebben aangezien medisch studenten de neiging hebben om de therapiekeuzes van hun 
docenten te kopiëren, met name vanwege hun eigen gebrek aan ervaring. Studenten moeten in 
een vroeg stadium van de medische opleiding blootgesteld worden aan klinische therapeutische 
problemen. Dit zal ze niet alleen een kans geven om ervaring op te bouwen in het oplossen van 
medische problemen, maar zal ook betekenis geven aan wat ze bestuderen in tegenstelling tot het 
louter reproduceren van wat ze leren of kopiëren wat ze verteld wordt.
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Context
Hoofdstuk 4
Om te onderzoeken of een preklinisch context gebonden farmacotherapie onderwijs programma 
een lange termijn en transfer effect heeft op het rationeel voorschrijfgedrag van medisch 
studenten, hebben we een observationele studie uitgevoerd tijdens de klinische fase van het 
medisch curriculum. Een grote groep studenten volgde het gehele onderwijsprogramma (n=197), 
een controle groep volgde het programma niet (n=33), een groep volgde het programma voor 
een jaar en een andere groep voor twee jaar. Preklinisch farmacotherapeutisch context gebonden 
leren verbeterde het rationeel voorschrijfgedrag van medisch studenten tijdens het coschap 
interne geneeskunde (lange termijn effect). Deze verbetering werd niet alleen gezien voor klinische 
ziektebeelden die getraind waren tijdens het farmacotherapie curriculum, maar ook voor nieuwe 
ziektebeelden. Dit betekent dat de studenten zich niet alleen de specifieke informatie herinnerden 
die geleerd was tijdens de trainingen maar dat ze ook in staat zijn om de opgedane vaardigheden 
toe te passen in nieuwe situaties (transfer effect).
Hoofdstuk 5
Om de mogelijke effecten te onderzoeken van het niveau van realisme van context gebonden 
leren op de voorschrijfvaardigheden van medisch studenten tijdens de coschappen, hebben we in 
een exploratieve studie de optimale leercontext voor voorschrijfvaardigheden tijdens de klinische 
fase van het medisch curriculum onderzocht. We vonden dat het verhogen van het realisme 
van context gebonden leren de rationele voorschrijven vaardigheden van medische studenten 
tijdens hun klinische stage interne geneeskunde verbeterd. Klinische (farmacologie) docenten 
moeten zich er bewust van zijn dat ogenschijnlijk kleine aanpassingen aan de leer context van 
de voorschrijf training tijdens coschappen (dat wil zeggen met of zonder betrokkenheid bij 
en verantwoordelijkheid voor de patiëntenzorg) een relatief grote invloed op de voorschrijf 
vaardigheden van toekomstige artsen zou kunnen hebben.
Hoofdstuk 6
In dit hoofdstuk onderzochten we de haalbaarheid van het opnemen van gestructureerde 
therapeutische consulten in het coschap interne geneeskunde. Deze consulten werden als 
haalbaar beschouwd als de studenten in staat waren om een therapeutisch plan op te stellen en 
een therapeutisch consult uit te voeren, en als de studenten en hun opleiders deze therapeutische 
consulten als werkbaar en nuttig beschouwden. Deze studie toonde aan dat het opnemen van een 
gestructureerd therapeutisch consult met een echte patiënt in het coschap interne geneeskunde 
haalbaar en van toegevoegde waarde was. Dit kan een belangrijke stap zijn in de verbetering van 
de voorschrijf vaardigheden en attitudes van net afgestudeerde basisartsen en arts-assistenten bij 
het verminderen van hun voorschrijf fouten na afstuderen.
Structuur
Hoofdstuk 7
Om het effect te onderzoeken  van een verdere structurering van één van de stappen van het 
WHO 6 stappen plan (therapeutisch doel) op de voorschrijfvaardigheden van medisch studenten, 
hebben we een prospectief, gerandomiseerde minimale interventie studie uitgevoerd met een 
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controle en twee interventie groepen (WHO groep en de SMART groep). Tweede jaar medisch 
studenten werd gevraagd om een WHO 6 stappen behandelplan op te stellen voor vier papieren 
patiënten casus met als onderwerp astma. De behandelplannen werden beoordeeld met behulp 
van een standaard beoordelingsmodel, dat is ontwikkeld met behulp van een Delphi procedure 
onder longartsen van alle acht universitaire medische centra in Nederland. Het gebruik van de 
SMART-criteria verbeterde het vermogen van de studenten om therapeutische doelen te stellen 
en om de behandeling te controleren.  Het beter vaststellen van therapeutische doelen was 
geassocieerd met een betere controle van de behandeling. SMART-criteria kunnen een effectieve 
manier zijn om het vaststellen van therapeutische doelen te verbeteren en kunnen worden 
toegevoegd aan de volgende editie van de WHO Guide to Good Prescribing. 
Hoofdstuk 8
Tot slot, om te onderzoeken in hoeverre patiënten dossiers voor gestructureerd zijn (dat wil zeggen 
pre geformatteerd met relevante kopjes) met betrekking tot therapeutische informatie, van welke 
therapeutische gegevens vinden arts-assistenten in opleiding en specialisten het essentieel dat 
ze genoteerd worden in het patiënten dossier, en in welke mate wordt deze informatie ook 
daadwerkelijk door arts-assistenten zelf genoteerd, hebben we een multicenter observationele 
studie uitgevoerd op de polikliniek interne geneeskunde van vijf opleidingsziekenhuizen in 
Nederland. Wat beschouwd werd als relevante informatie en het daadwerkelijke noteren van 
therapeutische informatie werden beide vergeleken met een referentielijst bestaande uit 35 
therapeutische items gebaseerd op de WHO Guide to Good Prescribing (zoals geneesmiddelnaam, 
dosering van het geneesmiddel, indicatie voor het geneesmiddel, controle op contra indicaties). 
De structuur en de inhoud van de huidige papieren en elektronische medische dossiers bleek 
niet voldoende te zijn. Ondanks dat zowel de arts-assistenten in opleiding en de specialisten het 
eens waren over het belang van het opnemen van de meeste van de 35 therapeutische items, 
noteerden arts-assistenten het meeste van deze informatie zelf niet in de praktijk.   
2. SAMenGeSTelD THeOreTISCH MODel vAn De (FArMACO) 
THerAPeuTISCHe PrAkTIJk, reDeneren en leren
Om ons begrip van succesvolle onderwijs strategieën om de transitie van medisch student naar 
arts-assistent wat betreft voorschrijf verantwoordelijkheden te vergroten, is het nodig om de 
manier waarop we naar CPT onderwijs kijken te verbreden. Het voorschrijven van medicatie is 
een complexe taak waarbij artsen verschillende cognitieve processen van hoog niveau moeten 
combineren. Wij stellen dat de ontwikkeling van succesvolle strategieën om voorschrijfgedrag 
aan te leren complexer is dan  alleen het aanbieden van een 6-stappen normatief model van 
therapeutisch redeneren (WHO 6 stap). We denken dat, naast het WHO-6 stappen model, een 
strategie voor het farmacotherapie onderwijs ook het hypothetisch model van therapeutisch 
redeneren en het concept van contextueel leren moet bevatten. Zo’n strategie of model kan 
dienen als een kader voor toekomstig onderzoek en onderwijs innovaties.  Dit kader zou de huidige 
kennis van het normatieve WHO 6 stappen model, de kennis (en hypotheses) van de verschillen in 
therapeutisch redeneren tussen ervaren en onervaren voorschrijvers, en de kennis van essentiële 
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componenten van de leer context combineren. Dit samengestelde model helpt ons om de relaties 
tussen deze drie (hypothetische) modellen beter te begrijpen. 
Beschrijving van de drie individuele modellen
Model 1: WHO 6 stappen model
De WHO 6 stappen methode is een normatief model voor therapeutisch redeneren en voorschrijven en 
biedt een zes-stap handleiding voor het proces van rationeel voorschrijven (zie tabel 1). Alle zes stappen 
zijn deels gebaseerd op kern leerdoelen zoals geformuleerd door Nierenberg en Walley, namelijk kennis, 
vaardigheden en attitudes. De 6 stappen zijn: stap 1, definieer het probleem van de patiënt;  stap 2, 
specificeer het therapeutisch doel; stap 3, kies een (medicamenteuze) behandeling, rekening houdend 
met alle relevante patiënt kenmerken; stap 4, schrijf een recept; stap 5, geef informatie aan de patiënt; 
en stap 6, controleer de behandeling. Na stap 6, begint het therapeutisch proces weer bij stap 1 nadat 
de resultaten van de controle bekend zijn. De WHO 6 stappen methode wordt wereldwijd gebruikt, 
en ook in alle 8 medische faculteiten in Nederland, om het rationeel voorschrijven van medicatie te 
stimuleren. Het is aangetoond dat de WHO 6 stappen methode het voorschrijven verbeterd. 
Tabel  1 | Wereld Gezondheids Organisatie (WHO) 6-stappen  model  van rationeel voorschrijven
Stappen Beschrijving
Stap 1 Definieer het probleem van de patiënt
Stap 2 Specificeer het therapeutisch doel
Stap 3a Kies je standard therapie (P-drug)
Stap 3b Controleer de geschiktheid van jouw behandeling 
Stap 4 Start de behandeling
Stap 5 Geef informatie, instructies en waarschuwingen
Stap 6 Controleer (en stop!) de behandeling
Model 2: Therapeutisch redeneren
Gezien de overeenkomsten tussen therapeutisch en diagnostisch redeneren , is het mogelijk om 
een hypothetisch model voor therapeutisch redeneren te construeren (figuur 2). Als de diagnose is 
vastgesteld, zullen één of meerdere therapeutische scripts opgeroepen worden vanuit het geheugen. 
Om vervolgens de juiste behandeling te kunnen bepalen wordt mede op basis van de hoeveelheid 
ervaring van de arts een analytische of non-analytische route gevolgd om tot een uiteindelijke 
therapiekeuze te komen. Deze twee routes zijn hetzelfde als bij het proces van diagnostisch 
redeneren. De gekozen behandeling en het effect van deze ingestelde behandeling zullen vervolgens 
bijdragen aan de aanpassing van reeds bestaande therapeutische scripts of zal leiden tot de vorming 
van nieuwe therapeutische scripts. In psychologische studies naar beoordeling en keuze, worden 
de analytische en non-analytische processen gelabeld als systeem 1 (non-analytisch) en systeem 
2 (analytisch). Experts nemen vaak beslissingen op basis van het non-analytische systeem 1, wat 
gekarakteriseerd kan worden als snel, onbewust, intuïtief, gebaseerd op ervaring, moeiteloos, en 
impliciete oordelen die bestuurd worden door gewoonte en herkenning. In tegenstelling tot niet 
experts  die vaak beslissingen nemen op basis van het analytische systeem 2. Dit systeem wordt 
gekarakteriseerd als langzaam, bewust, systematisch, gebaseerd op theorie, inspannend en expliciet.
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Figuur 2 | Hypothetisch model van therapeutisch redeneren
Model 3: Context gebonden leren
Context gebonden leren wordt gedefinieerd als leren in een setting die gelijk is aan de setting van de 
toekomstige beroepsuitoefening. Het tegelijkertijd verwerven en toepassen van kennis in de praktijk 
is essentieel voor het leren (figuur 3). In veel opzichten, lijkt context gebonden leren effectiever 
dan sequentieel leren, waarin het opdoen en toepassen van de kennis twee losstaande activiteiten 
zijn. De grotere effectiviteit van context gebonden leren kan verklaard worden vanuit de cognitieve 
psychologie en de medische probleem oplossing theorie, waarbij de manier waarop kennis  wordt 
opgeslagen in de hersenen essentieel is voor het oproepen en toepassen van deze kennis. Daarom 
zal het opslaan van kennis in combinatie met de situatie (context) waarin deze kennis zal worden 
toegepast, de snelheid en kwaliteit waarmee deze informatie wordt opgeroepen ten goede komen.  
Beschrijving van het samengestelde theoretische model
Gebaseerd op de literatuur en op de uitkomsten van dit proefschrift, hebben we een samengesteld 
theoretisch/conceptueel model (figuur 4) ontwikkeld dat de relaties beschrijft tussen het 
normatieve rationeel voorschrijfproces in de klinische praktijk (WHO 6 step), therapeutisch 
redeneren (in ervaren en onervaren voorschrijvers), en context gebonden leren. Met een aantal 
kleine aanpassingen aan de drie hypothetische modellen, geeft het samengestelde model inzicht 
in de relatie tussen de drie (hypothetische) modellen en kan dit een kader vormen voor toekomstig 
onderzoek en onderwijs innovaties.
Aanpassingen en nieuwe inzichten gebaseerd op dit proefschrift
Normatief therapeutisch proces (WHO 6 step) (gele kader)
De horizontale kern van het samengestelde model bestaat uit model 1, de WHO 6 step (gele 
kader), dat het normatieve farmacotherapeutische proces beschrijft in de klinische praktijk. 
Zoals eerder beschreven, nemen onervaren voorschrijvers zoals niet experts, therapeutische 
beslissingen op basis van een langzaam analytisch redeneer proces. Desondanks zullen onze 
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Langzaam, bewust, 
systematisch, evidence 
based, beginner
Non-analytisch
snel, onbewust, 
heuristieken, experience 
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Diagnose Behandeling/therapie
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hersenen altijd proberen om shortcuts te creëren om het beslissingsproces makkelijker en sneller 
te maken. Dit wordt geïllustreerd door de bevindingen in hoofdstuk 3. Deze resultaten lieten zien 
dat coassistenten geneigd zijn om de therapiekeuzes van hun klinische docenten te kopiëren als 
manier om een ‘short cut’ te creëren in het therapeutisch proces. Hoewel dit het therapeutisch 
proces kan versnellen, kan het gevaarlijk zijn als studenten niet de redenen kennen waarom een 
therapie was gekozen hetgeen zou kunnen leiden tot ongepaste therapeutische beslissingen als 
studenten nieuwe  patiënten met dezelfde ziekte maar met andere patiënt kenmerken (zoals 
leeftijd, zwangerschap, co morbiditeit en comedicatie) gaan behandelen. Het is essentieel dat 
klinische docenten duidelijk uitleggen waarom ze een bepaalde therapie keuze gemaakt hebben, 
zodat voorkomen kan worden dat studenten incorrecte of incomplete therapie scripts opslaan 
in hun geheugen. Experts zouden het moeilijk kunnen vinden om de argumenten achter hun 
therapiekeuzes uit te leggen omdat ze hun beslissing waarschijnlijk onbewust en non analytisch 
genomen hebben. Dit probleem kan  opgelost worden door gebruik te maken van de ‘achterwaarts 
redeneer’ techniek, waarbij experts achteraf proberen de argumenten voor hun beslissing te 
formuleren. ‘Achterwaarts redeneren’ is toegevoegd aan het samengestelde model als een paarse 
pijl (figuur 4). Een andere manier om kopieergedrag te voorkomen is door studenten vroeg in 
de geneeskunde opleiding bloot te stellen aan klinische therapeutische problemen (bijvoorbeeld 
tijdens rollenspel training), om ze op die manier een kans te geven ervaring op te doen met het 
oplossen van medische problemen.
In de studie in hoofdstuk 4 vonden we dat een preklinisch context gebonden farmacotherapie 
onderwijs programma gebaseerd op de WHO 6 step methode niet alleen korte termijn effect had 
direct na het afronden van het programma, maar ook een lange termijn en een transfer effect. 
Figuur 3 | Model van context gebonden leren waarbij kennis op hetzelfde moment wordt opgedaan als toege-
past in de klinische praktijk
Context gebonden Leren
Klinische praktijk Theorie (boeken, etc.)
Specifieke ervaringen Abstracte theoretische concepten
geheugen netwerken
 
Therapeutische
scripts
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Dit betekent dat de verbetering in rationeel voorschrijven aanhield tijdens de coschappen (lange 
termijn effect). Daarnaast  toonden we ook aan  dat studenten deze vaardigheid konden toepassen 
in nieuwe klinische situaties (transfer effect). 
Tot slot, beschrijven de studies in hoofdstuk 6 en 7 dat het aanbieden van extra structuur, 
bijvoorbeeld, SMART criteria bij het stellen van therapeutische doelen (stap 2 van de WHO 6 step) 
en het structureren van therapeutische informatie in het patiënten dossier, kan helpen bij het 
therapeutisch redeneren van onervaren voorschrijvers in de praktijk.
Therapeutisch redeneren (bruine kader)
Het eerste kleine maar belangrijke verschil in het samengestelde model in vergelijking met 
het eerder beschreven hypothetisch model van therapeutisch redeneren (figuur 2) is dat de 
‘P(ersoonlijke) therapieën’ specifiek gekoppeld zijn aan het analytische systeem 2, en ‘therapie 
scripts’ aan het non-analytische en intuïtieve systeem 1. In het hypothetische model van Bissesur 
waren ‘therapie scripts’ gekoppeld aan beide systemen. Echter, een ‘therapie script’  kan 
worden gedefinieerd als de intuïtieve herkenning van een combinatie van diagnose, specifieke 
patiënt factoren (bijvoorbeeld leeftijd, co morbiditeit, etc.), en de beste farmacotherapeutische 
behandeling in die specifieke situatie. Daarom passen ‘therapie scripts’ niet in het analytische 
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Figuur 4 | De huidige inzichten in hoe studenten en arts-assistenten leren medicatie voor te schrijven kan worden 
samengevat in een samengesteld model gebaseerd op drie afzonderlijke modellen, namelijk het normatieve 
rationale voorschrijf proces in de klinische praktijk (WHO 6 step), therapeutisch redeneren (bij ervaren en 
onervaren voorschrijvers) en context gebonden leren
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systeem waarbij therapeutische opties expliciet met elkaar worden vergeleken. Dit is in 
overeenstemming met eerder psychologisch onderzoek naar intuïtieve beslissingen door ervaren 
beslissers die onder druk werken in real life situaties (brandweercommandanten, paramedici en 
anderen die in een fractie van een seconde beslissingen moeten nemen tijdens het werk). Deze 
onderzoeken laten zien dat ervaren beslissers zelden moeten kiezen tussen verschillende opties 
omdat in de meeste gevallen alleen een enkele oplossingen opkomt in hun gedachten. Hoewel het 
niet uitgebreid onderzocht is, hebben we geen reden om aan te nemen dat de situatie anders is 
wanneer artsen intuïtieve therapeutische beslissingen nemen. 
Omdat onze hersenen een beperkte totale capaciteit hebben voor mentale inspanning, is 
intuïtieve besluitvorming van essentieel belang om iemand in staat te stellen te functioneren in 
een professionele omgeving waarbij complexe taken moeten worden uitgevoerd onder tijdsdruk. 
Bovendien wordt aangevoerd dat ervaren beslissers het vaak beter doen als ze hun intuïtie 
vertrouwen dan wanneer ze zich bezighouden met langzame analytische redeneer processen.  
Echter, intuïtieve besluitvorming is niet altijd vlekkeloos en wordt soms beïnvloed door cognitieve 
fouten of vooringenomenheid (bias). Daarom is één van de belangrijke taken van systeem 
2 (inspannend) het monitoren van de kwaliteit van beide systemen, inclusief de correctie 
van cognitieve fouten. In de cognitieve psychologie is dit proces van monitoren bekend als 
metacognitie (toegevoegd aan ons model en aangegeven met een blauwe pijl tussen systeem 1 en 
2) of ‘vertragen wanneer je moet’. 
Als we onszelf bewust zijn van de karakteristieken van systeem 1 en 2, is het natuurlijk de vraag 
of het farmacotherapie onderwijs zich moet focussen op systeem 1 of 2. Wij, evenals McLellan et 
al, pleiten ervoor dat het medisch onderwijs ervoor dient te zorgen dat studenten zoveel mogelijk 
experts worden in het voorschrijven van medicatie voordat ze afstuderen. Tot op heden, hebben 
de meeste farmacotherapeutische onderwijsinterventies zich altijd gericht op de ontwikkeling 
van het analytisch redeneer proces (systeem 2: langzaam, bewust, systematisch), bijvoorbeeld als 
onderdeel van de wereldwijd gebruikte WHO 6-step methode, in plaats van zich te focussen op 
het creëren van die leeromstandigheden die het therapeutisch redeneren als expert stimuleren.
Context gebonden leren (blauwe kader)
Het context gebonden leren kader is ideaal om te begrijpen welke leercondities de ontwikkeling 
van expertise stimuleren (d.w.z. rijk en gemakkelijk toegankelijke therapie scripts). Zoals 
beschreven in hoofdstuk 5, is context veel meer dan alleen de fysieke omgeving waarin het leren 
plaats vindt, en kunnen (klinische) docenten de leercontext met subtiele aanpassingen verrijken. 
Zoals geïllustreerd in figuur 4 door de groene pijl (tussen de WHO 6 step en de therapie scripts), is 
één van de manieren om therapie scripts te ontwikkelen doormiddel van het frequent trainen van 
voorschrijfvaardigheden (bijv. tijdens rollenspel trainingen) en het daarbij analytisch doorlopen 
van het WHO 6 stappen plan. Toch betogen we dat de meest effectieve manier, om rijke en 
makkelijk toegankelijke therapie scripts te ontwikkelen, is door te trainen in de echte praktijk 
met echte verantwoordelijkheid voor patiëntenzorg (toegevoegd aan het context gebonden 
leren model). In hoofdstuk 5, hebben we de toegevoegde waarde beschreven van deze echte 
verantwoordelijkheid tijdens de klinische training van voorschrijfvaardigheden. Ten slotte, hebben 
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we in hoofdstuk 6 laten zien dat de integratie van gestructureerde therapeutische consulten met 
echte verantwoordelijkheid voor patiëntenzorg in de coschappen zowel haalbaar als waardevol is. 
Conclusie
Het overlappende deel van de drie modellen laat zien dat therapie scripts en P(ersonal) treatment 
een cruciale rol spelen in hoe studenten leren om geneesmiddelen te kiezen voor individuele 
patiënten, zowel analytisch als non-analytisch. Wij pleiten ervoor dat de meest efficiënte manier 
om rijke en makkelijk toegankelijke therapie scripts te ontwikkelen is door het trainen in de 
echte praktijk zo vroeg als mogelijk tijdens het medisch onderwijs. Docenten moeten zich er 
bewust van zijn dat ogenschijnlijk kleine aanpassingen aan de leercontext tijdens het trainen van 
voorschrijfvaardigheden in de coschappen (d.w.z. met of zonder verantwoordelijkheid voor de 
patiëntenzorg) een relatief grote impact heeft op de ontwikkeling van voorschrijfvaardigheden. 
Het medisch onderwijs zou de ontwikkeling van de voorschrijfvaardigheden van studenten zo 
vroeg mogelijk moeten stimuleren, in ieder geval voor het eind van de master van het medisch 
curriculum, omdat net afgestudeerde artsen een groot deel van de medicatie voorschrijven in 
ziekenhuizen. Dit vereist rijke en makkelijk toegankelijke therapie scripts, die alleen bereikt kunnen 
worden door het opdoen van ervaring met het voorschrijven van medicatie voor echte patiënten. 
3. PrAkTISCHe IMPlICATIeS en TOekOMSTIGe PerSPeCTIeven vOOr HeT 
OnDerWIJS (In De klInISCHe PrAkTIJk), OnDerzOek en De OrGAnISATIe 
De studies in dit proefschrift onderzochten de mogelijkheden om het rationeel voorschrijven 
van medisch studenten te verbeteren tijdens een context gebonden farmacotherapie 
onderwijsprogramma gebaseerd op de WHO 6-step methode. Veel van de studies onderstrepen 
het belang van het begrijpen van succesvolle context gebonden onderwijs strategieën en de 
verschillen in het therapeutisch redeneren van ervaren en onervaren voorschrijvers, om de transitie 
van medisch student naar  arts-assistent te vergemakkelijken met betrekking tot de voorschrijf 
verantwoordelijkheden. We sluiten dit proefschrift af met een samenvatting van de praktische 
implicaties en toekomstige perspectieven van onze bevindingen voor het farmacotherapie 
onderwijs (in de klinische praktijk), het onderzoek en de organisatie. 
Onderwijs
1. Klinische docenten moeten zich er bewust van zijn dat medisch studenten hun therapie 
keuzes kopiëren tijdens de coschappen. Docenten moeten daarom expliciet de argumenten 
bespreken die achter hun medicatie keuze liggen, ondanks dat ze als experts deze keuze 
waarschijnlijk niet bewust en analytisch gemaakt hebben. Achterwaarts redeneren kan hen 
dan helpen om hun ’intuïtief’ gemaakte keuzes uit te leggen aan studenten. Dit kan ervoor 
zorgen dat er minder ‘verkeerde’ of ‘incomplete’ therapie scripts opgeslagen worden in het 
geheugen, wat zou kunnen leiden tot minder voorschrijffouten in de toekomst.  
2. Medisch onderwijs moet de ontwikkeling van therapeutisch (en diagnostisch) redeneren 
stimuleren bij studenten. Tot op heden zijn de meeste farmacotherapeutische onderwijs 
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interventies gericht op het stimuleren van de ontwikkeling van het analytisch redeneren (systeem 
2: niet expert, langzaam, bewust, inspannend, systematisch) in plaats van zich te focussen op het 
creëren van die leeromstandigheden die het therapeutisch redeneren als expert stimuleren. 
3. Studenten moeten de mogelijkheid krijgen om de volledige taak van het voorschrijven van 
medicatie te trainen in de complexe context van de praktijk en met verantwoordelijkheid 
voor patiëntenzorg. Dit leidt tot een snellere en betere ontwikkeling van rijkere en 
makkelijker beschikbare therapie scripts voordat medisch studenten daadwerkelijk 
voorschrijf verantwoordelijkheid hebben als arts-assistent. Docenten moeten zich er bewust 
van zijn dat ogenschijnlijk kleine aanpassingen aan de leercontext tijdens het trainen van 
voorschrijfvaardigheden in de coschappen (d.w.z. met of zonder verantwoordelijkheid voor 
de patiëntenzorg) een relatief grote impact kunnen hebben  op de voorschrijfvaardigheden 
van onze toekomstige artsen. Hoewel de studies in dit proefschrift zich met name richten op 
de training tijdens de coschappen, denken we dat het trainen van farmacotherapeutische 
vaardigheden met verantwoordelijk voor patiëntenzorg zo vroeg mogelijk zou moeten 
beginnen (vanaf het eerste jaar in het medisch curriculum). Een interessante methode om dit 
te kunnen bereiken is door studenten gerunde klinieken (SRC)  waarbij de lerende (de student) 
centraal staat (LC-SRC: learner-centred student-run clinic). Hierbij zijn teams van medisch 
studenten (1ste-5e jaar) verantwoordelijk  voor de therapeutische zorg van echte patiënten. 
Uit een recente systematische literatuur review naar de student uitkomsten na deelname 
aan door studenten gerunde klinieken, die veel voorkomen in Noord Amerika om zorg te 
verlenen aan onverzekerde patiënten, bleek dat studenten de vroege trainingsmogelijkheid 
waardeerden en dat de kwaliteit van zorg die geleverd werd in de klinieken goed was. Echter, er 
is  weinig bekend over het effect van deelname aan een SRC op de vaardigheden en kennis van 
studenten. In het VU medisch centrum is in 2013 een LC-SRC project op de polikliniek interne 
geneeskunde gestart (de eerste SRC met verzekerde patiënten) en een eerste pilot studie liet 
zien dat een LC-SRC in deze vorm uitvoerbaar bleek volgens studenten, patiënten en klinische 
supervisors. Op basis van dit voorlopige succes is het LC-SRC project recent uitgebreid met 
een aantal nieuwe initiatieven.  Zo is er onder andere gestart met  een door studenten gerund 
cardiovasculair risicomanagement programma in de universitaire huisartspraktijk en  een 
door studenten gerunde polikliniek voor de behandeling van schildklieraandoeningen. Tot 
slot is er ook een project gestart in samenwerking met het Nederlands Bijwerkingen Centrum 
Lareb waarbij studenten echte bijwerkingen meldingen die binnengekomen zijn bij Lareb 
beoordelen.  De effecten van al deze LC-SRC’s wordt op dit moment onderzocht. 
4. Indien nodig kan er extra structuur worden geboden om onervaren voorschrijvers te helpen 
rationeel voor te schrijven, bijvoorbeeld bij het vaststellen van therapeutische doelen 
en het vastleggen van therapeutische informatie in het patiëntendossier. SMART criteria 
kunnen een effectieve manier zijn om het stellen van therapeutische doelen te verbeteren. 
Dit  zou toegevoegd kunnen worden aan de volgende editie van de WHO Guide to Good 
Prescribing. Het op een gestructureerde manier vastleggen van therapeutische informatie 
in het patiëntendossier kan de medicatie veiligheid en de training van nieuwe generaties 
voorschrijvers verbeteren.  Daarom moet de noodzakelijkheid, optimale inhoud en het effect 
van het hebben van een gestructureerde sectie in het patiëntendossier bepaald gaan worden. 
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Toekomstig onderzoek
5. In dit hoofdstuk hebben we het samengestelde theoretische/conceptuele model (figuur 4) 
gepresenteerd dat de relatie beschrijft tussen het normatieve rationele farmacotherapeutische 
proces in de klinische praktijk (WHO 6 step), therapeutisch redeneren (bij ervaren en 
onervaren voorschrijvers) en context gebonden leren voorschrijven. Dit kader, dat gebruikt 
kan worden voor toekomstig onderzoek en onderwijs innovaties, geeft niet alleen inzicht 
in de relaties en de overlap tussen de drie bestaande modellen, maar helpt ook bij het 
identificeren van leemtes in ons begrip van het conceptuele model. Dit leidt onder andere 
tot de volgende onderzoeksvragen die in de toekomst beantwoord moeten gaan worden:  
• In hoeverre leidt leren in de echte praktijk met verantwoordelijkheid voor patiëntenzorg 
(bijv. in de LC-SRC) tot een versnelling in de ontwikkeling van rijke en makkelijk 
toegankelijke therapie scripts in het geheugen?
• Wat is de invloed van leren met verantwoordelijk voor patiëntenzorg in de aller vroegste 
fases van het medisch curriculum (bijv. het 1ste jaar)?
• Wat zijn de verschillen in therapeutisch redeneren tussen niet ervaren, gemiddeld 
ervaren en ervaren voorschrijvers van medicatie?
• Is metacognitie of ‘vertragen wanneer je moet’  train baar bij het nemen van 
therapeutische beslissingen?
• In hoeverre zal een gestructureerde bespreking van medicatie keuzes tussen artsen in 
opleiding en hun supervisors leiden tot betere (rijk en makkelijk toegankelijk) therapie 
scripts?
• Wat is de optimale inhoud en het effect van een gestructureerde sectie voor 
therapeutische informatie in het patiëntendossier? Is deze structuur nuttig voor 
onervaren voorschrijvers, zoals coassistenten en arts-assistenten in opleiding. 
Organisatie
6. Zoals beschreven in hoofdstuk 2, is het moeilijk om voldoende steun van beleidsmakers, zoals 
faculteitsbesturen, te krijgen voor een CPT curriculum. Om een succesvol, longitudinaal (jaar 
1-6) en geïntegreerd CPT curriculum te creëren,  is de inbreng van andere professionals, zoals 
artsen, apothekers en het lokale instituut voor onderwijs en opleiden nodig, omdat klinisch 
farmacologen hier niet alleen aan kunnen en zouden moeten werken. Maar het belangrijkste 
is de bijdrage van medisch studenten. Daarom is onze belangrijkste aanbeveling, met 
betrekking tot de organisatie van CPT onderwijs, om studenten een belangrijke rol te laten 
spelen bij het organiseren, uitvoeren en onderzoeken van CPT onderwijs. In veel Europese 
medische faculteiten zijn de afdelingen farmacologie en klinische farmacologie vaak klein en 
denken docenten  dat ze niet instaat zijn om een relatief arbeidsintensief context gebonden 
onderwijsprogramma in de farmacotherapie te kunnen verzorgen (bijv. rollenspel trainingen, 
werkgroepen,  door studenten gerunde klinieken, etc.). Dit ‘probleem’ kan opgelost worden 
door het actief betrekken van studenten bij het farmacotherapie onderwijs. De sectie 
Farmacotherapie, van de afdeling Interne geneeskunde in het VU medisch centrum, heeft 
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meer dan 20 jaar ervaring met actieve student participatie. Student assistenten spelen een 
belangrijke rol in het leveren van de energie en ideeën voor constante verandering en innovatie. 
De sectie Farmacotherapie organiseert onder andere een MAsterclass Farmacotherapie 
(MAF). De masterclass is voor gescoute studenten die bijzondere bekwaamheid hebben 
getoond tijdens de farmacotherapie trainingen en wordt geleid door drie studenten 
coördinatoren (die eerder de masterclass hebben gevolgd). Deelnemers worden getraind om 
onderwijs te geven volgens de WHO 6-step methode en krijgen daarnaast training in het 
lesgeven aan kleine groepen van de afdeling Docentprofessionalisering van het VUmc School 
of Medical Sciences. Deze participanten geven vervolgens farmacotherapie trainingen aan 
jongere jaar studenten (ten minste 1 jaar onder hen), onder supervisie en met coaching van 
ervaren docenten. De student docenten worden ook getraind door klinisch experts (zoals 
klinisch farmacologen, klinisch specialisten en apothekers) om hun kennis en therapeutisch 
redeneer vaardigheden te verdiepen met betrekking tot specifieke klinische casus. Naast 
expliciete training voor de lessen, worden er ook andere activiteiten georganiseerd voor 
de masterclass participanten, zoals verdiepende bijeenkomsten over drugs, toxicologie, 
doseren van medicatie bij patiënten met een verminderde nierfunctie en locatie bezoeken 
aan medicatie ontwikkelingsfaciliteiten. De centrale rol van studenten bij het organiseren, 
uitvoeren en onderzoeken van farmacotherapie onderwijs is een win-win situatie voor 
zowel de studenten als de faculteit (of afdelingen). Het biedt studenten de mogelijkheid 
om een dieper begrip te krijgen van de klinische farmacologie en het geven van onderwijs 
(inclusief onderzoek en ontwikkeling van onderwijs). Daarnaast voorziet het de afdeling van 
een constante stroom van nieuwe energie en bereidheid om het onderwijs te ontwikkelen 
en verbeteren met en voor studenten. Ten slotte geeft het op deze manier betrekken van 
studenten, bij alle facetten van het onderwijs, hen verantwoordelijkheid voor het omgaan 
met echte (onderwijs) problemen. Dit zal hopelijk leiden tot een generatie van artsen die 
gedurende hun hele carrière intrinsiek gemotiveerde docenten blijven. 
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DAnkWOOrD
Ik schrijf dit dankwoord vanuit Pahang’s Rainforest in Maleisië. Na drie uur varen in een long-tail 
boot over de laagstaande Tembeling rivier kom je bij het nationale park Taman Negara. Dit park 
bestaat uit een bijzonder tropisch regenwoud en is meer dan 130 miljoen jaar oud. Het is daarmee 
een van de oudste regenwouden ter wereld en bijvoorbeeld veel ouder dan de Amazone. Het 
regenwoud doet vanavond zijn naam eer aan, de regen klettert op het dak van ons houten chalet. 
Als het wat zachter gaat regenen aan het begin van de nacht, is het enige wat je verder hoort 
het ‘oorverdovende’ maar heerlijke constante geknisper en getsjirp van de insecten in de jungle. 
Absoluut een heerlijke achtergrond voor het schrijven van dit dankwoord.
De afgelopen 2 maanden heb ik de rust gevonden en de ruimte gekregen om mijn proefschrift 
af te ronden waar ik de afgelopen jaren  hard en met ongelofelijk veel plezier aan gewerkt heb 
naast (en soms ook tijdens) mijn fulltime baan bij de sectie Farmacotherapie. Nu ik terugkijk op 
de afgelopen jaren overheerst een trots en vooral ook dankbaar gevoel voor de ontwikkeling die 
ik door heb mogen maken.
Uiteraard lukt dit niet alleen en ik prijs mijzelf dan ook gelukkig met alle mensen om mij heen die 
ieder op hun eigen manier mij gestimuleerd, gepusht, geholpen en altijd maar weer belangstelling 
getoond hebben of soms juist de ruimte hebben geboden om het er gewoon even lekker niet over 
te hebben. Een aantal van deze mensen wil ik in het bijzonder noemen.
Prof. dr. De Vries, promotor. Beste Theo, ondertussen bijna 15 jaar geleden mocht ik samen met 3 
vrienden komen werken als student assistent bij jou. Achteraf gezien heeft dit ‘farmacotherapie 
avontuur’ dat begon als ‘bijbaantje’ een enorme impact gehad op mijn ontwikkeling als persoon en 
daarmee ook op mijn leven. Ik kan wel zeggen dat ik ondertussen vergroeid ben geraakt met het 
farmacotherapie onderwijs en daar heb ik nog geen seconde spijt van gehad. Theo bedankt voor de 
vriendschap, de wijze raad wanneer nodig, de fascinerende real life lessen in ‘pharmaco-politics’, de 
passie voor het farmacotherapie onderwijs,  de ruimte om creatief te mogen zijn ook als dit betekent 
dat je buiten de gebaande paden moet gaan, het rotsvaste vertrouwen, en alle kansen die je mij 
hebt gegeven in de afgelopen jaren. Dit proefschrift is wat mij betreft de perfecte bekroning van 
onze samenwerking de afgelopen 15 jaar en een mooie afspiegeling van onze gedeelde passie voor 
en visie op het farmacotherapie onderwijs. Ik ben er super trots op om jouw (waarschijnlijk) laatste 
promovendus te zijn!
Dr Richir, copromotor. Beste Milan, jij was een van de 3 vrienden waarmee voor mij het 
‘farmacotherapie avontuur’ begonnen is. We zijn overigens al vrienden sinds de allereerste 
colleges die we samen volgden op de allerlaatste rij links achterin FG-1. Daarnaast ben je de 
allerbeste copromotor geweest die ik me had kunnen wensen. Je was altijd geduldig, op de juiste 
momenten ‘boos’, altijd bereid om te overleggen, zeer gefocust op de juiste ‘flow’ in de artikelen 
en altijd positief en stimulerend tijdens het hele traject. Milan, ik kan je waarschijnlijk nooit 
genoeg bedanken voor alles wat je voor me betekent hebt, dus je zult het moeten doen met nog 
eens minstens 40 tot 50 jaar vriendschap!
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De leden van de leescommissie, prof. dr. G. Croiset, prof. dr. T. Dornan, prof. dr. T. van Gelder, prof. 
dr. H. de Vries, dr. C. Kramers en dr M.A. van Agtmael wil ik graag bedanken dat ze de tijd en moeite 
genomen hebben om mijn proefschrift te beoordelen. 
Uiteraard wil ik ook graag alle studenten, coassistenten, arts-assistenten, huisartsen en specialisten 
bedanken die op allerlei verschillende manieren hebben deelgenomen aan de onderzoeken. 
Zonder jullie deelname was dit proefschrift er in ieder geval nooit geweest.
Iedereen die de sectie farmacotherapie kent, weet dat dit een hele bijzondere en vaak ‘jonge’ club 
mensen is met een gedeelde passie voor het farmacotherapie onderwijs. Het is voor mij de plek 
waar ik mezelf thuis en gewaardeerd voel. Er heerst een bijzondere en aanstekelijk enthousiaste 
sfeer die gekenmerkt wordt door altijd willen vernieuwen, het geven van verantwoordelijkheid 
aan vaak jonge mensen en studenten, saamhorigheid, en de bereidheid om eventuele problemen 
altijd als team te willen oplossen. Ik ben er trots op dat we samen zo’n hecht team vormen, want 
dit is zeker niet overal gemeengoed. Iedereen van de sectie waar ik de afgelopen jaren mee samen 
gewerkt heb, bedankt! Een aantal mensen van de sectie wil ik in relatie tot het proefschrift nog in 
het bijzonder noemen. Sinds een paar jaar is Michiel het nieuwe hoofd van de sectie geworden 
na het pensioen van Theo. Ondanks dat het zeker niet altijd makkelijk is om sectiehoofd te zijn 
van een club met zo’n bijzondere structuur als die van ons, weet ik dat dat je met ongelofelijk 
veel plezier leiding aan dit ‘zootje ongeregeld’ geeft. Michiel, dank je wel voor de manier 
waarop je de sectie overgenomen hebt, voor het vertrouwen in mij en voor alle steun, ruimte, 
aansporingen en duwtjes om het proefschrift echt af te ronden. Lieke wordt altijd omschreven 
als de ‘mama’ van de sectie en eigenlijk is dat een perfecte omschrijving voor jouw onmisbare, 
centrale en stabiele rol binnen de verder nogal vluchtige bezetting. Ik waardeer (zoals je weet) 
onze jarenlange samenwerking, ons regelmatige overleg waarbij ik altijd met een veel te lange 
to do list naar buiten loop, jouw welgemeende betrokkenheid en jouw loyaliteit heel erg. Dus 
dank je wel Lieke! Ton, ondanks dat je sinds kort met pensioen bent gegaan noem ik jou toch 
bij de sectie, omdat je daar wat mij betreft gewoon nog steeds bij hoort. Ik heb jarenlang met 
jou samengewerkt en wat mij betreft was jij met jouw ‘eeuwige’ bereidheid om in te vallen bij 
problemen de verpersoonlijking van het teamgevoel binnen de sectie. Wat betreft het onderzoek 
heb je in dit proefschrift een essentiële rol gespeeld bij het opzetten van het farmacotherapie 
onderwijs in de coschappen. Dit heeft uiteindelijk geleid tot een aantal mooie publicaties die nu de 
kern vormen van dit proefschrift. Uiteindelijk heeft dit jarenlange ‘geflirt’ met de afdeling interne 
geneeskunde er zelfs toe geleid dat de sectie onderdeel is geworden van die afdeling. Iedereen bij 
de afdeling interne geneeskunde heel erg bedankt voor het warme welkom en het DB dank dat 
jullie de filosofie van onze sectie zo waarderen en steunen. Daarnaast wil ik de afdeling interne 
geneeskunde (i.h.b. Abel, Prabath, Mark, Jos, Sven, Frank en Frans) ook bedanken voor het altijd 
bereid zijn om nieuwe onderwijsprojecten uit te proberen. Zonder jullie was het onmogelijk om de 
studies in hoofdstuk 4, 5 en 6 uit te voeren. 
Ninja en Jane dank voor jullie hulp bij respectievelijk de statistiek en het corrigeren op soms UK 
en dan weer US Engels afhankelijk van de thuisbasis van het tijdschrift. Voor beiden geldt dat jullie 
altijd een stapje verder meedenken dan je misschien eigenlijk zou mogen verwachten. Ik heb hier 
altijd heel erg veel aan gehad dus dank daarvoor allebei! Tot slot excuus voor de altijd onmogelijke 
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deadlines, waardoor er soms zelfs nog op de ochtend voor het geven van een praatje op een 
congres powerpoint-slides heen en weer gestuurd moesten worden.
Alle medeauteurs van de artikelen in dit proefschrift (Coen, Sjoerd, David, Ton, Abel, Prabath, 
Robert, Pieter, Erik, Ninja, Hans, Harm, Frank, Sven, Michiel, Milan en Theo) wil ik heel erg 
bedanken voor de hun rol bij het schrijven van de artikelen, het verzamelen van de data of het 
analyseren en interpreteren hiervan. Het heeft soms ‘even’ geduurd, maar het is ons gezamenlijk 
mooi gelukt om alle artikelen van dit proefschrift in goede tijdschriften gepubliceerd te krijgen! 
De afgelopen jaren is een deel van de onderzoek focus komen te liggen op landelijke en Europese 
onderzoeksprojecten naar farmacotherapie onderwijs. In Nederland werk ik als voorzitter van 
de landelijke NVKF&B COZ werkgroep onderzoek van onderwijs met heel erg veel plezier samen 
met mede enthousiastelingen en werkgroep leden Karen, Floris, Robert en Milan. Daarnaast wil 
ik iedereen bedanken van de werkgroep landelijke eindtoets medicatieveiligheid onder leiding van 
Kees en iedereen van de landelijke werkgroep Onderwijs van de NVKF&B onder leiding van Robert 
voor het enthousiaste deelnemen aan alle lopende onderzoeksprojecten. 
A special thanks to all the (new and old) board members of the workgroup Education of the 
EACPT for their support in the creation of a European research network on CPT education. The 
first research project in 17 different countries has been successful and the second larger research 
project with more than 150 different universities is currently being executed. 
De meeste van mijn vrienden ken ik al heel erg lang. Ondanks dat ik altijd opensta voor nieuwe 
dingen in het leven, zijn lange vriendschappen een van de vastigheden in mijn leven waar ik zeer 
aan hecht. Roel, Peter, Coen en Milan, zoals Peter laatst ook al omschreef in het dankwoord van 
zijn proefschrift kijk ik ook altijd erg uit naar onze ‘bourgondische’ etentjes in hippe restaurantjes 
in Noord en uiteraard ook naar onze ‘mannen’ wintersport. Voor komend seizoen staat begin 
maart al een week geblokt in onze agenda’s. Heel veel zin in! 
Menno, wij zijn al vrienden sinds de middelbare school en sinds ons samenwonen is onze band 
alleen maar hechter geworden. We hebben altijd heerlijke avondjes waarbij werkelijk alles 
besproken wordt. Mijn proefschrift is nu af, dus binnenkort weer een etentje?
Guus, Danny, Rein, Remco en George al jaren hebben we 1 keer per jaar een fantastische 
traditie, namelijk een mannenweekend naar de WK rally in Trier Duitsland. Zoals jullie 
weten hou ik helemaal niet van auto’s, maar dit super gezellige weekend in augustus met 
braadworsten op de barbecue tussen de wijnranken aan de Moezel wil ik absoluut niet 
missen. Al is het alleen maar vanwege de goddelijke broodjes döner van onze favoriete Imbiss 
Antalya in Hermeskeil, die we dan ook minstens 3 keer halen in dat weekend. We noemen 
onszelf ook wel de ‘eetclub’ als alle vrouwen en vriendinnen erbij zijn. In dat geval koken we 
uitgebreid thuis met een goed flesje wijn of gaan we decadent uit eten bij Mario (als er een 
groupon actie is). 
Met de grote groep vrienden en vriendinnen, die ik maar de ‘vriendenclub van vv DZS’ noem, is 
het altijd gezellig, of het nou op zaterdag in de kantine is, op een feestje thuis, op een feestweek 
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in Neck of de Beemsterkermis, in de kroeg of met een deel zelfs op een techno feestje. Als je zin 
hebt in een feestje moet je hier zijn.
Teamgenoten van DZS 3. Het is heerlijk om 3x per week met jullie te kunnen voetballen. Sinds 
twee jaar spelen we samen in het 3e elftal en ik ben er trots op de oudste speler (door sommigen 
ook wel omschreven als ‘de vedette’) te zijn van dit nu al binnen en buiten het veld legendarische 
DZS team (derde helft, teamuitjes met bowlingballen, ziekenhuisopnames en ‘Will Grigg’s on fire’). 
Lieve pa en ma, familie en schoonfamilie dank voor al jullie liefde, gezelligheid als we samen zijn, 
vertrouwen in de goede afloop, belangstelling en ‘eeuwige’ geduld. Pa en ma, jullie hebben mij 
altijd meegegeven dat ik alles kon worden en bereiken wat ik wilde, zolang ik er maar gelukkig van 
werd. Bedankt dat jullie altijd achter me staan! Al mijn opa’s en oma’s leven niet meer, maar ik 
weet zeker dat die net als jullie ook apetrots zouden zijn. 
En tot slot de vrouw en liefde van mijn leven Roos. Al meer dan 15 jaar ben ik gek op ‘aardbeien’ 
(jou) en zijn we een fantastisch ‘team’ zoals jij dat altijd noemt. De afgelopen jaren hebben we 
genoten van al het moois dat het leven te bieden heeft. We hebben met z’n tweetjes veel van de 
wereld gezien en op menig (techno)feestje en festival gedanst tot in de late uurtjes. Je accepteert 
en steunt me altijd, ook als ik weer iets mafs bedacht heb en ook als het allemaal even iets langer 
duurt dan gepland. Voorlopig is deze verre reis naar Maleisië de laatste die we met zijn tweetjes 
zullen maken al was dat met zijn tweeën eigenlijk al niet meer waar. Ik heb net als jij ongelofelijk 
veel zin in het grootste avontuur dat we tot nu toe aan gaan! 
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